Investigating the epidermal Notch activation during wound healing and the consequences of prolonged Notch activity during skin wound healing by BOROUMAND, SOULMAZ
Durham E-Theses
Investigating the epidermal Notch activation during
wound healing and the consequences of prolonged Notch
activity during skin wound healing
BOROUMAND, SOULMAZ
How to cite:
BOROUMAND, SOULMAZ (2014) Investigating the epidermal Notch activation during wound healing and
the consequences of prolonged Notch activity during skin wound healing, Durham theses, Durham
University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/10785/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Oﬃce, Durham University, University Oﬃce, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
2
 Investigating the epidermal Notch activation during 
wound healing and the consequences of prolonged 
Notch activity during skin wound healing 
 
Soulmaz Boroumand 
PhD Thesis 
 
School of Biological and  
Biomedical Sciences 
Durham University 
 
March 2014 
 
 
 
  
 2 
Declaration 
I declare that this thesis is my own work and that I have correctly acknowledged the 
work of others. This submission is in accordance with University and school on good 
academic conduct. 
I certify that no part of the material offered has been previously submitted by me for a 
degree or other qualification in this or any other university. 
 
 
 
Soulmaz Boroumand  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Table of Contents 
1	   INTRODUCTION	  ......................................................................................................................	  14	  1.1	   THE	  SKIN	  ...............................................................................................................................................	  14	  1.2	   SKIN	  STRUCTURE	  .................................................................................................................................	  14	  1.3	   EPIDERMIS	  ............................................................................................................................................	  16	  
1.3.1	   Basal	  layer	  .....................................................................................................................................	  16	  
1.3.2	   Spinous	  layer	  ................................................................................................................................	  17	  
1.3.3	   Granular	  cell	  layer	  .....................................................................................................................	  17	  
1.3.4	   Cornified	  layer	  .............................................................................................................................	  17	  
1.3.5	   Epidermal	  T-­‐cells	  ........................................................................................................................	  17	  
1.3.6	   Epidermal	  appendages	  ............................................................................................................	  18	  1.4	   BASEMENT	  MEMBRANE	  ......................................................................................................................	  18	  1.5	   DERMIS	  ..................................................................................................................................................	  20	  
1.5.1	   Extracellular	  matrix	  ..................................................................................................................	  20	  
1.5.2	   Connective	  tissue	  cells	  ..............................................................................................................	  21	  1.6	   HYPODERMIS	  ........................................................................................................................................	  21	  1.7	   EPIDERMAL	  STEM	  CELLS	  ....................................................................................................................	  21	  1.8	   WOUND	  HEALING	  .................................................................................................................................	  22	  
1.8.1	   Hemostasis	  .....................................................................................................................................	  25	  
1.8.2	   Inflammation	  ...............................................................................................................................	  25	  
1.8.3	   Proliferation	  .................................................................................................................................	  29	  
1.8.4	   Remodeling	  ...................................................................................................................................	  32	  1.9	   SKIN	  WOUND	  HEALING	  .......................................................................................................................	  33	  
1.9.1	   Epidermal	  wound	  healing	  ......................................................................................................	  35	  
1.9.2	   Dermal	  wound	  healing	  .............................................................................................................	  37	  
1.9.3	   Connective	  tissue	  repair	  ..........................................................................................................	  37	  1.10	   FACTORS	  THAT	  EFFECT	  WOUND	  HEALING	  ....................................................................................	  40	  
1.10.1	   Enhanced	  inflammatory	  responses	  ..................................................................................	  40	  
1.10.2	   Altered	  growth	  factor	  production	  and/or	  signaling	  ................................................	  41	  1.11	   FURTHER	  EFFECTIVE	  LOCAL	  FACTORS	  DURING	  WOUND	  HEALING	  ...........................................	  42	  
1.11.1	   Enhanced	  proteinase	  activity	  .............................................................................................	  42	  
1.11.2	   Pressure	  and	  Tension	  .............................................................................................................	  43	  1.12	   INTRODUCTION	  TO	  NOTCH	  SIGNALING	  .........................................................................................	  43	  
1.12.1	   Notch	  history	  .............................................................................................................................	  44	  1.13	   THE	  NOTCH-­‐PATHWAY	  PARTICIPANTS,	  STRUCTURE	  AND	  FUNCTION	  .....................................	  45	  
 4 
1.13.1	   Notch	  receptors	  ........................................................................................................................	  45	  
1.13.2	   Notch	  Ligands	  ...........................................................................................................................	  47	  
1.13.3	   Nuclear	  effectors	  ......................................................................................................................	  47	  1.14	   NOTCH	  SIGNALING	  CASCADE	  ...........................................................................................................	  47	  
1.14.1	   Proteolytic	  cleavages	  of	  Notch	  ...........................................................................................	  50	  
1.14.2	   Notch-­‐ligand	  activity	  .............................................................................................................	  50	  
1.14.3	   Notch	  target	  genes	  ..................................................................................................................	  52	  
1.14.4	   Termination	  of	  Notch	  signaling	  ........................................................................................	  52	  1.15	   NOTCH1	  AND	  NOTCH2	  ASSOCIATION	  ...........................................................................................	  53	  1.16	   NOTCH	  SIGNALING	  FUNCTION	  .........................................................................................................	  54	  
1.16.1	   Notch	  Signaling	  and	  embryogenesis	  ...............................................................................	  54	  
1.16.2	   Notch	  signaling	  and	  systematic	  development	  .............................................................	  55	  
1.16.3	   Notch	  and	  Regulation	  of	  tissue	  homeostasis	  in	  adults	  ............................................	  55	  1.17	   NOTCH	  AND	  SKIN	  ...............................................................................................................................	  56	  
1.17.1	   Sites	  of	  activated	  Notch	  pathway	  in	  developing	  and	  adult	  skin	  .........................	  59	  
1.17.2	   Postnatal	  maintenance	  of	  the	  epidermis	  and	  Notch	  receptors	  ...........................	  61	  1.18	   NON-­‐CELL	  AUTONOMOUS	  EFFECTS	  OF	  NOTCH	  IN	  SKIN	  ..............................................................	  62	  1.19	   NOTCH	  NON-­‐AUTONOMOUS	  EFFECTS	  AND	  INFLAMMATORY	  RESPONSES	  ...............................	  62	  1.20	   NOTCH	  SIGNALING	  AND	  WOUND	  HEALING	  ...................................................................................	  64	  1.21	   HYPOTHESES	  ......................................................................................................................................	  66	  
2	   MATERIALS	  &	  METHODS	  .....................................................................................................	  67	  2.1	   MICE	  .......................................................................................................................................................	  67	  2.2	   DERMAL	  WOUNDS	  AND	  QUANTIFICATION	  OF	  HEALING	  ................................................................	  68	  2.3	   HISTOLOGY	  ............................................................................................................................................	  70	  
2.3.1	   Hemotoxylin	  and	  Eosin	  (H&E)	  staining	  ............................................................................	  70	  
2.3.2	   Elastic	  Tissue	  Fibers	  -­‐Verhoeff’s	  Van	  Gieson	  (EVG)	  staining	  ...................................	  71	  2.4	   IMMUNOHISTOCHEMISTRY	  .................................................................................................................	  71	  
2.4.1	   Antigen	  retrieval	  .........................................................................................................................	  71	  
2.4.2	   Antibody	  incubation	  and	  antigen	  visualisation	  ............................................................	  72	  
2.4.3	   Confocal	  Microscopy	  .................................................................................................................	  72	  2.5	   PROTEIN	  ANALYSIS	  SDS-­‐PAGE	  AND	  WESTERN	  BLOTTING	  .......................................................	  74	  
2.5.1	   Tissue	  preparation	  .....................................................................................................................	  74	  
2.5.2	   Bicinchoninic	  Acid	  Protein	  Assay	  ........................................................................................	  75	  
2.5.3	   Denaturation	  and	  reduction	  of	  protein	  ............................................................................	  75	  
2.5.4	   Gel	  electrophoresis	  .....................................................................................................................	  75	  
2.5.5	   Coomassie	  blue	  staining	  ..........................................................................................................	  77	  
 5 
2.5.6	   Transfer	  of	  protein	  bands	  from	  gel	  onto	  PVDF	  membrane	  ......................................	  77	  
2.5.7	   Visualization	  of	  all	  separated	  proteins	  after	  migration	  ............................................	  78	  
2.5.8	   Blocking	  of	  the	  PVDF	  membranes	  .......................................................................................	  79	  
2.5.9	   Antibody	  staining	  .......................................................................................................................	  80	  
2.5.10	   Detection	  and	  Band	  Density	  Analysis	  .............................................................................	  82	  2.6	   MOLECULAR	  BIOLOGY	  TECHNIQUE	  ..................................................................................................	  82	  
2.6.1	   Total	  RNA	  isolation	  ...................................................................................................................	  82	  
2.6.2	   Quantification	  and	  purity	  of	  RNA	  ........................................................................................	  83	  
2.6.3	   Assessment	  of	  RNA	  quality	  .....................................................................................................	  84	  
2.6.4	   cDNA	  synthesis	  .............................................................................................................................	  84	  
2.6.5	   Q-­‐PCR	  ...............................................................................................................................................	  86	  
2.6.6	   qPCR	  primer	  validation	  ...........................................................................................................	  86	  
2.6.7	   Quantitative	  polymerase	  chain	  reaction	  (QPCR)	  .........................................................	  87	  
3	   NOTCH	  SIGNALING	  ACTIVATION	  DURING	  NORMAL	  SKIN	  WOUND	  HEALING	  ....	  89	  3.1	   INTRODUCTION	  ....................................................................................................................................	  89	  3.2	   EXPERIMENTAL	  PLAN	  .........................................................................................................................	  94	  
3.2.1	   Dermal	  Wounds	  and	  Quantification	  of	  Healing	  ............................................................	  94	  
3.2.2	   Epidermal	  Notch	  activation	  via	  a	  4OHT-­‐inducible	  transgene	  ...............................	  96	  3.3	   RESULTS	  ................................................................................................................................................	  98	  
3.3.1	   Histological	  analyses	  of	  normal	  Skin	  Wound	  Healing	  ...............................................	  98	  
3.3.2	   The	  Notch	  signalling	  pathway	  is	  activated	  in	  wound	  healing	  ..............................	  101	  
3.3.3	   Transcription	  of	  Notch	  family	  genes	  during	  wound	  healing	  .................................	  109	  
3.3.4	   Notch2	  activation	  in	  response	  to	  forced	  epidermal	  Notch	  activity	  via	  the	  
K14NICDER	  transgene	  ...........................................................................................................................	  112	  3.4	   DISCUSSION	  ........................................................................................................................................	  116	  
4	   THE	  TIMING	  AND	  DURATION	  OF	  NOTCH	  ACTIVITY	  IMPACTS	  WOUND	  CLOSURE	  
AND	  INFLAMMATORY	  CELL	  RECRUITMENT.	  ....................................................................	  122	  4.1	   INTRODUCTION	  .................................................................................................................................	  122	  4.2	   CHRONIC	  WOUNDS	  ............................................................................................................................	  123	  4.3	   MECHANISMS	  INVOLVED	  IN	  CHRONIC	  WOUND	  FORMATION	  .....................................................	  123	  4.4	   NOTCH	  SIGNALLING	  AND	  IT’S	  INTERACTIONS	  WITH	  INFLAMMATION	  .....................................	  125	  4.5	   EXPERIMENTAL	  PLAN	  ......................................................................................................................	  130	  4.6	   RESULTS	  .............................................................................................................................................	  132	  
4.6.1	   Persistent	  Notch	  signalling	  results	  in	  delayed	  cutaneous	  wound	  healing	  ......	  132	  
 6 
4.6.2	   The	  proliferation	  of	  basal	  cells	  decreased	  with	  respect	  to	  over-­‐activation	  of	  
Notch	  signalling	  .......................................................................................................................................	  138	  
4.6.3	   Additional	  macrophage	  infiltration	  as	  an	  effect	  of	  over-­‐inflammation	  ...........	  141	  
4.6.4	   Q-­‐PCR	  analysis	  ...........................................................................................................................	  144	  
4.6.5	   Accumulation	  of	  dermal	  MMP1	  as	  a	  result	  of	  over-­‐activation	  of	  Notch	  
signalling	  .....................................................................................................................................................	  161	  4.7	   DISCUSSION	  ........................................................................................................................................	  163	  
5	   DIFFERENT	  RATE	  OF	  HEALING	  ON	  WOUNDS	  LOCATED	  AT	  DIFFERENT	  
ANATOMIC	  REGIONS	  OF	  THE	  MOUSE	  BODY	  ......................................................................	  170	  5.1	   INTRODUCTION	  .................................................................................................................................	  170	  5.2	   EXPERIMENTAL	  PLAN	  ......................................................................................................................	  172	  5.3	   RESULTS	  .............................................................................................................................................	  174	  
5.3.1	   Anterior	  and	  mid-­‐region	  wound	  healing	  was	  delayed	  compared	  with	  posterior	  
wounds	  in	  mice	  back	  skin	  .....................................................................................................................	  174	  
5.3.2	   The	  delayed	  re-­‐epithelialisation	  in	  upper	  and	  middle	  body	  wounds	  may	  be	  a	  
result	  of	  decreased	  keratinocyte	  proliferation	  ...........................................................................	  180	  
5.3.3	   No	  Changes	  in	  the	  Notch1	  activity	  at	  different	  regional	  wounds	  .......................	  183	  
5.3.4	   No	  detectable	  change	  in	  production	  of	  inflammatory	  cytokines	  in	  wounds	  at	  
different	  regions	  .......................................................................................................................................	  185	  
5.3.5	   SM22	  expression	  and	  local	  MMP-­‐1	  differ	  at	  different	  location	  ............................	  191	  5.4	   DISCUSSION	  ........................................................................................................................................	  195	  
6	   GENERAL	  DISCUSSION	  .......................................................................................................	  198	  6.1	   FURTHER	  RESEARCH	  ........................................................................................................................	  202	  
7	   REFERENCES	  .........................................................................................................................	  206	  	  	  	  	  	  	  	  	  	  
 
 7 
List of Figures  
Figure	  1.1	  Diagram	  of	  human	  skin	  structure.	  .............................................................................................................	  15	  
Figure	  1.2	  Epidermal	  layers	  and	  skin	  stem	  cells.	  .......................................................................................................	  19	  
Figure	  1.3.	  Wound	  healing	  phases.	  ...................................................................................................................................	  24	  
Figure1.4.Wound	  healing	  during	  Inflammation	  phase	  (3	  days	  after	  injury).	  ...............................................	  27	  
Figure	  1.5.The	  production	  of	  bioactive	  mediators	  by	  macrophages.	  ................................................................	  28	  
Figure	  1.6.	  Wound	  healing	  during	  Proliferation	  phase	  (5	  days	  after	  injury).	  ...............................................	  30	  
Figure	  1.7.	  The	  orchestrated	  sequence	  of	  events	  in	  response	  to	  skin	  injury.	  .................................................	  34	  
Figure1.8.Epidermal	  wound	  healing.	  ..............................................................................................................................	  36	  
Figure1.9.	  Dermal	  wound	  healing.	  ...................................................................................................................................	  39	  
Figure1.10.Canonical	  regulators	  of	  Notch	  signaling.	  ...............................................................................................	  46	  
Figure	  1.	  11.Core	  Notch	  signaling	  pathway.	  ................................................................................................................	  49	  
Figure.1.12.	  Diagram	  of	  Notch	  protein	  and	  the	  proteolytic	  cascade	  of	  Notch	  activation.	  ......................	  51	  
Figure1.13.	  Notch1	  function	  in	  epidermis.	  ....................................................................................................................	  58	  
Figure	  1.14.Expression	  of	  Notch	  ligands	  and	  receptors.	  .........................................................................................	  60	  
Figure 2.1 The	  constract	  that	  was	  made	  of	  NICD	  was	  in	  to	  the	  Keratin14	  (K14)	  promoter	  cassette.68	  
Figure	  2.2.Schematic	  diagram	  of	  the	  punch	  wounds	  model.	  ................................................................................	  69	  
Figure	  2.	  3.	  Intact	  RNA.	  ..........................................................................................................................................................	  84	  
Figure	  2.4	  Summery	  of	  cDNA	  synthesis,	  using	  a	  Superscript	  III	  first-­‐strand	  synthesis	  kit	  (Invitrogen)
	  ..........................................................................................................................................................................................................	  85	  
Figure	  3.1.	  Characterisation	  of	  K14NICDER	  transgenic	  mice.	  .............................................................................	  92	  
Figure	  3.2	  Experimental	  plan1.	  ..........................................................................................................................................	  95	  
Figure	  3.3.	  Experimental	  plan	  2	  ........................................................................................................................................	  97	  
Figure	  3.4.	  Representative	  histological	  features	  of	  cutaneous	  wound	  healing	  in	  mice..	  ..........................	  99	  
Figure	  3.5.	  Epithelial	  thickness	  at	  wound	  site.	  .........................................................................................................	  100	  
Figure	  3.6.	  Notch1	  and	  Notch2	  are	  activated	  in	  response	  to	  an	  injury	  in	  skin.	  .........................................	  102	  
Figure	  3.7	  Quantified	  levels	  of	  activation	  Notch1	  during	  skin	  wound	  healing.	  .........................................	  103	  
Figure	  3.8	  Quantified	  levels	  of	  activation	  Notch2	  during	  skin	  wound	  healing.	  .........................................	  105	  
Figure	  3.9	  Quantified	  levels	  of	  full-­‐length	  Jagged1	  during	  skin	  wound	  healing.	  ......................................	  107	  
Figure	  3.10.	  Jagged1	  involved	  in	  skin	  wound	  healing.	  ..........................................................................................	  108	  
Figure	  3.11.	  Relative	  Notch1	  and	  Notch2	  expression	  detected	  by	  qPCR.	  .....................................................	  110	  
Figure	  3.12.	  Relative	  Jagged1	  mRNA	  levels	  detected	  by	  qPCR.	  .........................................................................	  111	  
Figure 3.13 in	  absence	  of	  physical	  damage	  if	  Notch2	  was	  activated	  in	  a	  jagged1-­‐dependent	  
mechanism	  in	  K14NICDER	  transgenic	  mice	  ..............................................................................................................	  112	  
Figure	  3.14	  Forced	  epidermal	  Notch1	  activity	  via	  the	  K14NICDER	  transgene,	  results	  in	  activation	  of	  
Notch2.	  .......................................................................................................................................................................................	  114	  
Figure	  3.15.	  Notch2	  activation	  in	  K14NICDER	  is	  a	  Jagged-­‐1	  dependent	  mechanism.	  ............................	  115	  
Figure	  3.16:	  Notch	  signalling	  activation	  in	  the	  skin	  during	  the	  wound	  healing.	  ......................................	  119	  
 8 
Figure	  4.1	  Mechanisms	  involved	  in	  the	  development	  and	  persistence	  of	  chronic	  wounds	  ...................	  125	  
Figure	  4.2.	  Experimental	  plan.	  ........................................................................................................................................	  131	  
Figure	  4.3.	  Full-­‐thickness	  dermal	  wounds	  were	  created	  on	  back	  skin	  of	  K14NICDER	  mice	  and	  wild	  
type	  mice	  ...................................................................................................................................................................................	  133	  
Figure	  4.4.	  Wound	  sizes	  percentage	  at	  the	  indicated	  time	  points	  in	  K14NICDER	  and	  wild	  type	  mice.
	  .......................................................................................................................................................................................................	  134	  
Figure	  4.5.	  Histological	  features	  of	  wound	  healing	  in	  mice	  with	  increased	  Notch	  activity	  and	  wild	  
type.	  .............................................................................................................................................................................................	  136	  
Figure	  4.6	  Epidermal	  thicknesses	  in	  control	  and	  4OHT-­‐treated	  wild-­‐type	  and	  K14NICDER	  mice,	  ..	  137	  
Figure	  4.7	  Activation	  of	  Notch	  signalling	  before	  wounding	  caused	  delayed	  wound	  healing	  coincident	  
with	  a	  delay	  in	  epidermal	  proliferation.	  .....................................................................................................................	  139	  
Figure	  4.8.	  A	  graph	  to	  show	  percentage	  of	  total	  cells	  which	  were	  Ki67	  positive	  epidermal	  cells	  within	  
500	  μm	  of	  wound	  site.	  .........................................................................................................................................................	  140	  
Figure	  4.9.	  5dpw	  back	  skin	  tissues	  were	  sectioned	  and	  stained	  with	  an	  antibody	  to	  F4/80	  antigen	  
(green)	  and	  (Blue)	  DAPI	  counterstained	  ....................................................................................................................	  142	  
Figure	  4.10.	  F4/80	  positive	  dermal	  cells,	  as	  a	  percentage	  of	  total	  cells	  counted,	  in	  wild	  type	  animals	  
compared	  to	  K14NICDER	  mice	  from	  both	  treatment	  groups	  5	  days	  post	  wounding	  .............................	  143	  
Figure	  4.11.	  Relative	  Notch1	  mRNA	  level	  ...................................................................................................................	  145	  
Figure	  4.12.	  Relative	  2	  mRNA	  level	  ...............................................................................................................................	  146	  
Figure	  4.13.	  Relative	  Jagged1	  mRNA	  level	  .................................................................................................................	  147	  
Figure	  4.14.	  Relative	  TGFβ	  mRNA	  level	  .......................................................................................................................	  149	  
Figure	  4.15.	  Relative	  TNF-­‐α	  mRNA	  level	  .....................................................................................................................	  150	  
Figure	  4.16.	  Relative	  IL22	  mRNA	  level	  ........................................................................................................................	  153	  
Figure	  4.17.	  Relative	  IL23	  mRNA	  level	  ........................................................................................................................	  154	  
Figure	  4.18.	  Relative	  SM22-­‐	  α	  mRNA	  level	  .................................................................................................................	  156	  
Figure.	  4.19	  back	  skin	  tissues	  were	  sectioned	  and	  stained	  with	  an	  antibody	  to	  SM22	  ..........................	  158	  
Figure	  4.20.	  Relative	  	  Mip1	  mRNA	  level	  ......................................................................................................................	  160	  
Figure	  4.21.	  Quantification	  of	  MMP1	  Levels.	  ............................................................................................................	  162	  
Figure	  5.1	  Diagram	  showing	  the	  relative	  position	  of	  injured	  sites.	  ................................................................	  173	  
Figure	  5.2.	  Daily	  measurements	  of	  wound	  size	  at	  different	  locations	  ...........................................................	  175	  
Figure	  5.3.	  Representative	  micrographs	  of	  wounded	  skin	  at	  days	  4	  and	  7	  post	  wounding	  .................	  177	  
Figure	  5.4	  distances	  between	  the	  original	  wound	  sites	  and	  migrated	  epidermis	  ....................................	  178	  
Figure	  5.5.	  Verhoeff’s	  Van	  Gieson	  staining	  for	  elastic	  fibres	  ..............................................................................	  179	  
Figure	  5.6.	  The	  epidermal	  and	  dermal	  Ki67-­‐positive	  cells	  ..................................................................................	  181	  
Figure	  5.7.	  Quantification	  of	  Ki67	  positive	  basal	  epidermal	  and	  dermal	  cells	  ..........................................	  182	  
Figure	  5.8.	  Relative	  levels	  of	  activated	  Notch1	  at	  different	  locations	  ............................................................	  184	  
Figure	  5.9.	  Relative	  TNF-­‐α	  mRNA	  level	  .......................................................................................................................	  186	  
Figure	  5.10.	  Relative	  TGFβ	  mRNA	  level	  .......................................................................................................................	  187	  
Figure	  5.11.	  Immunostaining	  with	  CD3	  and	  DAPI	  ..................................................................................................	  189	  
Figure	  5.12.	  Quantification	  of	  CD3	  positive	  T	  cells	  within	  500	  microns	  of	  the	  wound	  site	  ...................	  190	  
 9 
Figure	  5.13.	  Immunostaining	  of	  mouse	  back	  skin	  with	  SM22α	  ........................................................................	  192	  
Figure	  5.14	  Immunostaining	  of	  mouse	  back	  skin	  with	  MMP1	  ..........................................................................	  194	  
 
 
 
 
List of tables  
Table1.	  1Growth	  factors	  involve	  in	  wound	  healing	  ..................................................................................................	  32	  
Table	  2.1.	  List	  of	  antibodies	  used	  in	  Immunohistochemistry	  ................................................................................	  74	  
Table	  2.2.	  Polyacrylamide	  gels	  ...........................................................................................................................................	  76	  
Table	  2.	  3Running	  buffer	  ......................................................................................................................................................	  77	  
Table	  2.4.	  Transfer	  buffer	  .....................................................................................................................................................	  78	  
Table	  2.5	  (x20)	  TBS	  .................................................................................................................................................................	  79	  
Table	  2.6.	  (x1)	  TBST	  ................................................................................................................................................................	  79	  
Table	  2.7.	  Blocking	  buffer	  .....................................................................................................................................................	  80	  
Table	  2.8.	  Incubation	  buffer	  ................................................................................................................................................	  80	  
Table	  2.9	  List	  of	  antibodies	  used	  for	  western	  blotting	  .............................................................................................	  81	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10 
List of abbreviation  
 
4OHT              4-hydroxytamoxifen 
 AKN               Ankyrin repeat  
BM                  Basement membrane 
cDC                 Conventional dendritic cell 
CR                   Cysteine rich domain 
DC                   Dendritic cell 
DETC              Dendritic epidermal T cells 
DSL                 Delta-Serrate-Lag2 region 
ECD                Extracellular domain 
ECM                Extracellular matrix 
EGF                 Epidermal growth factor 
GSI                   γ-secretase inhibitor 
Hh                   Hedgehog 
Hes                  Hairy/enhancer of split 
HF                   Hair follicles 
ICDs               Intracellular domains 
IFE                  Interfollicular epidermis 
IFN                  Interferon 
IL                     Interleukin 
ILCs                Innate lymphoid cells 
IRS                  Inner rooter sheath 
 K14                Keratin 14 
KGF                Keratinocyte growth factor 
LNRs               Lin12-Notch repeats 
MAML            Mastermind-like 
MIP                 Macrophage inflammatory protein 
MMPs             Matrix metalloproteases 
NEXT             Notch EXternacellular Truncation 
NICD              Notch intracellular domain 
NK                  Natural killer cells 
 11 
NLS                Nuclear localization signals 
ORS                Outer rooter sheath 
PDGF             Platelet-derived growth factors 
PEST                 Domain rich in proline, aspartic acid, serine and threonine residues 
RAM                 RBP-Jκ associated molecule 
RBP-Jκ              Recombination signal sequence binding protein Jκ 
SG                     Sebaceous gland 
TA                    Transit amplifying cells 
TGFβ               Transforming growth factor β 
Th                    T helper cells 
TMIC              Trasmembrane and Intercellular domain 
TNFα               Tumor necrosis factor-α 
 
 
  
 12 
Acknowledgments 
 
I would like to thank my supervisors Dr.Carrie Ambler and Dr. Arto Maatta for their 
invaluable advice and guidance throughout my studies and during my write-up.  
 
Dr.Ian Cummins, Rebecca Lamb, Zhi Li and Nattalie Dugget for their friendship and 
support throughout my studies.  
 
My parents for their love, support and encouragement in initiating and undertaking 
my studies.  
 
And finally I would like to thank, and dedicate this thesis to, Babak and Tiana for 
their love, support and encouragement throughout my studies, and their patience 
during my write-up.    
 13 
Abstract  
 
The Notch signaling pathway is critically involved in cell fate decisions during skin 
development and homeostasis. In the present study an in vivo model (seven-week-old 
male, C57BL/6) was used to elucidate the role of epidermal Notch activation in the 
healing of full-thickness dermal wound. Immunolocalization of activated Notch1, 
Notch2 and Jagged1 was performed during skin wound healing in vivo in mice. The 
expression level of Notch1, Notch 2 and Jagged1 in the C57BL/6   skin was examined 
by quantitative PCR (qPCR).  This study shows that skin injury rapidly actives Notch 
signaling in the epidermis. Epidermal forced Notch1 activation results in a Jagged1 
dependent Notch2 activation in epidermis. Data presented in this thesis also 
demonstrate that the prolonged epidermal Notch activation via a 4-hydroxy-
tamoxifen-inducible transgene before and after wounding caused an over-activation of 
Notch during early stages of the healing of full-thickness dermal wounds. The 
expression level of Notch1, Notch2 and the inflammatory Notch related genes, in the 
transgenic wounded skin was examined by quantitative PCR (qPCR). The phenotypes 
and morphology of the transgenic skin were compared with that of wild type (WT) 
controls. The skin response to wound healing was studied by H&E staining at the 
microscopic level at 2, 5 and 8 days post injury. These data show that the prolonged 
epidermal Notch activity may do more harm than good in terms of an increased 
inflammatory response at the wound site. These data suggest that Notch plays an 
important role in the early stages of the skin wound healing process, a finding that has 
implications in wound inflammatory responses. This thesis also examines skin wound 
healing in different anatomical locations on seven-week-old male, C57BL/6 mice 
model. 4mm full thickness dermal wounds were made at different anatomic regions; 
upper posterior, middle to posterior and posterior-most (caudal). These data showed 
that lower body wounds healed significantly better than those in the upper posterior, 
or middle to posterior of the mouse back skin. The data presented here show that 
anatomical location is important in wound healing responses, as reflected by 
differences in keratinocyte proliferation and differentiation.   
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1 Introduction 
1.1 The Skin   
 
The skin is the largest organ of the human body; it weighs approximately 15% of an 
adult’s body weight. As well, the skin is in a direct contact with the outside 
environment, and helps to maintain four essential physical functions. These functions 
are retention of moisture and prevention of loss of other molecules, regulation of body 
temperature, sensation and protection of the body from microbes and harmful external 
threats.  During the interaction between the organism and the environment, the skin is 
at risk of exposure to injury from a variety of agents. In addition to injury through 
trauma or disease processes, skin may be wounded as a necessary part of surgical and 
other invasive medical procedures. Fortunately, the skin has a great capacity for 
healing (Matoltsy and Odland, 1955, Slater and Goldsmith, 1993, Tobin, 2006). 
Therefore, a basic understanding of cutaneous biology and functions of normal skin is 
essential for studying the wound healing response in the skin.  
1.2 Skin Structure  
The skin is a dynamic organ composed of three primary layers, an outer epidermis 
and an inner dermis, with an underlying layer known as the hypodermis. All 
functional properties of the skin are a reflection of the structural features of the skin 
(Matoltsy and Odland, 1955, Slater and Goldsmith, 1993, Tobin, 2006). The diagram 
in Figure 1.1 provides an overview of the basic anatomic features of the skin.  
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Figure 1.1 Diagram of human skin structure.  
Representing the two main layers of skin epidermis and dermis. The epidermal barrier 
layer is attached to the underlying dermis by basement membrane zone Image 
adapted, from MacNeil, 2007.  
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1.3 Epidermis  
The epidermis is the outer most layer of the skin; the predominant cell type in the 
epidermis is the keratinocyte that is committed to a program of terminal 
differentiation. Figure 1.2 illustrates   the epidermal layers, which, from the bottom to 
the top are basal, spinous, granular and cornified layers.  A continuous cell transition 
from the basal layer of the epidermis, entering the spinous layer first and then the 
granular layer and finally forming the uppermost keratinized layer of the epidermis is 
principle to the   renewal process of the epidermis that takes 3 to 6 weeks (Grove and 
Kligman, 1983, Slater and Goldsmith, 1993, Blanpain and Fuchs, 2006).Keratinocytes 
proliferate and divide in the epidermal basal layer and  traverse to the upper layers; 
during terminal differentiation, the keratinocyte produces intercellular keratins and 
lipid-filled granules, although its cell nucleus becomes inactive and condensed. The 
restoration of damaged epidermis is brought about by regeneration. The cells of the 
basal layer multiply and migrate from undamaged areas to replace damaged cells.  
1.3.1 Basal layer 
The basal layer is the innermost layer of the epidermis, consisting of basal cells 
including the epidermal stem cell subpopulation. Basal cells vary in shape from cubic 
to columnar. The basal cells continually divide, producing new cells that constantly 
push older ones up toward the surface of the skin, where they are eventually shed. 
Also, the basal layer is maintained by cell mitosis, although once a cell exits the basal 
layer, it is committed to the differentiation pathway and is no longer capable of cell 
division.  The basal keratinocyte is the primary cell involved in the epidermal wound 
healing response (Slater and Goldsmith, 1993). Melanocytes constitute a small 
quantity of the basal cells that produce pigment to provide protection against 
ultraviolet radiation; other cells residing in the epidermis are markel cells, a 
neuroendocrine cell, which consists of a small proportion of the basal cell population. 
These cells are in an intimate engagement with cutaneous nerves and are involved in 
light touch sensation (Tobin, 2006) (Figure1.2).  
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1.3.2 Spinous layer 
Reproduction, maturation and migration of the basal cells toward the outer layer of 
skin usually result in the formation of the spinous layer that is adjacent to the basal 
cells. Suprabasal cells are polygonal in the lower layer and somewhat flattened in the 
upper layers. They are larger than basal cells and contain a small amount of chromatin 
in their circular nucleus. Intercellular bridges that are made of desmosomes  provide 
the “prickles” appearance to the cell population within this epidermal layer 
(Figure1.2). Other cells residing in the spinous layer are the Langerhans cells that are 
a type of dendritic immunologically active cell; these cells act as antigen–presenting 
cells in skin immune reactions (Slater and Goldsmith, 1993, Tanaka, 2012, Toebak et 
al., 2009).  
1.3.3 Granular cell layer 
Throughout the transition of the basal cells to the skin surface, the cells continue to be 
structurally flattened, losing their nuclei and their cytoplasm appears granular at this 
level (Figure1.2). The cells and nuclei in the granular cell layers are even flatter than 
those in the suprabasal layer (Slater and Goldsmith, 1993, Fuchs, 2008, Fuchs and 
Horsley, 2008).  
1.3.4 Cornified layer 
Non-viable cornified cells are flat hexagonal-shaped and found in the outer layer of 
epidermis which is the final outcome of the keratinocytes’ maturation process, and 
their cytoplasm is filled with aggregated keratin fibers (Fuchs, 2008, McLafferty et 
al., 2012). These cells are systematically  shed or sloughed from the surface of the 
skin. The dead cells of the cornified layer are composed of cell membranes, keratin 
proteins, and complex lipids, which form the major barrier against water loss and 
microbial or chemical invasion (Slater and Goldsmith, 1993) (Figure1.2). 
1.3.5  Epidermal T-cells  
There are several other cells residing in the epidermis which play key roles during 
skin wound healing and they are the dendritic epithelial T cells (DETC), a specialized 
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subset of T cells that express the γδ-T-cell receptor (Allison and Havran, 1991), while 
activated DETCs produce keratinocyte growth factors and chemokines, raising the 
prospect that DETCs are critical in wound repair cascade. Previous studies have 
shown a reduction in keratinocyte proliferation and tissue reepithelialization during 
the healing of experimental wounds in mouse skin lacking DETCs (Jameson et al., 
2002). Another study in mice also has proposed that the recognition of expressed 
antigens from injured keratinocytes by DETCs induce the production of factors that 
directly affect healing (Born and O'Brien, 2002).  
1.3.6 Epidermal appendages 
Epidermal appendages including the hair follicle, sebaceous gland and sweat glands 
are specialized structures that arise from the epidermis during a defined stage of 
embryonic development by means of dermal-epidermal induction (Mackool et al., 
1998). It has been reported that epidermal stem cells, located in the bulge of the hair 
follicle, contribute to the renewal of basal keratinocytes and follicular epithelium 
(Alonso and Fuchs, 2003, Bickenbach and Kulesz-Martin, 2007). 
1.4 Basement membrane  
The cutaneous basement or basement membrane (BM) is the boundary between the 
epidermis and the dermis. A specific assemblage of the basal keratinocyte, 
extracellular matrix (ECM), basal lamina, anchoring filaments and fibrils form the 
specialized structural integrity of the BM region (Figure1.2). Most of the components 
of this region are synthesized by epithelial cells and must be reproduced during 
wound healing.  The lack of a linkage network results in the separation of the 
epidermis from the dermis (Chetty et al., 1992, Fuchs, 2008, Fuchs and Horsley, 
2008).  
 
 
 
 19 
 
 
 
 
 
 
Figure 1.2 Epidermal layers and skin stem cells.  
( A) , schematic representation of the stratified layers of the epidermis (basal, spinous, 
granular and cornified layers). The differentiated squames in the stratum corneum 
initiates by the differentiation of the mitotically active basal cells to spinous cells in 
the upper layer, which are transcriptionaly active. Subsequently the enucleated 
granular cells form in the granular layer.  The proliferative basal layer is adjacent to 
the basement membrane (BM). Stem cells (SC) generate transit amplifying (TA) cells 
which will differentiate to form the stratified layers.(B), section of mouse skin stained 
to distinguish the different compartments of the hair follicle (hf).(C), schematic 
representation of a hair follicle and the multipotent SCs  localizing to the bulge 
region. These cells migrate to populate the bulb region of the follicle, the sebaceous 
gland and the interfollicular epidermis (IFE; pink). IRS, inner root sheath; ORS, outer 
root sheath. Adapted from J.A.Serge, 2006. 
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1.5 Dermis  
The dermis is the structural layer of the skin that is thicker than the epidermis and 
supports the epidermis. In addition, the dermis consists of different cell types 
including fibroblasts that are known as a source of collagen production, elastin and 
structural proteoglycans, mast cells and macrophages. Dermis is designed to keep its 
integrity under an assault of physical forces and delivers metabolic and 
communicative support for the epidermis. The dermal vascular network, afferent 
sensory nerves and nerve endings, run through the dermis and end just below the BM 
zone (see Figure 1.1). Epidermal appendages including sweat glands and hair follicles 
are also supported by dermis. Specialized smooth muscle of hair follicles, arrector pili 
muscle, is located within the dermal region. (McLafferty et al., 2012, Singer and 
Clark, 1999). It is important to note that the repair of damaged dermis is dependent on 
the level of injury. During the healing process of the skin full-thickness wound, the 
formation of granulation tissue (combination of the macrophages, new capillary blood 
vessels, collagen, fibroblasts, and plasma cells) within the dermis at the injured site is 
a crucial phase (Singer and Clark, 1999).  
1.5.1 Extracellular matrix  
Collagen type III and I are the predominant components of the dermis, forming cross-
linked fibrils of high tensile strength, while collagen types VI and VII are a small but 
functionally critical component (Keene et al., 1997, Keene and McDonald, 1993). In 
normal skin, collagen is a highly stable molecule with a reasonably low turnover; but 
after injury, dermal fibroblasts synthetize collagen via a complex intracellular and 
extracellular biosynthetic pathway. The elastic properties of the skin are conferred by 
elastin fibers, a combination of elastin and other complex glycoproteins. Elastin is 
also a very stable molecule in normal skin condition but, unlike collagen, it is not 
readily synthetized following injury (Broughton et al., 2006b). 
 
 
 
 21 
1.5.2 Connective tissue cells  
In the normal dermis fibroblasts are the  principle cell type, and other dermal residing 
cells including mast cells and tissue macrophages are minor components (Slater and 
Goldsmith, 1993). As mentioned before skin is an immunologically active organ 
composed of B and T lymphocytes (Streilein, 1983). During the inflammatory 
process, including the wound healing, neutrophils and macrophages rapidly enter the 
connective tissue to participate in the wound healing response (Kanzler et al., 1986). 
 
1.6 Hypodermis  
Underneath the dermis is a thick layer of sub-cutaneous tissue; this is the connection 
point between the skeleton and skin (see Figure 1). This soft tissue is a type of 
connective tissue composed of fat. This layer provides a cushion and separates the 
dermis from underlying muscle and bone. Without the sub-cutaneous tissue skin 
would slide off the muscles (Slater and Goldsmith, 1993). Previous studies indicated 
that mesenchymal stem cells reside in the hypodermis and may contribute to dermal 
wound healing. Under normal conditions this type of skin cells do not readily undergo 
mitosis, and following injury the hypodermis is not regenerated but is replaced by 
scar tissue (De Ugarte et al., 2003). 
1.7 Epidermal stem cells  
Dermis is originated of embryonic mesoderm and is separated from the overlying 
ectodermal originated epidermis by basement membrane. During embryonic 
development under the stratification process, the outward movement of the 
proliferative basal cells towards the surface of the skin creates stratified squamous 
epithelium. The stratification process is repeated during the life of the organism and 
provides the protective and water barrier functions between the body and the 
environment (Kalinin et al., 2002). Such an accomplished continuous epidermis 
renewal process that directs the consequent production of the epidermal layer requires 
the involvement of the primary stem cells (SCs). 
Previous studies have confirmed three locations of multipotent SCs within the adult 
epidermis: cells found in the bulge area of the hair follicle (Oshima et al., 2001, 
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Taylor et al., 2000), keratinocytes of interfollicular epidermis (IFE) and the sebaceous 
gland (Ghazizadeh and Taichman, 2001) (Figure 1.2.c). Reports have shown that the 
multipotent SCs within the bulge region of the hair follicle are the main source of 
epidermal SCs that replenish hair, IFE and sebaceous lineages (Cotsarelis et al., 1999, 
Fuchs and Raghavan, 2002, Watt, 2001).  
Several lines of evidence indicate that there are sub-population cell types within the 
basal layer of IFE that are able to self-renew, undergo terminal differentiation and 
give rise to non-SCs known as transit amplifying cells (TA) (Figure 1.2).  Limited 
division and proliferation capacity have been considered as indicators for TA cells 
(Barrandon and Green, 1987, Jones and Watt, 1993, Hunt et al., 2000, Tanaka, 2012).    
Specification of epithelial stem cells in the skin during development enables them to 
form the three main epithelial lineages including epidermis, hair follicle and 
sebaceous gland. Each of these lineages has the ability to renew and maintain their 
own stem cell population. In response to injury due to the damage of stem cells at the 
injured site of the skin, resident stem cells from other sites within the epithelium have 
the capability of migration to the injured site and contribute to the repair of the 
epithelial tissue (Tanaka, 2012).  
1.8 Wound healing  
Wound healing is a complex process in which the injured tissue self-repairs. Different 
chronological phases of the healing process include: homeostasis, inflammation, 
proliferation and remodeling (Figure 1.3). The primary objective of the hemostasis 
phase of wound healing is to control bleeding. While the inflammatory phase is 
characterized by a host of cells that work together to mount an inflammatory 
response, synthesize granulation tissue, and restore the epithelial layer. The objective 
of the inflammatory phase of wound healing is to clean the wound of cellular debris. 
Accumulation of macrophages encourages fibroblast mitosis and migration into the 
wound. This phase is known as the proliferation phase of wound healing.  At the final 
stage of wound healing collagen is remodeled and realigned under a process that is 
termed maturation and remodeling (Broughton et al., 2006b, Gantwerker and Hom, 
2012). 
 The cellular events that take place during the wound healing are: infiltration of 
neutrophils and inflammatory components within the early days of healing (1-2 days); 
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migration of epithelial-mesenchymal cells to initiate re-epithelialization (within 1-2 or 
3 days); migration of fibroblasts and myofibroblasts differentiation to the wound site 
to be involved in progressive alignment, collagen production and matrix contraction 
(between 4 and 15 days after wounding); increased angiogenesis (formation of new 
blood vessels) occurs within 4 to 5 days after wounding, as does the production of 
dermal matrix, which can last for almost 14 days.  Two weeks after wounding the 
remodeling stage starts, which can last several weeks to months, depending on wound 
size (Figure 1.3). 
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Figure 1.3. Wound healing phases.  
Hemostasis immediate after wounding, inflammation 1-3 days post wounding, 
proliferation 3-5 days and remodeling from day 7 up to weeks post wounding 
(adapted from (Hunt et al., 2000, Tanaka, 2012). 
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1.8.1 Hemostasis 
Hemostasis occurs right after the initial injury to approximately 3 hours post injury. 
At the time of injury epinephrine, a chemical that constricts peripheral blood vessels, 
is released in an attempt to minimize bleeding into the soft tissues. The key cell, 
which is responsible for this function, is the platelet, which causes the body to form a 
clot to prevent further bleeding. At this stage there is an increased aggregation of 
platelets to enable the wounded vessels to complete the clotting process.  Platelets 
also release key cytokines such as platelet-derived growth factors (PDGF) that cause 
the accumulation of cells to participate in later phases of healing.  Hence the objective 
of the hemostasis phase of wound healing is to control bleeding.  (Certosimo et al., 
1998, Gantwerker and Hom, 2012). 
1.8.2 Inflammation  
It is a well-known fact that inflammation is essential for the establishment of 
cutaneous and other tissues homeostasis, immediately following injury.   The specific 
subsets of inflammatory cell lineages, and other inflammatory orchestrating networks 
involved with tissue repair including cytokines have been identified and examined in 
recent experimental research.  Therefore, a more specified investigation into 
mechanisms controlling the inflammatory response during repair, and how 
inflammation controls the consequence of the healing process will help as an 
important milestone in the therapy of pathological tissue repair. Immediately after 
injury, the infiltrating leukocytes,  principle cellular components of the inflammatory 
response, initiate the healing process.  Infiltrating leukocytes are involved in stopping 
entering pathogens, tissue degradation and tissue formation. Previous studies have 
shown that reduction or induction of leukocytes infiltration into the damaged tissue 
may effect cell migration, proliferation, differentiation, and the quality of the healing 
response (Eming et al., 2007).  It has been demonstrated in several experimental 
studies that inflammatory response during normal healing is characterized by 
changing patterns of various leukocyte subsets (Singer and Clark, 1999, Gantwerker 
and Hom, 2012); therefore the well-defined monitoring of these events is critical for 
optimal repair.  
An extended inflammatory phase and any disruption in the decontamination process 
can lead to the continued elevation of pro-inflammatory and stretch the inflammatory 
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phase. Matrix metalloproteases (MMPs) accumulation is the result of elongated 
inflammatory phase that can degrade the ECM and delay wound healing (Edwards 
and Harding, 2004, Jones et al., 2004, Menke et al., 2007).  
 
1.8.2.1 Polymorphonuclear leukocytes (neutrophils, PMN)  
Immediately after injury, platelets and polymorphonuclear leukocytes (neutrophils, 
PMN) accumulated in the blood clot, release a wide range of chemoattractants for 
cells involved in the inflammatory phase (Szpaderska et al., 2003). Proinflammatory 
cytokines IL-1β, tumor necrosis factor-α (TNF-α), and IFN-γ at the wound site 
activate the endothelial cell wall of blood capillaries which leads to release of the bulk 
of neutrophils in the wound. A previous experimental research revealed that migration 
of PMNs to skin wounds induces a large transcriptional activation program, which 
may regulate cellular fate and function and promote wound healing (Theilgaard-
Monch et al., 2004). The fact that neutrophils can be beneficial or detrimental to 
healing has been shown by depletion of neutrophils in wound healing assays since the 
1970s.  These studies have confirmed that although, dermal repair parameters were 
not affected by neutropenia, reepithelialization was significantly accelerated. Indirect 
regulation of the innate immune response during wound healing by neutrophils has 
been described in a recent in vitro study that demonstrated; neutrophils isolated from 
wound site can modulate the cytokines profile expression of macrophages (Daley et 
al., 2005). However, the fact remains unclear, whether the lack of PMNs has a direct 
beneficial effect on reepithelialization, or whether the relative increase in other 
subsets of inflammatory cells, such as the macrophages, might be responsible for 
accelerated epithelialization (Dovi et al., 2003). 
1.8.2.2 Monocytes/Macrophages 
Within 2 days after injury, the neutrophil infiltration at the wound site ends, and 
alongside resident macrophages, the major quantity of macrophages at the wound site 
is recruited from the blood. Platelets trapped in the fibrin clot, hyperproliferative 
keratinocytes at the wound edge, fibroblasts, and leukocytes, are introduced as the 
major source of growth factors, proinflammatory cytokines, and macrophage 
inflammatory protein 1-α(Mip-1α), that regulate the macrophage infiltration into the 
wound site (Werner and Grose, 2003). Activation and differentiation of monocytes 
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extravasate from the blood vessel; transform these cells into mature tissue 
macrophages that lead to significant changes in gene expression. Regulatory function 
of mediators present in the wound site, to control monocyte maturation procedure, has 
been confirmed previously (Gordon, 2003) (Figure 1.4). 
 
 
Figure1.4.Wound healing during Inflammation phase (3 days after injury).  
Growth factors thought to be necessary for cell movement into the wound are shown. 
Adapted from (Singer 1999). 
 
 
 
A fundamental role for macrophages in wound healing in guinea pigs was proven 
over 30 years ago, where depletion of macrophages showed a significant delay of 
healing (Leibovich and Ross, 1975). More recent studies not only have supported and 
extended these initial findings but also suggested more integral roles of macrophages 
in a successful outcome of the healing response. Immunological functions of 
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macrophages, as antigen-presenting cells and phagocytes, beside other functions 
including, synthesis of numerous potent growth factors, such as TGF-β, TGF-α, basic 
fibroblast growth factor, platelet-derived growth factor, and vascular endothelial 
growth factor, which promote cell proliferation and the synthesis of extracellular 
matrix molecules by resident skin cells during wound healing, has pronounced 
macrophages as strategic elements of skin wound healing (Figure 1.5) (DiPietro and 
Polverini, 1993). 
 
 
 
Figure 1.5.The production of bioactive mediators by macrophages.  
Macrophages synthesize and release a vast array of regulatory molecules relevant to 
all the major tissues types involved in wound healing (adapted from DiPietro and 
Polverini, 1993). 
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1.8.2.3 T-cells 
Cells of the adaptive immune response, in particular T cells, play a crucial role in 
wound healing (Fishel et al., 1987). However, a more definitive understanding of T-
cell function during wound healing requires further investigation; a role for T-cells in 
tissue remodeling has been supported by previous studies. Secretion of cytokines by 
T-cells may also suggest the association of T-cells and remodeling (Azouz et al., 
2004). Macrophages appear to be a major source for these cytokines. Using  IFN-γ-
deficient mice, in a wound healing assay demonstrated, significant reduction in the 
number of neutrophils, macrophages and T-cells at the wound site. These findings 
proved that there was a role for T-cells in tissue remodeling and, suggested a delayed 
wound closure and PMNs reduction occurred, as a consequence of the lack of the 
endothelial activation.  
 A previously discovered unique population of T-cells, termed γδ T cells, are also 
reported to be effective in epidermal repair in skin (Jameson et al., 2002). It has been 
confirmed that γδ T cells play a critical role in keratinocyte proliferation and 
differentiation during wound healing as they have been identified as a source of key 
growth factors such as fibroblast growthfactor-7, -10 (Jameson et al., 2002). It has 
also been shown that this population of T-cells are involved in macrophage 
infiltration into the wound site (Jameson et al., 2005). Secreting different cytokines 
profile from T-cell subsets including, Th1 and Th2, may propose different regulatory 
functions for these T-cells (Azouz et al., 2004). Releasing of IFN-γ, TNF-α and IL-2 
are most likely to be regulated by Th1, whereas, Th2 release IL-4, 5and 10. The 
demonstrated novel functions of T-cells during the healing process may deliver a new 
perspective on T-cell regulation in wound healing. 
 
1.8.3 Proliferation  
One of the first cells that are attracted into the wound, as  a result of the coordinating 
cytokine growth factor releasing activity of the macrophages, are fibroblasts. The 
cytokines released from macrophages stimulate the fibroblast, which then encourages 
the fibroblast mitosis and migration into the wound. The proliferation phase involves 
the migration of fibroblasts and beneficial cells and also the destruction of dead 
materials, the bacteria and cell debris at the wound site (Hunt et al., 1999). 
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The fibroblasts in the wound produce collagen that causes a significant tensile 
strength of the wound. As well as collagen, the fibroblast also produces a glycoprotein 
called Extra Cellular Matrix (ECM) that fills up the gaps between the cells and the 
collagen strands (Figure 1.6). Therefore, the activation of fibroblast causes the wound 
to be filled with matrix and also collagen strands have held wound edges together. 
Fibroblasts are identified as a key factor for secretion of growth factors that attract 
epithelial cells to the wound site (Table 1.1).  
 
Figure 1.6. Wound healing during Proliferation phase (5 days after injury).  
Blood vessels are seen sprouting into the fibrin clot as epidermal cells resurface the 
wound. Proteinases thought to be necessary for cell movement are shown. MMP-1, 
2,3 and 13: matrix metalloproteinases 1,2,3 and 13(collagenase 1, gelatinase A, 
stromelysin 1, and collagenase 3, respectively).  Adapted from Singer, 1999.  
1.8.3.1 Angiogenesis and granulation  
As previously mentioned, monocyte-derived macrophages are located around the 
wounded tissue and also into the wound site. Growth factor produced by the 
macrophages, affects the adjacent capillaries and causes the growth of capillaries into 
the wound. The growth of new blood vessels into the wound that is fundamental to 
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supply the wound with oxygen and nutrients is known as angioneogenesis. 
Regeneration of the epithelium is also stimulated by macrophage-derived growth 
factor.  Two days after the injury, the bed of the wound will be infiltrated by helper T 
lymphocytes known as T-Cells. Secretion of cytokines from helper T cells causes the 
accumulation of more T-cells, which results in the increase of macrophages, and helps 
the angiogenesis process. 
The combination of the macrophages, the new capillary blood vessels, the collagen 
the ECM, the fibroblast and the plasma cell is called the granulation tissue. 
Granulation tissue is the essential intermediate tissue, produced by the body to 
facilitate wound healing (Hunt et al., 2000, Quinn and Wells, 1998). 
 
Growth 
factor  
                
Abbreviation Main origins 
 
 
Effects 
Epidermal 
Growth Factor 
EGF Activated 
macrophages 
Salivary glands 
Keratinocytes 
 
Keratinocyte and 
fibroblast mitogen 
Keratinocyte migration 
Granulation tissue 
formation 
 
Transforming 
growth factor-α 
TGF- α Activated 
macrophages 
T-lymphocytes 
Keratinocytes 
 
Hepatocyte and 
epithelial cell 
proliferation 
Expression of 
antimicrobial peptides 
Expression of 
chemotactic cytokines 
 
Transforming 
growth factor-β 
TGF-β Platelets 
T-lymphocytes 
Macrophages 
Endothelial cells 
Keratinocytes 
Granulocyte, 
macrophage, 
lymphocyte, fibroblast 
and smooth muscle cell 
chemotaxis 
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Smooth muscle cells 
Fibroblasts 
 
Angiogenesis 
Fibroplasia 
Matrix 
metalloproteinase 
production inhibition 
Keratinocyte 
proliferation 
 
Keratinocyte 
growth factor 
KGF Keratinocytes Keratinocyte 
migration, proliferation 
and differentiation 
 
Table1. 1Growth factors involve in wound healing (Hunt et al., 2000, Quinn and Wells, 
1998). 
 
Wounds can heal in one of two ways; they can heal by regeneration or fibrosis. In a 
good wound healing environment there is more regeneration because there is also 
more mitosis and migration of the original cells which are going to replace the 
damaged cells. In the case of fibrosis the accumulation of more collagen based fibers 
tissue results in scar tissue at the wound site. Regeneration and fibrosis in bigger 
wounds are combined and that is one of the reasons that larger wounds result in scar 
formation. Due to the regeneration as time goes on the wound gets smaller. The 
epithelial cells from the surface of the skin need to migrate in a moist environment 
underneath the blood clot and the epithelial cells migrate over the surface of the 
healthy living granulation tissue and re-epithelialiase  the wound (Hunt et al., 1999).  
1.8.4 Remodeling 
The final stage of healing is called remodeling or the maturation phase.  Over time the 
scar gets faint or smaller. Collagen fibers get organized and re-formed and that 
increases the tensile strength of the wound. Reduction in vascularity, re-ordering of 
the collagen, differentiation of the fibroblast in the wound from the being individual 
fibroblasts into being strips of fibroblasts (myofibroblasts) are all indicators for this 
phase of healing process (Gomez et al., 1991). Myofibroblasts are attached to the 
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edges of the wound and contract and reduce the size of the wound, which can end up 
with a shortened scar. At the end of the wound healing phase, collagen is remodeled 
and realigned under a process which is characterized as maturation and remodeling 
(Midwood et al., 2004). The myofibroblast is a cell that generates in vivo essential 
forces for wound contraction. Structural and features, such as being contractile and 
synthetic, have made myofibroblasts suitable to promote granulation tissue 
contraction and exerting fractional forces on surrounding connective tissue during 
wound healing. During wound contraction myofibroblasts establish a grip on the 
edges of the wound and under a contraction mechanism promote the closure of the 
wound  (Midwood et al., 2004).  
1.9 Skin Wound healing  
An injured skin with the broken protective barrier undergoes the normal physiologic 
process of wound healing which initiates immediately after receiving an injury. The 
response of cells from different layers of the skin to injury is related to their capacity 
of basic cellular processes including, cell movement, cell replication and restoration 
of specialized function. At the injured site of the skin the barrier is compromised, 
cells and ECM are damaged or lost, the blood supply is disrupted and there is at least 
a partial loss of function. The coordinated sequence of events in response to skin 
injury involving migration (cell movement), mitosis (cell proliferation) and 
maturation (restoration of specialized function) is summarized in the flow diagram in 
Figure 1.7.  
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Figure 1.7. The orchestrated sequence of events in response to skin injury.  
(Adapted from Singer, 1999) 
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1.9.1 Epidermal wound healing  
The high regenerative capacity of basal keratinocytes is achieved by a regulated 
sequence of migration, mitosis and maturation of these cells (Figure 1.8).  
Cytokines, growth factors, and other wound signals acting on basal keratinocytes at 
the site of injury are known as essential key factors in epidermal wound healing .To 
initiate the healing and achieve the normal epidermal structure and barrier function of 
the epidermis, epidermal cells in close proximity to the wound margins undergo 
structural and functional changes to facilitate motility while retaining cell-cell 
association to move as an epithelial sheet (Clark, 1993). During the healing process, 
proliferation of epidermal keratinocytes, increase the cell mass and replace tissue 
volume at the injured site; and following the epithelialization complete resurfacing of 
the wound will be achieved.  Finally, the terminal differentiation of the cells in the re-
epithelialized wound reestablishes the normal epidermal structure and barrier 
function. All these coordinated degradation and regeneration processes during the 
healing cascade require a delicate balance of biochemical signaling, which is 
mediated by local release of growth factors and cytokines (Hebda et al., 1990).   
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Figure1.8.Epidermal wound healing.  
Injury to the epidermal layer induces epidermal keratinocytes to undergo a process of 
migration (1), mitosis (2) and maturation (3) to reconstitute the epidermis and restore 
barrier function. At the wound edges, these keratinocytes form the socalled 
hyperproliferative epithelium, which strongly proliferates and migrates to replenish 
the wounded area with new tissue. Cells from the hyperproliferative epithelium 
overtime displace the fibrin clot. Adapted from (Singer, 1999). 
 
 37 
 
 
 
1.9.2 Dermal wound healing  
Dermal injury occurs when the injury crosses the BM, and causes damage to blood 
vessels is the dermis. Preventing the blood flow by released platelet and formation of 
a fibrin clot is described as platelet-induced hemostasis; the fibrin clot is the first 
provisional matrix for wound healing that forms at the site of the injury. Additional 
agents released from platelets and mast cells produce inflammation and edema at the 
injured site (Clark, 1993, Singer and Clark, 1999). Chemokines attract neutrophils to 
the site during the early inflammatory phase of healing; neutrophils phagocytose 
bacteria. Circulating monocytes are also attracted to the site by chemokines. 
Monocytes rapidly activated to developed macrophages and phagocytose` any 
remaining contamination, as well as tissue debris. Macrophages are involved in 
releasing growth factors that serves as important signals for and mediators of wound 
healing (Leibovich and Ross, 1975, Martin and Leibovich, 2005). Inflammatory 
response induces the formation of granulation tissue; this loose connective tissue is 
the second provisional matrix forms in wound healing and is named for its granular 
appearance. Granulation tissue forms the scab (the dried, compacted fibrin clot) that is 
the third final matrix of dermal repair and maintains the collagen deposition (Singer 
and Clark, 1999). 
 
1.9.3 Connective tissue repair  
Establishment of granulation tissue in a loose connective tissue provides a nutrient-
rich environment for fibroblast proliferation and collagen synthesis. Replacement of 
granulation tissue with a collagenous matrix forms the mature connective tissue of the 
healed wound. Although, the newly formed matrix is functionally sufficient, the 
original structural organization and function are not perfectly restored.  
Following dermal injury, key factors for collagen remodeling including the collagen 
production by fibroblasts and matrix metalloproteinases (MMPs) activity up-regulate; 
however the maximal of tensile strength achieved after healing is lower than in 
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uninjured skin (Lorenz et al., 1993). In the case of dermal injury, normally resting 
dermal fibroblasts become activated and chemotactic signals direct the migration of 
this cell population into the wound. At the wound bed, following proliferation some 
of the fibroblasts recommit to the collagen synthesis and other ECM molecules, 
although other fibroblasts morphologically change to become myofibroblasts and 
contribute to contraction and remodeling of the healing wound as it matures (Figure1. 
9(A) (Darby et al., 1990, Lorenz et al., 1993).  
The skin injury disturbs the blood vessels within the dermis. As the viability and 
metabolism of all tissues, including skin, depend on sufficient blood supply, any 
disruption to this part of the skin must be restored as part of the healing process. 
Endothelial cells migrate through weak spots in the BM in response to chemotactic 
agents, at the vessel margins. Endothelial cells proliferate in response to released 
growth factors in the wound bed (Figure 1.9 (B). Finally, the remodeling of blood 
vessels takes place in coordination with the decreasing demands of the wound as it 
matures (Clark, 1993, Hunt et al., 2000).  
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Figure1.9. Dermal wound healing.  
A) Injury to dermis induces an inflammatory response that triggers fibroblasts in the 
adjacent tissue to undergo a process of migration, mitosis and maturation to repair the 
dermal connective tissue and restore structural integrity. B. Wound angiogenesis. 
Injury of the connective tissue includes damage of the vascular supply. The resulting 
inflammatory response induces endothelial cells in vessels in the wound margins to 
undergo a process of migration (1), mitosis (2), and maturation to bring vessels and a 
blood supply into the wound bed (Darby, Skalli, & Gabbiani, 1990; Hunt, Hopf, & 
Hussain, 2000).  
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1.10 Factors that effect wound healing 
The immediate goal in repair is to achieve tissue integrity and homeostasis (Singer 
and Clark, 1999). Three phases overlap in time during the healing process, involving 
inflammation, tissue formation, and tissue remodeling, to achieve a perfect repair. 
infiltration of leukocytes into the wound site at the initial stages of healing, 
epithelialization and newly formed granulation tissue and conclusive deposition of 
structural extracellular matrix molecules are indispensable for initiating repair and 
progression into the healing state.  Direct cellular interaction, as well as the indirect 
crosstalk between different cell populations, by soluble mediators, acts as essential 
cellular responses to injury. During skin wound healing, an organized communication 
between the epidermal and dermal compartment is critical. Numerous factors have 
been recognized that are involved in a complex communication between epidermal 
and dermal cells to facilitate wound repair. The balance between stimulating and 
inhibitory mediators during different stages of repair is necessary in achieving tissue 
homeostasis following injury (Werner and Grose, 2003). 
Impaired healing of wounds can be induced by numerous factors both local and 
systemic. Local factors include the presence of foreign particles or microorganisms, 
ischemia, pressure and infection whereas systemic factors comprise age, vascular 
insufficiencies, immune suppressive medication and underlying conditions such as 
diabetes mellitus(Hess and Kirsner, 2003, Nzietchueng et al., 2002). Identification of 
a delayed wound healing and managing wounds of all types, may be achievable with 
an understanding of the various essential factors such as anatomy and physiology of 
the skin, different stages of the wound repair progression and the type of wound.  
1.10.1 Enhanced inflammatory responses 
 
Although pro-inflammatory responses are essential for wound healing, they become 
detrimental in wounds where inflammation persists. In the cases where bacteria 
cannot be eliminated, leucocytes in the wound continue to produce pro-inflammatory 
mediators. Consequently the influx of new leucocytes, such as neutrophils, monocytes 
and macrophages increases (Wetzler et al., 2000). This leads to excessive pro-
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inflammatory responses in these wounds, which attract even more cells that also 
produce pro-inflammatory cytokines(Hirano et al., 2007). Phagocytes are activated to 
release proteolytic enzymes and also to produce large amounts of reactive oxygen 
species (ROS)(Gauss et al., 2007) as a consequence of pro-inflammatory cytokines 
and/or bacterial products present in the wound. In agreement with this, chronic 
wounds are associated with elevated expression of pro-inflammatory cytokines, such 
as TNF-α, compared to normal healing wounds(Goren et al., 2003); the levels of 
these cytokines decrease when the wound begins to heal.  
1.10.2 Altered growth factor production and/or signaling 
Chronic wounds may differ in the levels of growth factors and/or in the cellular 
responses to these factors from normal healing wounds. It has been reported that 
growth factors such as PDGF, TGF-β, FGF and VEGF, which are involved in the 
recruitment and stimulation of cells that are responsible for repair, are decreased in 
chronic wounds(Pierce et al., 1995). However, other reports mention no local growth 
factor deficiency in chronic wounds, whereas increased levels of PDGF and VEGF 
have been found as well (Trengove et al., 2000). Of note, increased levels of VEGF in 
chronic wounds were accompanied by increased levels of the VEGF inhibitor and/or 
its degradation(Trengove et al., 2000). These contrasting results for the levels of 
growth factors may be caused by differences in wound pathology and cell types or 
localisation of the cells within the wound and should be further investigated. 
Furthermore, the mechanisms underlying the imbalances in growth factors and their 
inhibitors in chronic wounds remain to be elucidated. Excess levels of proteinases 
may cause growth factor degradation/inactivation. Furthermore, growth factors may 
bind to protein macromolecules and become ‘trapped’ so that they are unable to bind 
and activate cells (Lauer et al., 2000). Another possible explanation is that an 
impaired ECM composition diminishes the actions of growth factors via a decrease in 
integrin binding. Finally, intracellular signal transduction may be dysfunctional in the 
cells(Chen et al., 1997). 
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1.10.2.1 Wound healing and Type β-Transforming Growth 
Factor (TGF-β) 
Type β-Transforming Growth Factor 1 (TGF-β1) is a low-molecular-weight protein 
with a broad variety of biological effects. TGF-β1 is a dimer of two identical subunits 
and binds to a plasma-membrane receptor and has been detected from a wide variety 
of normal adult tissue (Roberts et al., 1983). The hypothesis that TGF-β1 might play a 
role in wound repair was surprising, especially when studies suggested the presence 
of TGF-β1 activity in serum derived from platelets (Childs et al., 1982). It is also 
important to note that lymphocytes with established functions in inflammation and 
wound repair are a source of TGF-β1. It has been confirmed that transcription of the 
TGF-β gene and secretion of the growth factor can be induced by lymphocyte 
activation (Kimble and Simpson, 1997).  
1.10.2.2 Wound healing and tumor necrosis factor-alpha (TNF-α) 
Tumor necrosis factor-alpha (TNF-α) is a cytokine produced by macrophages, CD4 
positive lymphocytes and many other cell types involved in inflammation. 
Documented results indicate the involvement of TNF-α in increasing the expression 
level of inflammation genes, cytokine, Toll-like receptor and also nuclear factor-kB 
pathways. Previous data suggest that this growth factor may be involved in 
enhancement of apoptosis and reduction of proliferation of fibroblast. Also an in vitro 
investigation showed that TNF-α induced gene sets regulate a number of pathways 
that could influence inflammation and apoptosis (Siqueira et al., 2010).  
1.11 Further effective local factors during wound healing  
1.11.1 Enhanced proteinase activity 
Increased levels of pro-inflammatory cytokines enhance the synthesis and/or release 
of several matrix metalloproteinases and serine proteases (Agren and Werthen, 2007). 
In agreement with this, increased proteolysis has been observed in chronic wounds. 
Elevated levels of MMP-1, MMP-2, MMP-8 and MMP-9 have been reported for 
delayed healing wounds(Lobmann et al., 2002), as compared to normal healing 
wounds. Altered distribution of proteinase-producing cells in specific wound areas 
has been observed. Other proteinases, such as elastase, have been reported to be 
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elevated as well in chronic wounds due to the large numbers of activated neutrophils. 
Interestingly, one study showed that elastase degrades MMPs in vivo and the authors 
suggested that elastase is the main cause of ECM destruction(Grinnell and Zhu, 
1996). 
 
 
1.11.2 Pressure and Tension  
 Previous studies have shown that by 5 to 7 days post wounding, the tensile strength 
of wounds closed under tension in rats is significantly higher than the tensile strength 
of wounds closed without tension(Wang and Zhao, 2006). Moreover, the beneficial 
effect of platelet derived growth factors (PDGF) in accelerating healing in wounds 
closed under tension has been demonstrated (Tzikas et al., 1996).  Additionally a 
strong relationship between the rate of contraction and the maximum thickness of the 
granulation tissue was demonstrated. In this study fibroblasts, blood vessels and 
connective tissue fibers, were introduced as effectively a contractile engine. An in 
vitro quantification of granulation tissue samples confirmed that total cellularity 
paralleled the tension developed. Pervious research suggested the reduction in 
cellularity preceded by approximately 4 days post wounding, the decrease in the 
tension developed that led to an increase in the collagenous scaffolding.  Also it has 
been indicated that the portion of fibroblast with the myofibroblasts characteristics 
primarily increases fast, and then remains constant throughout the contraction phase 
and decreases as contraction terminates (Snowden and Cliff, 1985).  
 
1.12 Introduction to Notch signaling    
One crucial factor for the development of multicellular three-dimensional structure is 
the ability to form complex biological patterns from a single cell. Pattern 
establishment is the consequence of coordinated gene action that targets the 
developmental fate of individual cells. Essential, cell-autonomous factors as well as 
non-autonomous, guide and orchestrate the cell proliferation, migration, growth, 
differentiation, and death, through developmental path to bring together cellular 
groups in a defined manner.  The mechanism of contribution of the essential 
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developmental factors in specification of cell fates describes the main issue of 
developmental biology.  Notch signaling is an evolutionary conserved mechanism that 
is used by metazoans to control cell fates through local cell interactions (Artavanis-
Tsakonas et al., 1999).  
 
1.12.1 Notch history 
In 1914, John Dexter identified and discovered Notch in the fruit fly (Drosophila 
Melanogaster) for the first time. The name ‘Notch’ is derived from the characteristic 
notched wing found in flies with haploinsufficency of the Notch gene (Okuyama et 
al., 2008). Further research in the 1970s demonstrated that the homozygous mutations 
result in lethal phenotypes in fruit flies, due to neurogenic aberrations, where cells 
destined to become epidermis switch fate and give rise to neural tissue (Wright, 
1970).The involvement of Notch in several other developmental processes in 
Drosophila, such as bristle formation (Heitzler and Simpson, 1991)maintenance of 
muscle founder cells (Bate et al., 1993), midgut progenitor cells and cell fate 
regulation decisions in stem cell progeny (Heitzler and Simpson, 1991) have also 
been shown.  The functional roles of Notch in cell specification has been credited by a 
study of the nematode Caenorhabditis elegans (C.elegans); where two Notch 
homologues, LIN-12 and GLP-1, were reported in C.elegans (Kimble and Simpson, 
1997). Further studies that applied to model organisms such as Drosophila 
melanogaster and Caenorhabditis elegans, have revealed a steady path to gene 
cloning, functional and genetic characterization of Notch signaling pathway in the 
1980s (Kimble and Simpson, 1997). The Notch gene encodes a single Notch receptor 
and two ligands, which are present on adjacent cells in Drosophila (Fehon et al., 
1990). Notch receptors have been identified in all vertebrate species. In mice and 
humans, four Notch proteins (Notch1-4) and five Notch ligands (Delta-like 1,3 and 4; 
Jagged 1 and 2 have been identified (Okuyama et al., 2008, Wang, 2011) (Figure 10). 
The function of the Notch receptors and ligands are briefly discussed below.  
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1.13 The Notch-pathway participants, structure and function 
1.13.1 Notch receptors 
The intermediary function of Notch in cell fate decisions has been well known and 
documented. Due to the conservation of Notch molecular structure the general 
function of Notch has been highly conserved during evolution (Artavanis-Tsakonas et 
al., 1995). During biosynthesis a furin cleavage produces the mature Notch receptor. 
Figure 10 shows the molecular structure of Notch signaling participants. Notch is a 
transmembrane protein; the extracellular domain of Notch that functions as a receptor 
in cell-cell interactions, has 29 to 36 tandem epidermal growth factor (EGF) repeats 
and three cysteine rich lin-12/Notch repeats (LNR) and a region that links to the 
transmembrane and intercellular fragment. This linker is critical in preventing 
premature activation of Notch receptors.  Six cdc10/SWI6/ankyrin repeats, putative 
nuclear localization signals (NLS), and a C-terminal OPA/PEST region, make the 
Notch intracellular domain (NICD). Cdc10 region of the molecule is very critical for 
intercellular signal transduction and also is the extremely conserved portion of Notch 
molecule (Bigas et al., 1998, Coffman et al., 1993, Fortini et al., 1993) (Figure1.10). 
 
 
 
 46 
 
Figure1.10.Canonical regulators of Notch signaling.  
Protein structures of canonical Notch pathway receptors and ligands are shown. All 
proteins contain 6–36 EGF-like domains and are type I transmembrane proteins.  
The total number of EGF-like domains in each protein is shown above the last EGF-
like domain. The four Notch receptors include LIN-12-Notch repeats (LNR) adjacent 
to the plasma membrane and also contain large modular intracellular domains 
(NICDs) that act in the nucleus. The ligands all contain DSL domains at the N-
terminus. Their intracellular domains are very short. Dll should not be confused with 
Dlk, a pair of non-canonical ligands (Wang, 2011). 
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1.13.2 Notch Ligands 
Notch ligands are transmembrane proteins that are illustrated by an N-terminal DSL 
(DSL proteins, such as Delta, Serrate, and Lag-2) an extracellular domain that is 
crucial for interaction with the Notch receptor (Figure1.10). Ligand binding of Notch 
molecule results in activation of this receptor. It has been reported that among a group 
of cells having comparable cell fate potentials, expressing higher levels of Notch in 
some cells inhibits differentiation and directs cells to remain multipotent.   Functions 
of different parts of Notch molecules in several systems have been elucidated (Lieber 
et al., 1993).  
 
1.13.3 Nuclear effectors  
CSL (CBF1, Su (H), Lag-1) that is a DNA-binding protein acts as a key transducer of 
Notch signaling pathway. CSL is characterized by a β-trefoil domain (BTD) between 
the two Rel-homolohy regions (RHR-N, RHR-C) (Kovall and Hendrickson, 2004). 
Most of the DNA contacts are mainly made through the RHR-N and BTD domain. It 
has been reported that a hydrophobic pocket within the BTD domain facilitates the 
interaction with the NICD. Mastermind (Mam) is a co-activator that is essential to 
activate transcription .   
 
1.14 Notch signaling cascade 
The cell-to-cell contact that leads to interaction between Notch receptors and their 
ligands (Delta or Jagged) promotes two proteolytic cleavage events in Notch receptor 
(Figure1.11). The ADAM-family of metalloproteases mediates the first cleavage and 
an enzyme complex that contains presenilin, nicastrin, PEN2 and APH1 that is known 
as  γ- secretase controls the second proteolytic cleavage (Bray, 2006) . The second 
cleavage releases the Notch intracellular domain (NICD), which then translocate to 
the nucleus and cooperates with the CSL (DNA-binding protein RBP-J) and its co-
activator Mastermind (Mam), and acts as a transcriptional co-activator. This 
activation leads to the conversion of CSL (CBF1, Su (H), Lag-1) proteins from 
repressors to transcriptional activators and triggers the up-regulation of target genes 
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such as HES (Hairy/Enhancer of Split genes). The Notch signaling pathway is 
illustrated in Figure 1.11.  
Binding NICD to RBP-J in the nucleus removes corepressors from RBP-J, and leads 
to the derepression of promoters containing RBP-J binding sites and consequently 
recruits a coactivator complex by which the transcription of Notch target genes gets 
activated (De Strooper et al., 1999).  
The mechanism that regulates Notch activation as a result of an interaction between a 
ligand and the Notch extracellular domain (ECD) is still unclear (Bray, 2006). The 
factor that determines in which cells the ligand and the receptor are active has been 
the ambition of numerous different studies as an interesting subject to be well defined. 
It has been described that dramatic differences presented in signaling and signal 
reception between cells are not linked with recognizable alterations in the expression 
levels of ligands or the receptors. However the full complexities of Notch regulation 
are still to be clarified, the post-translational modifications and trafficking of the 
Notch ligands and receptor are the main factors by which the pathway activation can 
be affected (Bray, 2006).   
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Figure 1. 11.Core Notch signaling pathway.  
The core elements of Notch signaling pathway are shown. Notch and most of its 
ligands are transmembrane proteins, so the cells expressing the ligands typically must 
be adjacent to the notch-expressing cell for signaling to occur. These include the 
Notch receptor, DSL ligands, CSL transcriptional factors and target genes such as 
HES family of basic helix-loop-helix transcriptional regulators. Upon binding ligand 
the Notch signaling converts CSL from a transcriptional repressor to a transcriptional 
activator. This conversion is via direct protein-protein interactions between the Notch 
intracellular domain and the CSL. A metalloprotease (ADAM) controls the first 
cleavage of Notch after ligand binding and the second cleavage controls by γ-
secretase complex. The release of intracellular domain of Notch (NICD) is the result 
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of these cleavages that can be transported to the nucleus, where it cooperates with 
transcription factors to regulate gene activity (Adapted from Tsakonas, 1995). 
 
 
1.14.1 Proteolytic cleavages of Notch 
Three different cleavage sites are reported during Notch receptor activation known as 
S1, S2 and S3 (Figure1.12). First cleavage (S1) is a non-activating cleavage that 
occurs during Notch receptor maturation.  Furin-like convertase mediates this 
cleavage that is required for cell surface expression of heterodimeric full-length Notch 
receptor-Ca++ coordinated bond between Transmembrane and Intercellular domain 
(TMIC) and Extracellular Notch (ECN). The second cleavage is an activating 
cleavage that is mediated by two metalloproteases known as ADAM10 and tumour-
necrosis factor-α (TNF-α)- converting enzyme (TACE; also known as ADAM17).  
This cleavage occurs at an exracellular site (S2) between Ala 1710 and Val 1711 residues, 
almost 12 amino acids outside the transmembrane domain (Figure1.12). S2 is a 
ligand-induced proteolytic cleavage that ends to a carboxy product called NEXT (for 
Notch EXternacellular Truncation) that is an intermediate precursor to S3 cleavage 
(Mumm et al., 2000). The third cleavage site termed site 3  (S3) is an activating 
cleavage and occurs within the transmembrane domain following S2 cleavage. S3 
results in the release of NICD and activation of CSL-associated downstream targets.  
This cleavage is dependent upon the Presenilins that is a γ-secretase-like protease.   
The proteolytic fragment found to be the result of proteolysis between glycin 1743 
and valine 1744 of mouse Notch1(Schroeter et al., 1998)(Figure1.12). 
1.14.2 Notch-ligand activity 
Contribution of Notch ligands to differential activity of the pathway, expression of 
Notch ligands by a distinct population of cells, and the involvement of Notch ligands 
during development are well established.  
Identification of an adaptor protein known as E3ubiquitin ligases that is essential for 
ligand activation and interacts directly with Notch ligands describes the regulation of 
pathway and the link between ligand activity, ubiquitylation and endocytosis (Chitnis, 
2006).   
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Figure.1.12. Diagram of Notch protein and the proteolytic cascade of Notch activation.  
A) Schematic of Full-length Notch protein, and amino acid sequence of mouse 
Notch1 encompassing each known cleavage site is shown within the open rectangle. 
Precise sites of S1,S2 and S3 cleavage are shown by arrows and the amino acid 
number of the respective C-terminal ends. The shaded rectangle shows an 
approximated transmembrane domain with a 24 amino acids. B) A diagram of the 
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proteolysis-mediated model of ligand-induced Notch activation. Abbreviations: ECN, 
Extracellular Notch; TMIC, Transmembrane and Intracellular domain. NEXT, Notch 
Extracellular Truncation; NICD, Notch Intercellular Domain. Figure is adapted from 
(Mumm, 2000). 
1.14.3 Notch target genes  
In various cellular and developmental contexts a limited set of Notch target genes 
have been identified. The hairy/enhancer of split (Hes) family genes that are described 
as neurogenic genes in Drosophila are some of the most critical highly conserved 
proteins that are regulated by Notch in multiple cell types.    The transcription factors 
Hes1, Hes5 and Hey1 (subfamily of Hes) that function as transcriptional repressors 
are described as the main Notch target genes in mammals (Fischer and Gessler, 2007, 
Kageyama and Ohtsuka, 1999). CD25 and GATA3 were also identified to be Notch 
target genes in T-cell and T-cell later developmental stage transcription factors 
respectively (Amsen et al., 2007, Fang et al., 2007, Reizis and Leder, 2002). Notch 
target genes, which are, involved in cancer, are described as c-Myc (Palomero et al., 
2006, Satoh et al., 2004), cyclinD1 (Ronchini and Capobianco, 2001) and p21/Waf1 
(Rangarajan et al., 2001). Furthermore a number of other Notch target genes have 
been reported including NFkB2 (Oswald et al., 1998), Ifi-202,Ifi204,Ifi-D3 and 
ADAM19 (Deftos et al., 2000).  
1.14.4 Termination of Notch signaling  
Notch activation releases the most important part of the signal in the form NICD from 
the transmembrane. It has been reported that the optimization of signal strength is 
under the control of different mechanisms involved in NICD production. It has been 
also mentioned that NICD acts in the nucleus and must be removed from the mitotic 
cells(Kopan, 1999). The significance of the proteasome in Notch signaling has been 
demonstrated (Schweisguth, 1999).  Previous studies reported post-transcriptional 
modification of NICD on its PEST domain by the CDK8 kinase, and proteasomal 
degradation by the E3 ubiquitin ligase Sel10/Fw7. This modification removes NICD 
from the DNA-binding complex and releases the cell ready for the next round of 
signaling. Additional phosphorylation sites that regulate Notch signaling still remain 
to be identified (Hubbard et al., 1997).  
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1.15 Notch1 and Notch2 association  
Both intercellular and extracellular domains of Notch act equivalently in Notch 
activation mechanism. It has been demonstrated that a segment of Notch enters and 
functions in the nucleus after cleavage of the transmembrane protein. It has been 
established that the Notch intercellular domain (NICD) functions directly within the 
nucleus as a transcriptional adapter protein and the nuclear localization signal (NLS) 
is the NICD site of action, which is functional in the nucleus (Lieber et al., 1993).   
 Observation of the function of the Notch molecules lacking the extracellular domain, 
demonstrated a behavior of these molecules as constitutively as activated forms of 
Notch. Therefore these studies reported that ligand binding Notch activation results 
can be comparable to the form of Notch activity achieved by the expression of only 
the intracellular domain (Fortini et al., 1993). These studies endorse the significance 
and critical function of Notch intracellular domain. The essential roles of Notch1 and 
Notch2 structurally conserved genes for the development of various organ systems in 
mammals are well established. A study by Kraman and his group hypothesized that 
the differences between the amino acid sequence within the intracellular domains 
(ICDs) of Notch1 and Notch2 could be responsible for exerting the functional 
differences observed between these two genes in vitro (Kraman and McCright, 2005). 
To investigate the Notch ICD functions in vivo, transgenic mice were created that 
contained a replaced non-conserved region of the Notch2 ICD comprises 426 amino 
acid with the homologous region of Notch1. The main aim of this study was based on 
identification differences in the signaling and functional capabilities of the Notch1 
and Notch2 ICD. Unexpected results from this experiment demonstrated no native 
Notch2 message, however the organ (the kidney glomeruli and intrahepatic bile ducts) 
structural development, which required Notch2, was perfectly formed. This report has 
shown that the activation domain on Notch receptor (ICD) between Notch1 and Notch 
2 in mice is functionally conserved. As the amount of conservation in the ankyrin 
repeat region of NICD is high, hence it has been hypothesized that the replacement of 
the entire Notch2 ICD would have presented the same results (Kraman and McCright, 
2005).  Nevertheless, another in vitro investigation has shown that the C-terminus of 
both Notch1 and Notch2 could activate transcription; another study has reported 
potential distinct functions of mice Notch1 and Notch2 in hematopoietic 
differentiation due to transcriptional activating differences between the different 
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Notch ICDs (Bigas et al., 1998). This study spotted a region C-terminal of the ankyrin 
repeats that presented differential cytokine response to the Notch1 and Notch2 ICDs 
in myeloid progenitor cells undergoing differentiation. Association of the structural 
differences between Notch1 and Notch2, within Notch cytokine response (NCR) 
regions, contribute to functional specificity in this system (Bigas et al., 1998). It can 
be concluded from previous studies that Notch1 and Notch2 ICDs are functionally 
redundant, however the differential ligand interaction or extracellular domain 
modifications could be termed as the main factors that can effect Nocth1 and Nocth2 
activation. As Notch1 and Notch2 ICDs apply the same downstream effects, to active 
the signaling pathway to control the cell fate decision and developmental functions, 
Notch1 and Notch2 ICDs can be used.   
 
1.16 Notch signaling function 
The Notch signaling pathway is significantly involved in cell-cell communication, 
cell fate decisions and regulation of the embryonic developmental cascade (Austin 
and Kimble, 1987). The Notch signaling pathway is a highly conserved network that 
plays a key role in the proliferation and differentiation of many tissues. Notch 
signaling pathway orchestrates cell-fate decision in the different systems of many 
organisms ranging from insects to human (Bray, 2006). 
1.16.1 Notch Signaling and embryogenesis  
Involvement of Notch signaling in embryonic polarity has been confirmed by 
demonstrating the abnormality in anterior-posterior polarity in somites in the absence 
of Notch signaling (Feller et al., 2008). Furthermore, the functional role of Notch 
signaling during left-right asymmetry determination in vertebrates has also been 
reported(Levin, 2005). It has been demonstrated that Notch signaling is required in 
segmentation of somities as abnormal somitogenesis and loss of anterior-posterior 
polarity were reported in Delta mutant mice(Conlon et al., 1995).  
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1.16.2 Notch signaling and systematic development  
Contribution of Notch signaling pathway has not only been reported in the 
development of the  Central Nervous System (CNS) in Drosophila, but it has also 
been found that Notch pathway is critical for maintaining neural progenitor cells 
(NPC) in developing brain, glial cell specification (Furukawa et al., 2000, Scheer et 
al., 2001), regulation of dendritic development (Redmond et al., 2000) as well as adult 
brain function such as learning and memory (Costa et al., 2003). 
It has been presented that Notch signaling performs key functions in mouse 
cardiovascular formation and morphogenesis not only during the developmental 
process but also in disease. It has been reported that three main cardiac developmental 
cascades known as: Atrioventricular canal development, myocardial development and 
cardiac out flow tract (OFT) in mice are all regulated by the Notch signaling pathway 
(Niessen and Karsan, 2008). It has been stated that differentiation of mouse vascular 
smooth muscle cells during embryonic and adult arteriogenesis requires Notch 
signaling (Chang et al., 2012). In addition endothelial cellular behavior during blood 
vessel development that occurs throughout angiogenesis, likewise is coordinated by 
Notch signaling (Leslie et al., 2007). 
1.16.3 Notch and Regulation of tissue homeostasis in adults  
There is much evidence to suggest that Notch signaling has an effect on the regulation 
of tissue homeostasis in adults in mice. Involvement of Notch signaling in 
angiogenesis has been confirmed by the mutation of Notch receptors and ligands in 
mice, by which the abnormality in the vascular system and many other tissues was 
detected (Krebs et al., 2000).  
It has been confirmed that the effects of Notch signaling regulate a wide range of 
cellular process including the maintenance of stem cells, cell fate specification, 
differentiation and proliferation in many different organs in various mammalian stem 
and early progenitor cells (Chiba, 2006). Involvement of Notch signaling in the 
vertebrate hematopietic system has been shown by the effect of Notch on balancing 
the differentiating stem cells population by inducing these cells to retain the 
undifferentiated state (Jones et al., 1998).  
The participation of Notch signaling in specification of cell fate to preserve 
undifferentiated states has been reported during the development of neuronal 
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precursor cells in Drosophila. A group of original equipotent cells that have the 
potential to be either epithelial cells or neuronal cells were monitored.  The epithelial 
cell fate was reported in cells that received Notch signals whereas neuronal cell fate 
was observed in cells that express ligands (Kimble and Simpson, 1997). Furthermore 
Notch signaling can also influence cell fate choice during mice lymphocyte 
development (Radtke et al., 2004, Wilson et al., 2001) and induce terminal 
differentiation during epidermis formation (Radtke and Raj, 2003). There is also 
substantial evidence of involvement of Notch1 activation in leukemia and a variety of 
cancer cells in human (Purow et al., 2005). Although  previous studies demonstrate 
that the involvement of Notch activation during cancer cell growth depends on cell 
types, the role of Notch signaling in tumorigenesis and cancer are still far from being 
elucidated (Sriuranpong et al., 2001, Talora et al., 2002). 
1.17 Notch and skin 
Mammalian skin undergoes constant regeneration throughout homeostasis, and, in 
addition, must be primed to undergo wound repair in response to injury. Skin 
capability for maintaining tissue homeostasis, regenerating hair, and repairing the 
epidermis after injury is controlled by its stem cells, which reside in the adult hair 
follicle, sebaceous gland, and epidermis. The generation of the interfollicular 
epidermis (IFE), hair follicles (HF) and sebaceous glands (SG), is the consequence of 
the well-regulated terminal differentiation of epidermal stem cells. The differentiation 
pathway selected by these stem cell populations is principally determined by local 
micro-environmental signals (Jones et al., 2007, Watt et al., 2006). Understanding the 
mechanism by which these stem cell populations respond to activate migration, 
signaling networks, proliferation, differentiation and maintaining the normal 
homeostasis and wound repair in the skin along a specific lineage is particularly 
critical. Nevertheless the principles of these mechanisms are not clearly described yet; 
there is much evidence that support the involvement of signaling pathways in the 
regulation of skin SCs. It has been documented that a set of molecular archetypes 
including the Wingless (Wg/Wnt), Hedgehog (Hh), Transforming Growth Factor-
β(TGFβ), Receptor Tyrosin Kinase/Phosphotase and Notch pathway perform to 
interpret and transmit signals as distinct cellular transcriptional responses (Gerhart, 
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1999). These signaling pathways appear to be also critical in the regulation of the skin 
SCs behavior (Fuchs and Horsley, 2008).  
It has been shown that Wnt signaling regulates SCs in the HF during differentiation, 
although limits the SG maintenance and differentiation. BMP signaling has a positive 
function in HF SCs quiescence while it has a negative effect on these SCs activation.  
There is reported effect of BMP signaling on the epidermis or SG linages. TGFβ 
signaling pathway performs a critical function in controlling epidermal homeostasis 
whereas Notch signaling has been introduced as an universal regulator of all SC 
linages in the skin epithelium (Fuchs and Horsley, 2008).    
Although the identification of these fundamental signaling pathways that regulate the 
differentiation program of the stem cell compartment of many tissues have been 
considerably progressed in recent years (Blanpain et al., 2007, Watt et al., 2006), the 
mechanism that controls the epidermal highly organized differentiation program has 
not been established in detail. The basal layer localizes to the basement membrane 
and consists mostly of transient amplifying cells with a few SC interspersed. The 
basal cell layer gives rise first to the spinous layer followed by the granular layer and 
then the cornified layer. Notch1 signaling induces the expression of early 
differentiation markers such as Keratin1 and Involucrin, and partially represses the 
expression of Loricrin and Filaggrin, two late differentiation markers (Watt et al., 
2008, Koch and Radtke, 2010) (Figure 1.13).  
The Notch pathway plays an important role in the regulation epidermal 
differentiation. The expression of Notch ligands, receptors and effectors in adult and 
embryonic skin in mice has been previously reported (Okuyama et al., 2008, Watt et 
al., 2008). The effects of cell-autonomous and non-autonomous of Notch on 
epidermal differentiation have also been the focus in recent studies. Here the diverse 
ways in which Notch signaling regulates epidermal differentiation are described.  
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Figure1.13. Notch1 function in epidermis.  
The epidermis is composed of several layers, each in different stages of 
differentiation. Specific proteins are expressed in each cell layer. Notch1 enhances the 
expression of keratin1 and involucrin, and prevents the induction of filaggrin and 
loricrin, which are induced in much later stages (Koch, 2010). 
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1.17.1 Sites of activated Notch pathway in developing and adult skin 
Several Notch receptors and ligands are expressed in both developing and adult skin 
(Kopan and Weintraub, 1993). In epidermal development Notch receptors 1-3 and 
their ligand, Jagged1, expression is detected suprabasaly, whereas Jagged2 expression 
has been reported in basal cells during skin development in mice (Powell et al., 
1998)..  
The up-regulated Notch1, Notch2, Notch3 and Notch4 expression in both suprabasal 
cells of IFE (Blanpain et al., 2006, Nickoloff et al., 2002) and hair follicles (Kopan 
and Weintraub, 1993) have been detected in cells that are initiating or are undergoing 
terminal differentiation in adult skin in mice. Notch ligands (Delta1, Jagged1 and 
Jagged2) have also been detected in the adult epidermis. Previous studies reported the 
expression of Jagged1 primarily in the suprabasal layer of the upper outer root sheath 
and bulb pre-cortex and in some basal cells; Jagged2 expression was detected in the 
hair follicle bulb cells next to the dermal papilla and in the basal layer of the outer 
root sheath (Favier et al., 2000, Powell et al., 1998) (Figure 1.14). Recent studies have 
provided evidence that in the mouse skin, Delta1 is expressed in the dermal papilla 
and in the epithelial cells at the base of the hair follicle, and in clusters of cells in the 
basal layer of the IFE in embryonic but not adult epidermis (Estrach et al., 2008). 
Previous investigations suggest that the expression of Notch pathway elements is 
noticeable in both embryonic and adult epidermis   and this pathway is primarily 
active in cells of the IFE or HF that are committed to, or undergoing, terminal 
differentiation(Watt et al., 2008).  
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Figure 1.14.Expression of Notch ligands and receptors.  
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Neonatal interfollicular epidermis (top panel) and hair follicles (bottom panel) in 
mouse are shown. Hatched shading indicates co-expression. CL: cornified layer; GL: 
granular layer; SL: spinous layer (Watt, 2008). 
1.17.2 Postnatal maintenance of the epidermis and Notch receptors 
A previous study by applying the postnatal ablation of Notch1 has confirmed a 
hyperproliferation of epidermis and suggested the tumor suppressor function for 
Notch1 in epidermis in mouse (Rangarajan et al., 2001, Okuyama et al., 2008).  
Deletion of Notch2, Notch3 or Notch 4 alone, did not suggest any effect on the mice 
embryonic or adult epidermis (Krebs et al., 2000, Krebs et al., 2003, Pan et al., 2004). 
Deletion of Notch1 or Jagged1, only, has suggested similar effects including the 
normal HF formation in the embryo, whereas in adult, disturbed HF and immature 
sebocytes were observed (Pan et al., 2004). Deletion of Delta1 results in a delay of 
hair growth in postnatal, but no further effects on the HF (Estrach et al., 2008). These 
studies have suggested that Jagged1 is contributing in regulation of hair follicle 
differentiation, and Delta1 controls the IFE proliferation and differentiation.  
The effects of activation the Notch pathway by overexpressing NICD in different 
epidermal layers has been determined in recent studies. Expansion of the 
differentiated cell compartment of the IFE, disturbed differentiation of HF lineages 
and hair loss are the reported consequences of the overexpressing of NICD in 
suprabasal layers of the IFE and the HF inner root (Uyttendaele et al., 2004). 
Increasing the epidermal thickness due to an expansion of the IFE spinous layers and 
reduced granular cell differentiation are described as the results of the overexpression 
of NICD in the basal layer of the epidermis, SG and HF(Blanpain et al., 2006). These 
studies have delivered evidence of an essential postnatal role of Notch signaling for 
HF maintenance and the regulation of SG terminal differentiation within the IFE, 
while suggesting that Notch is not required for embryonic development of the 
epidermis (Watt et al., 2008). 
 
 
 62 
1.18 Non-cell autonomous effects of Notch in skin   
Numerous previous studies have acknowledged the cell-autonomous effects of Notch 
signaling in epidermal development and epidermal stem cells differentiation (Ambler 
and Watt, 2010, Blanpain and Fuchs, 2006, Estrach et al., 2006, Estrach et al., 2008, 
Moriyama et al., 2008).  
There is clear evidence that Notch has non-autonomous effects on epidermal 
differentiation. Contribution of Notch pathway in Drosophila development has been 
explained as one of the most important non-cell autonomous effects of Notch (Bray, 
2006). Another study confirmed that, epidermal deletion of Notch leads to increased 
epidermal production of thymic stromal lymphopoietin (TSLP), which triggers a B 
lymphoproliferative disorder with massive dermal accumulation of B cells(Demehri et 
al., 2008).  Introducing Notch as an epidermal tumour suppressor, has also confirmed 
the effects of non-cell autonomous effects of Notch in epidermis (Demehri et al., 
2009b, Estrach et al., 2008). Involvement of Notch signaling in wound healing and 
tissue repair, suggests more evidence of non-cell autonomous effects of Notch 
(Chigurupati et al., 2007, Nickoloff et al., 2002). 
 Previous research exhibited that, in adult skin, Notch signalling via Jagged 1 in the 
epidermis endorses downstream global changes to the dermal stroma (Ambler and 
Watt, 2010).  In this study Jagged 1 has been described as a key component of cell 
autonomous and non-cell autonomous Notch signaling in the skin. Examples of non-
cell autonomous effects of Notch in this study, extended to the up-regulation of TNFα 
following Notch activation by which the contribution of Notch to the inflammation 
and barrier defects might be explained (Ambler and Watt, 2010).  
 
 
1.19 Notch Non-autonomous effects and inflammatory 
responses  
Innate and adaptive arms of the vertebrate immune system need to be functionally 
organized to support immunity and to prevent immunopathology. Although, the 
Notch pathway was initially described as a pleiotropic mediator for cell fate in 
invertebrates, the regulation of immune cell development and function, by the Notch 
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pathway has recently arisen by different researches (Mochizuki et al., 2011, Radtke et 
al., 2013, Ambler and Watt, 2010).  
The roles of Notch in developing lymphocytes were initially reported, although 
recently Notch has been demonstrated to be  key in controlling the homeostasis of 
several innate cell populations (Mochizuki et al., 2011, Radtke et al., 2013). A non-
cell autonomous effect of Notch in adaptive immunity has been expanded, by 
involving in   regulation of T cell differentiation and function. The inflammatory T-
cell response is important for protecting the organisms against infections throughout 
wound healing. Thus, the regulation of effector T cells is essential during the 
inflammatory phase of repair. Accumulating evidence indicates that Notch plays 
critical roles in regulating the differentiation of antigen activated T cells into distinct 
lineages of effector T cells. Furthermore, significant progress has been made in the 
development of new methods in order to modulate Notch for inflammatory responses. 
Previous research showed that Notch activity, via Jagged1, stimulates epidermal 
production of proinflammatory TNFα and 14-21 days of persistent Notch activity 
leads to CD3+CD4+ T cell recruitment in mice (Ambler and Watt, 2010). 
Innate Lymphoid Cells (ILCs) is an essential population of lymphocytes, for 
secondary lymphoid tissue formation, hemostasis and cytokines production in 
response to infection. ILC22s as a subset of ILCs is explained as key factors in 
production of IL22 induced by IL23 from dendritic cells, in adult thymus 
regeneration. Recent wound healing research (Ambler and et al., unpublished data) 
demonstrated that, epidermal Notch1 activation results in the up-regulation of TNFα, 
which directly induces CCL20 expression recruiting ILC22 into the dermis. These 
data provide evidence that epidermal proliferation and macrophage entry into the 
dermis and production of essential wound healing cytokines is depending at the 
accumulation of ILC22, as a non-cell autonomous effect of Notch activation.   A 
previous study (Ambler and et al., unpublished data) showed that forced, ectopic 
epidermal Notch1 activity resulted in extensive, epidermal proliferation and severe 
inflammation, two phenotypic hallmarks of skin wound healing (Ambler and Watt, 
2010).  
In this project, we will discuss recent findings that help to gain insight into a better 
understanding of the mechanisms by which epidermal Notch activity may benefit 
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wound healing, via infiltration of immune regulatory factors to the injured mouse 
skin.   
1.20 Notch Signaling and wound healing  
The functional roles of the Notch receptor family in cell fate decision in many 
developmental systems are documented (Maillard et al., 2005).  Results from a 
previous study indicate that Notch family members induce T lymphopoiesis in a 
lineage-specific manner(Hozumi et al., 2003). Involvement of Notch signaling has 
been also reported in the regulation of lymphocyte expansion and immune function 
(Kared et al., 2006). The outcomes of a research that focused on involvement of 
Notch in regulation of the neural cell responses to injury suggest that Notch signaling 
may be a target for regeneration of damaged neural cells (Arumugam et al., 2006). 
Participation of Notch signaling in angiogenesis, formation of new blood vessels, 
(Xue et al., 1999, Krebs et al., 2000) and also in regulation of epithelial cell 
proliferation and migration during angiogenesis in normal tissue and tumors has 
previously been confirmed (Nakajima et al., 2003, Sainson et al., 2005). Notch has 
also been shown to influence the comportment of different cell types such as 
keratinocytes, fibroblasts and platelets(Rangarajan et al., 2001). Although there is not 
much evidence indicating a direct role of Notch in wound healing, the Influence of 
Notch signaling in the regulation of tissue homeostasis, angiogenesis, regulation of 
inflammatory functions, re-epithelialization and regulatory functions on keratinocytes, 
fibroblasts in epidermis, all provide a proposal of hypothetical contribution of Notch 
signaling during skin wound healing. Skin wound healing involves an initial 
inflammatory response that requires the release of chemokines and growth factor from 
stromal and epidermal compartments of skin. As mentioned before, during cell fate 
decision and pleiotropic functions in skin, Notch plays a key role. Previous studies 
that have confirmed an extensive epidermal proliferation, and also inflammation, after 
forced ectopic Notch activity (Ambler and Watt, 2010).  Elucidated models that have 
inhibited or activated Notch during the healing process,  all suggest that Notch might 
be involved in wound healing. Hence in this project we used the K14NICDER 
transgene contains a truncated, Notch1 intercellular domain (NICD) that can be 
temporally and spatially activated by 4-hydroxy-tamoxifen (4OHT) in the basal, 
keratin 14-expressing epidermis.  
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A jagged1-dependent mechanism of Notch1 activity was previously reported in 
4OHT-treated NICDER transgenic skin (Ambler and Watt, 2010), in this project we 
investigate if the Notch2 activation is also jagged1-related. The relative regulatory of 
inflammation response in wound healing by Notch2 activity and the relation of this 
activity and jagged1 function will be also determined by applying triple transgene 
K14NICDER/K14CreER/jag1flox/flox mice lacking jagged1.  
An extensive epidermal proliferation and inflammation after forced ectopic Notch 
activity was reported in 4OHT-treated NICDER transgenic skin (Ambler and Watt, 
2010). Notch signaling activation in the absence of a wound in the transgene model 
K14NICDER after one week of applying 4OHTon mouse back skin, confirmed the 
infiltration of CD4 and CD3 positive T-cells to the epidermis and dermis (Ambler and 
Watt, 2010). A natural wound healing response in the early inflammatory phase is the 
accumulation of CD4+, CD3+ and CD8+; to examine whether inducing Notch activity 
before wounding will enhance the wound healing rate and condition, the 
accumulation of early immune response cells before wounding in the back skin was 
hypothesized. To investigate the relative skin inflammatory response and wound 
healing may suggest the fundamental role of Notch signaling during skin wound 
healing.  Before wounding a week 4-OHT treatment of back skin of K14NICDER 
mice will cause the Notch activity in epidermis and also will provide us with the 
prospect of Notch activation and skin inflammatory relation.  
Therefore in this study we would like to demonstrate whether induced Notch activity 
effects the TNF-α expression in prior to wound 4OHT-treated K14NICDER, which 
the inflammatory responses are enhanced. In this study the continuing of 4OHT 
treatment after wounding is hypothesized to encourage the filtration of more 
immunocytes and other induced Notch activity consequences to the wounded skin, 
and monitoring the healing process. 
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1.21 Hypotheses  
I hypothesis that epidermal Notch signalling may be active in the skin as a response to 
wound healing. In addition, I hypothesis that forced epidermal Notch1 activity results 
in extensive, epidermal proliferation and severe inflammation; persistent Notch 
activity may lead to chronic inflammation and poor wound healing. I also hypothesise 
if the anatomical location of the wound affects the rate of wound closure on mouse 
back skin due to possible site dependent proliferation and differentiation rate in 
mouse back skin. 
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2 Materials & Methods 
All experimental procedures were conducted in compliance with Durham University 
and the School of Biological and Biomedical Sciences safety policy according to the 
control of substances Hazardous to Health (COSHH) regulations. All reagents were 
sourced directly through the relevant suppliers and COSHH regulations were 
followed throughout their usage.  
2.1 Mice 
Experimental procedures were performed under a UK government Home Office 
licence (Licence number: 60/3941). The generation and characterisation of transgenic 
mice (K14NICDER, K14CreERJag1 flox/flox) has been previously described (Brooker 
et al., 2006, Jensen et al., 2009, Kawamoto et al., 2000, Lo Celso et al., 2004, Estrach 
et al., 2006).  
The NICDER transgene model used in this project consists of amino acids 1751-2290 
of the mouse Notch1 intercellular domain (NICD). There is a FLAG sequence at the 
N-terminal of this gene and a modified oestrogen receptor (ER) fused in frame at the 
C terminus(Schroeder and Just, 2000).  The construct that was made of NICD was in 
to the Keratin14 (K14) promoter cassette (Vasioukhin et al., 1999) and injected into 
the pronucleus of (CBA×C57bl) F1 embryos. Potential founder lines were screened 
by PCR (forward: rabbitβ -globin intron 5′-TACTCTGAGTCCAAACCGGGC-3′ and 
reverse: mouse Notch1 5′-CACTCGTTCTGATTGTCGTC-3′) (Figure 2.1). 
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Figure 2.1 The construct that was made of NICD was in to the Keratin14 (K14) 
promoter cassette.  
 A NICD region is shown as part of the full-length (top). At the bottom, the   FLAG 
sequence at the N-terminal of Notch1 and a modified oestrogen receptor (ER) fused in 
frame at the C terminus.  
 
 
2.2 Dermal wounds and quantification of healing 
Mice were shaved at the back skin and anesthetized using 2 to 2.5% vaporized inhaled 
isoflurane.  Dorsal skin was cleaned with iodine povidone solution (10%), and wiped 
with distilled water. Full-thickness dermal wounds were created in the skin of the 
back of mice (Figure 2.2) using a 4-mm biopsy punch (Stiefel, manufactured, USA) 
pressed into skin with twisting motion until punched through both layers of skin.  
In a normal wound-healing assay it is quite important to have the wounds always 
at equal distance from the midline, To determine the rate of healing at different 
locations, wounds were created at three different parts of the back skin (Figure 2.2). 
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To active NICDER transgenes, 7-week-old mice were treated topically with 2mg 
4OHT(Sigma) dissolved in acetone (Estrach et al., 2006) or treated with vehicle 
(200µl of acetone) applied directly to the wound site three times a week.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.Schematic diagram of the punch wounds model.  
A) Punch wounds, 2 punch wounds on each side, in the center of the mouse back skin. 
This method was used for normal wound healing and K14NICDER wounding 
experiments. B) Punch wounds, 3 punch wounds at different locations of mouse back 
skin (Upper (1), middle (2) and lower (3)). All wounded samples were harvested at 
different assayed time points after wounding and processed for histological analysis 
by cutting each sample. 
 
 
 
At the desired time point (1-day, 4 and 7days old wounds for a normal wound healing 
experiment and 2,5 and 8 days for the wound location experiment) required numbers 
of the mice in each group were sacrificed. Skin tissue samples were cut out at the 
wounds including a few millimeters of the surrounding skin from all of the mice for 
histological and biochemical analyses. For RNA extraction and protein lysates the 
same amount of intact tissue was collected from each mouse. Digital photographs of 
the injury site were taken; wound size was measured and quantified.  
 
 70 
2.3 Histology 
To assess cellular infiltration into the wounded site of the skin, samples from three 
mice per group were collected at the desired time point. To obtain skin sample from 
the biopsied area mice were scarified and tissue removed by dissection. Wounded 
area of skin tissue were subsequently placed on a millipore filter for stabilization (any 
membrane that is resistant to organic solvents such as nitrocellulose) and cut exactly 
in two. Half the wound tissue were embedded either directly in Optimal Cutting 
Temperature (OCT) tissue freezing medium (for cryo-sections) or fixed overnight 
with 4% PFA and embed in paraffin, so that the sectioning can start in the middle of 
the wound. Formalin-fixed samples were sectioned at 8µm and stained with 
hemotoxylin and eosin.  
2.3.1  Hemotoxylin and Eosin (H&E) staining 
This procedure was performed with the slides in glass staining racks and the solutions 
in square glass staining jars. 
 Formalin fixed tissue was embedded in paraffin blocks before being sectioned and 
placed on a glass slide. 8 µm paraffin section of skin tissue, processed, sectioned and 
de-waxed and rehydrated by serial incubation in Xylene (2x3min), 
50:50Xylene/100%ethanol (1x3min), 100% ethanol (2x3min), 95% ethanol (1x3min), 
70% ethanol (1x3min), 50% ethanol (1x3min) and finally in H2O (1x5min).  Slides 
were stained with Hematoxylin (Harris Hematoxylin Solution Sigma, HHS32) for 5 
minutes at room temperature and subsequently were rinsed under running tap water in 
the staining jar until the water was no longer colored (~5 min.). Slides were immersed 
into acid alcohol (1%HCl in 70%ETOH)  2-3 times until the sections turn pink. Slides 
were rinsed with tap water for 3-5 minutes, and then were soaked in Ammonia 
Water (1mL NH4OH in 1L H2O) for 5-6 immersing until sections were darkened 
noticeably. Slides were rinsed with tap water for 3-5 minutes, followed be adding 
Eosin (Eosin Y Aqueous Solution Sigma, HT110232) to slides for 1minute. Slides 
were again rinsed under running tap water for 3-5 minutes. Slides then were 
dehydrated by serial incubation in 95% ethanol (2x3min), 100% ethanol (2x3min), 
50:50 Xylene/100%ethanol (1x3min) and Xylene (2x3min). Slides were kept in 
Xylene (no longer than one hour) until they were cover slipped using Permount or a 
Xylene-based mounting medium. 
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2.3.2  Elastic Tissue Fibers -Verhoeff’s Van Gieson (EVG) staining 
To demonstrate atrophy of elastic tissue in wounded skin EVG staining was done. 
This procedure was also performed with the slides in glass staining racks and the 
solutions in square glass staining jars. These reagents were prepared before starting 
the staining procedure.  
Alcoholic Hematoxylin: Hematoxylin 5.0 gm, Absolute alcohol 100.0 ml. Dissolved 
hematoxylin into alcohol with the aide of gentle heat, not boiled. 
10% Ferric Chloride: Ferric chloride 10.0 gm, Distilled water 100.0 ml, mixed well. 
Van Gieson's Solution: 1ml1% Acid fuchsin, 45ml Picric acid, saturated. 
 Formalin fixed tissue was embedded in paraffin blocks before being sectioned and 
placed on a glass slide. 8-µm paraffin section of skin tissue, processed, sectioned and 
de-waxed and rehydrated by serial incubation as described in the section 2.3.1 (H&E) 
staining. Sections were incubated in Verhoeff's hematoxylin(20ml Alcoholic 
hematoxylin,8ml10% ferric chloride,8ml Lugol's iodine).slides were rinsed with tap 
water for 5 minutes and then slides were differentiated in 2% ferric chloride solution 
and sections were checked microscopically for black fibers on a gray background. 
Slides were rinsed with tap water and were kept in 5% Hypo solution for 1 minute. 
Slides were washed under running tap water for 5 minutes and then counterstained in 
Van Gieson's for 5 minutes. Slides were dehydrated by serial incubation in 95% 
ethanol (2x3min), 100% ethanol (2x3min), 50:50 Xylene/100%ethanol (1x3min) and 
Xylene (2x3min). Slides were kept in Xylene (no longer than one hour) until they 
were cover slipped using Permount or a Xylene-based mounting medium. 
 
2.4 Immunohistochemistry 
2.4.1 Antigen retrieval 
Formalin fixed tissue was embedded in paraffin blocks before being sectioned and 
placed on a glass slide. 8 µm paraffin section of skin tissue, processed, sectioned and 
de-waxed and rehydrated by serial incubation in Xylene (2x3min), Xylene: ethanol 
(1x3min), 100% ethanol (2x3min), 95% ethanol (1x3min), 70% ethanol (1x3min), 
50% ethanol (1x3min) and finally in H2O (1x5min). Thereafter, antigen retrieval was 
performed by immersing the tissue sections in Tris-EDTA buffer (10 mM Tris, 1 mM 
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EDTA pH 8) or in 0.01 M citrate buffer (pH 6) that had been pre-heated for 3 minutes 
in a microwave (850W). The slides were heated for 10 minutes at 360W. Following 
this the slides were allowed to cool to room temperature (RT) for 30 minutes before 
washing in 1 x PBS. Sections were incubated with 0.1% Triton in PBS for 5 min and 
then washed in PBS in 3x5 min washes. Sections were taken through to the blocking 
step immediately. Non-specific binding of the primary antibody was blocked by 
incubating sections with 10% Goat serum, 1%BSA, 0.01%triton, diluted in PBS for 1 
hour at room temperature prior to antibody incubation. After 1 hour of blocking, 
slides were gently tapped onto blotting paper to remove the blocking solution.	  	  
2.4.2 Antibody incubation and antigen visualisation 
Primary antibodies were diluted in 0.5% BSA in PBS and each section was incubated 
with 120 µl primary antibody at 4°C overnight in humidity chamber. Negative 
controls were incubated in 0.5% BSA/PBS, omitting the primary antibody. Post 
incubation, unbound primary antibody was removed by washing 3 x 3 minutes in 
PBS. Thereafter, each slide was incubated with 120 µl poly-HRP-anti-
mouse/rabbit/rat IgG for 1 hour at RT. After washing in PBS (3x5min), coverslips 
were mounted using Mowie Oil and left to harden at room temperature. Results were 
visualized and photographed on a Confocal Leica microscope.  
  
2.4.3 Confocal Microscopy 
All images were acquired on a Leica TCS-SP5 confocal microscope at X40 or X20 
magnification. Excitation lasers for fluorescein isothiocyanate (FITC) and tetramethyl 
rhodamine isothiocyanate (TRITC) dyes were standardized for each experiment, with 
DAPI dye set by eye for each image as required. Image processing was carried out 
using Adobe® Photoshop® 7.0 imaging software (Adobe Systems Inc, San Jose, CA, 
US).  
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Antibody  Immunoglobulin  
Subtype  
Supplier and 
Code 
Specificity 
of 1° 
Antibody 
Source 
of 1° 
antibody 
Working 
conc. of 1° 
Antibody 
2° Antibody/ 
Supplier/ Code/ 
Working conc. 
Anti-
Rabbit 
Notch1 
IgG Abcam 
(Ab8925)  
Reacts with 
mouse 
Notch1 
Rabbit 
 
1:200 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
with DAPI 
Anti-
Rabbit 
Notch2 
IgG Abcam 
(Ab8926) 
Reacts with 
mouse 
Notch2 
Rabbit 1:200 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
with DAPI 
Goat anti 
Jagged 1 
 
IgG Abcam 
(Ab7771) 
Reacts 
Mouse 
Jagged1 
Rabbit  1:100 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
with DAPI 
Anti- 
Ki67 
IgG Abcam  
(Ab16667) 
Reacts with  
Mouse, 
Rat, 
Human 
Rabbit 1:400 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
with DAPI 
Anti 
F4/80 
 eBiosciences 
Clone BM8 
 
 
Reacts with 
mouse 
F4/80 
antigen  
Mouse 1:100 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
with DAPI 
Anti CD3  BDBiosciences 
Clone 17A2 
 
Reacts with 
mouse 
Mouse 1:100 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
 74 
with DAPI 
Anti 
SM22a 
 
 
IgG Abcam 
(ab14106) 
Reacts with 
Mouse, 
Rat, 
Human 
Rabbit  1:100 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
with DAPI 
Anti 
MMP1 
 
 
IgG 
 
Millipore 
Clone 4E7.2 
(Mab13439) 
 
Reacts with 
Human and 
non-human 
MMP1 
Human 1:200 Appropriate 
fluorescent 
Invitrogen/1:1000 
Counterstained 
with DAPI 
 
Table 2.1. List of primary antibodies used in Immunohistochemistry 
 
 
2.5 Protein Analysis SDS-PAGE and Western Blotting 
2.5.1 Tissue preparation  
0.5-1 cm2 sections of back skin were collected and immediately snap-frozen and 
stored in liquid nitrogen. To denature the protein samples a combination of physical 
and biochemical techniques was applied. RIPA buffer was applied because the target 
proteins in this project were mostly located in the nuclei and cytoplasm.   600 µl of 
RIPA (150 mMNaCl, 50 mMTris-HCl, pH 7.5, 1% Nonidet P-40, 0.25% Na 
deoxycholate) and one protease inhibitor cocktail tablet (Roche Diagnostics, GmbH, 
Cat. no. 11 836 170 001, Mannheim, Germany was added to 10ml of RIPA buffer) 
was used for preparation of the lysate. After adding RIPA buffer to the frozen tissues, 
samples were homogenised using a Polytron tissue homogeniser for 2 minutes. These 
events are slowed down by keeping the samples on ice (4°C) throughout the lysis 
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procedure and appropriate inhibitors were added fresh to the lysis buffer. The 
homogenized tissue-lysis buffer mixture was incubated on ice for 30 minutes with 
gentle regular mixing with a pipette. The lysed sample was then centrifuged at 12000 
rpm for 20 minutes at 4°C. The supernatant was then aspirated and transferred to a 
new tube and the pellet discarded. The samples were then stored on ice before 
proceeding to the next stage.   
 
2.5.2  Bicinchoninic Acid Protein Assay 
Protein concentration was determined by the Bicinchoninic Acid Protein Assay (BCA 
– Pierce: #23225). Prior to the assay lysates isolated as in 2.5.1 a standard curve 
derived from serially diluted 2mg/mL BSA was also prepared. Samples were loaded 
onto a 96 well plate as per manufacturer’s instruction and incubated at 37°C to 
improve assay sensitivity (Olson and Markwell, 2007) The plate was read at 570nm. 
2.5.3  Denaturation and reduction of protein 
To enable antibodies to recognize and access the epitope fraction of the target protein, 
the 3D conformation of the protein needs to be unfolded. Consequently denaturation 
and reduction of protein samples was required prior to immunoblotting. This 
procedure was carried out by preparing samples in 3x loading buffer (30mM 
NaH2PO4, 30% (v/v) glycerol, 0.05% (w/v) Bromophenol blue, 7.5% (w/v) sodium 
dodecyl sulphate (SDS), made up in dH2O), DTT (23.5mM final concentration, from 
a 200mM stock solution made with dH2O) with 10-50µg of protein and made up to a 
final volume of 15µl of dH2O. Samples were mixed by vortexing (both before and 
after heating for good resolution), centrifuged at 13,000 rpm for one minute, 
incubated for five minutes at 95°C, centrifuged at 13,000 rpm for one minute and 
thoroughly vortex again. Samples were then stored at -80°C or applied to an SDS-
PAGE gel for electrophoresis.  
 
2.5.4 Gel electrophoresis 
The proteins in the samples were separated using one dimensional polyacrylamide gel 
electrophoresis. SDS-PAGE (SDS Polyacrylamide Gel Electrophoresis) maintains 
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polypeptides in a denatured state as they run along the gel.  In this project a 4% 
stacking gel was used, which allowed the proteins to form a nice tight band at the 
interface between the stacking gel and the 9% separating gel.  
 
 
 
Reagents  Stacking 
Gel (4%) 
Reagents Separating 
Gel (9%) 
Supplier  
(Double distilled) Water 6.3ml (Double distilled) 
Water 
5.1ml  
0.5M Tris pH 6.8 
(60.5g Trizma base in 1L 
dd water, pH to 6.8 with 
conc. HCL) 
2.5ml 1.5M Tris pH 8.8 
181.65g Trizma base 
in 1L dd water, pH to 
8.8 with conc. HCL) 
2.5ml Trizma base 
Sigma-Aldrich 
T1503 
10% SDS 100µl 10% SDS 100µl Sigma-Aldrich 
L3771 
Acrylamide/Bis- 
acrylamide 49:1 ratio 
1ml Acrylamide/Bis- 
acrylamide 49:1 
ratio 
2.25ml Sigma-Aldrich 
AO924 
Ammonium persulfate 
(APS) 
100µl Ammonium 
persulfate (APS) 
50µl Sigma-
AldrichA3678 
N, N, N’, N’-
Tetramethylethylenediam
ine (TEMED) 
10µl  N, N, N’, N’-
Tetramethylethylen
ediamine (TEMED) 
5µl Sigma-Aldrich 
T9281 
 
Table 2.2. Composition of Polyacrylamide gels 
 
The wells of the gel were gently flushed with running buffer; Protein samples were 
loaded into the wells in the gel. 10-15µg of protein was loaded into each well. The 
gels were run at a voltage of 120 Volts for 20 minutes (until the protein ladder 
(Amersham ECL full-range rainbow marker) appeared to separate) and then at a 
constant voltage of 110 volts for 40-50 minutes (until the bromophenol blue had 
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migrated to the bottom of the gel ensuring that the proteins have separated into 
various bands in each well.  
 
 
 
 
 
Reagents  X10 Running Buffer  
(Double distilled) Water  1L 
Trizma Base  30g 
Glycine  144g 
SDS 10g 
 
Table 2. 3Running buffer 
 
2.5.5 Coomassie blue staining 
To visualise proteins post-SDS-PAGE, colloidal Coomassie staining was used. First, 
SDS-PAGE gels were fixed in 7% glacial acetic acid in 40% (v/v) methanol for 1 
hour. The gels were transferred to colloidal Coomassie solution (Sigma product 
B2025) activated in 20% methanol and incubated with rocking for 4 hours or 
overnight. Gels were destained with 10% acetic acid in 25% (v/v) methanol for 60 
seconds, rinsed twice with 25% methanol and destained for up to 24 hours. The 
destained gels were briefly rinsed with distilled water prior to drying down onto 
Whatman paper (GE Healthcare) with a gel drier for 40 minutes at 80°C. 
2.5.6 Transfer of protein bands from gel onto PVDF membrane 
To make the proteins accessible to antibody detection they are moved from within the 
gel onto a membrane made of polyvinylidenedifluoride (PVDF). Transfer was done in 
wet conditions during this project. PVDF membranes (Amersham) were pre-treated 
by soaking the membrane in methanol for 1-2 minutes. This was followed by a quick 
soak in water and then incubation in ice cold transfer buffer for 5 minutes. The wet 
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membrane was then placed on top of the gel, and a stack of transfer buffer soaked 
filter papers placed on top of that. This stack was sandwiched between two buffer 
soaked sponge pads and transferred to a tank filled with transfer buffer. The electro-
transfer was performed in a cold room at a constant voltage of 30 volts over night.   
 
 
 
 
 
Reagents  (x1) Transfer Buffer 
(Double distilled) Water 2L 
Trisma Base 6.06g 
Glycine 28.8g 
Methanol 400ml 
 
Table 2.4. Transfer buffer 
 
 
2.5.7 Visualization of all separated proteins after migration 
Ponceau S dye (P7170-IL, Sigma-Aldrich) was used to visualize the uniformity and 
overall effectiveness of protein transfer from the gel to the membrane. The 
membranes were incubated with Ponceau S dye (1:10 dilution with water) for 3-5 
minutes at room temperature on an agitator. The protein bands, if transferred 
effectively, appear as well-defined reddish-pink bands. The membranes were then 
washed extensively in (x1) Tris Buffered Saline-Tween (TBS-Tween) until the dye 
was washed off.  
 
 
 
Reagents  (x20) Tris Buffered Saline 
Solution (TBS) 
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NaCL 234g 
Trizma base  48.4g  
(Double distilled) Water  1L 
 
Table 2.5 (x20) TBS 
 
 
 
Reagents  (x1) Tris Buffered Saline 
Solution (TBS) 
1Litre  
Supplier  
(x20) TBS  50ml   
Tween-20  1ml Sigma-Aldrich 
27,434-8 
 
Table 2.6. (x1) TBST 
 
 
2.5.8 Blocking of the PVDF membranes 
The membranes with the transferred protein bands were then blocked in blocking 
buffer for 1 hour at room temperature on an agitator. Blocking the membranes 
prevented non-specific binding of the primary and/or secondary antibodies to the 
membrane.  
 
Reagents  Blocking buffer  Supplier  
(x20) Tris buffered Saline 
(TBS) 
2.5ml  
Tween-20  0.6ml Sigma-Aldrich 
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27,434-8 
Low-fat milk (Marvel) or 
BSA 
2.5g Dried skimmed milk, R. 
No. 92962, Marvel, 
Dublin, Ireland. BSA 
(Fisher BPE9702-100)  
 
Table 2.7. Blocking buffer 
 
2.5.9 Antibody staining 
The membranes were incubated with the primary antibody (diluted in incubation 
buffer) (table 8) overnight at 4°C on an agitator to enable adequate homogenous 
covering of the membrane and prevent uneven binding.  
 
 
Reagents  Incubation Buffer 
(x1) Tris Buffered Saline (TBS)-TX 50mls  
Low-fat milk (Marvel)/BSA/fish skin 
gelatine 
5g/5g/1.5ml 
  
Table 2.8. Incubation buffer 
 
Post overnight incubation with the primary antibody the membranes were washed in 
(x1) TBS-TX, three times, and 10 minutes each time. The washes were done at room 
temperature on an agitator. This step ensured that all excess unbound antibodies were 
washed off.  
The membranes were then incubated with the appropriate secondary antibody (diluted 
in incubation buffer) for 1 hour at room temperature on an agitator.  
The membranes were then washed in TBS-TX, four times, and 12-15 minutes each 
time, to get rid of any unbound secondary antibody.  
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Antibody  Immunoglobulin  
Subtype  
Supplier 
and Code 
Specificity 
of 1° 
Antibody 
Source 
of 1° 
antibody 
Working 
conc. of 
1° 
Antibody 
2° Antibody/ 
Supplier/ Code/ 
Working conc. 
Anti-
Rabbit 
Notch1 
IgG Abcam 
(Ab8925)  
Reacts 
with 
mouse 
Notch1 
Rabbit 
 
1:400 Anti-Rabbit IgG-
HRP conjugated/ 
1:10000 
(Sigma,A6154) 
Anti-
Rabbit 
Notch2 
IgG Abcam 
(Ab8926) 
Reacts 
with 
mouse 
Notch2 
Rabbit 1:500 Anti-Rabbit IgG- 
HRP 
conjugated/1:10000 
(Sigma,A6154) 
Goat 
anti 
Jaggde 1 
 
IgG Abcam 
 
Reacts 
Mouse 
Jagged1 
Goat 1:100 Anti-Goat IgG F 
HRP 
conjugated/1:10000 
(Sigma, A5420) 
 
 
Anti- 
Beta 
actin 
IgG1 Sigma  Mouse 1:3000 Anti-Mouse IgG F 
HRP 
conjugated/1:10000 
(Sigma, A4416) 
 
Anti 
MMP1 
IgG Millipore 
Clone 4E7.2 
(Mab13439) 
 
Reacts 
with 
Human 
and non-
human 
MMP1 
Human 1:300 Anti-Mouse IgG F 
HRP 
conjugated/1:10000 
(Sigma, A4416) 
 
Table 2.9 List of primary antibodies used for western blotting 
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2.5.10 Detection and Band Density Analysis 
Membranes then were washed three times, 10 minutes each, with 1x TBS before 
being covered with Enhanced Chemiluminescence (ECL – Pierce: #32106) substrate 
for 2 minutes. ECL was then drained from the membrane, which was then wrapped in 
cling film after which it was taped into a film cassette. The membrane was then 
exposed to HyperfilmTM for 10 minutes for the primary antibody and for three 
minutes with β-actin, the hyperfilm was then developed using Kodak-D19 developer 
and fixed for five minutes in Kodak Unifix fixative. 
Band density of western blots was analyzed by Image J software. Target protein 
marker band intensity was measured relative to controls. All bands were standardized 
against β- actin loading controls either co-probed on the same membrane or generated 
by strip and re-probed of the same membrane. Where applicable the mean and 
standard error of the mean (SEM) were generated and plotted with significance 
assayed by two-tailed student t-Test. 
 
2.6 Molecular Biology Technique  
2.6.1 Total RNA isolation 
All techniques were carried out under RNase free conditions using aerosol resistant 
filtered pipette tips. All solutions were autoclaved and stored in glass bottles, which 
had been baked at 140°C for 2 hours. The workspace was wiped clean with RNase 
Zap (Ambion Cat# AM9780). RNA was extracted using the RNeasy Mini Kit from 
Qiagen, (Cat#74104). This is a ready to use kit by which the purification of total RNA 
from skin samples was carried out as follows:  
25-30mg of intact skin tissue was snap frozen and stored in RNAlater overnight. Fat 
and muscle was removed by scraping. Weighed tissue was transferred from RNAlater 
to a 2ml cryovial and incubated on ice until ready to grind. Tissue was disrupted and 
lysate was homogenized in 600 µl of RLT buffer plus 10 µl/ml Beta-Mercaptoethanol 
(BME,sigma),for 1-3 minutes. Ground tissue was incubated at room temperature till 
all samples were homogenized. 1160 µl RNAse free water was added to each sample 
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plus 40 µl of proteinase K (10mgs/ml stock). Samples were mixed by inversing and 
incubated at 55°C for 10 minutes. Lysate was transferred to a 2ml eppendorf and 
centrifuged for 2 min at 13.4x103g. The supernatant was carefully removed by 
pipetting and transferred to a 50ml conical tube.  900 µl of 100% ethanol was added 
to the lysate, and mixed well by pipetting.  Up to 700 µl of each sample, was 
transferred to an RNeasy Mini spin column placed in a 2 ml collection tube, the lid of 
each tube was closed the, and centrifuged for 15 s at 13.4x103g and the flow-through 
was discarded. 350 µl Buffer RW1 was added to the RNeasy spin column and 
centrifuged for 15 s at 13.4x103g, flow-through was discarded. DNase digestion was 
performed on each column (kit from QIAGEN, # 79254), 10 µl of DNase plus 70 µl 
of RRD solution was added per column. Samples were incubated at room temperature 
for 15 minutes.  
350 µl Buffer RW1 was added to the RNeasy spin column and centrifuged for 15 s at 
13.4x103g, flow-through was discarded. 500 µl Buffer RPE was added to the RNeasy 
spin column and centrifuged for 2 min at 13.4x103g, flow-through was discarded. 
RNeasy spin column was placed in a new 1.5 ml collection tube (supplied in 
QIAGEN kit).  30–50 µl RNase-free water was added directly to the spin column 
membrane and centrifuged for 1 min at 13.4x103g to elute the RNA.   
2.6.2 Quantification and purity of RNA 
The concentration and purity of RNA was measured using a NanoDrop 
spectrophotometer (Thermo Fisher Scientific, UK). Briefly, 1 µl of sample was 
loaded onto the optical pedestal, the absorbance at 260 nm and 280 nm was measured, 
and the concentration of RNA was calculated. The A260:A280 ratio was used to assess 
RNA purity, with a value of 1.7-2.0 taken to indicate that the sample was sufficiently 
pure.   
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2.6.3 Assessment of RNA quality 
 
To assess the quality of extracted RNA, 2µl of each sample were electrophoresed on a 
2.0% gel, containing Ethidium bromide (0.1µg/ml) in 1x Tris Acetate-EDTA (TAE). 
Before electrophoresis, 2µl of loading buffer (0.25% bromophenol blue, 40% 
glycerol, made up in sterilised water was added to each sample.  2 sharp and clear 28s 
and 18s rRNA bands were expected to be seen. The intensity of the 28S rRNA band 
should be approximately twice as the intensity of the 18S rRNA band (Figure 2.3). 
This 2:1 ratio (28S: 18S) is a good indication that the RNA is completely intact. 
 
 
 
 
 
 
 
 
Figure 2. 3. Intact RNA.  
Two µg intact total RNA was run a 2% denaturing agarose gel. The 18S and 28S 
ribosomal RNA bands are clearly visible. 
 
 
 
 
 
2.6.4 cDNA synthesis 
Total RNA was reverse transcribed using a Superscript III first-strand synthesis kit 
(Invitrogen) and quantitative PCR was performed under standard conditions with an 
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ABI 7500 fast real-time PCR machine. A summery of cDNA synthesis procedure is 
shown in figure 2.4.   
 
     
 
 
 
 
 
 
 
   Figure 2.4 Summery of cDNA synthesis, using a Superscript III first-strand synthesis 
kit (Invitrogen) 
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2.6.5 Q-PCR  
In real time Quantitative Polymerase Chain Reaction (Q-PCR), aim is to amplify and 
quantify the nucleic acid sequences throughout the PCR reaction. In this method a 
thermocycler is applied to achieve the quantified measurements of molecules that give 
a florescent signal a result of probe hydrolysis (TaqMan, Applied Biosystems); probe 
hybridisation (LightCycler, Roche); hairpin probe hybridisation (LUX, Invitrogen); 
hairpin-loop hybridisation (Molecular Beacons, Sigma) or binding to double stranded 
DNA (SYBR Green) (VanGuilder et al., 2008). In a real time q-PCR reaction, during 
the exponential amplification phase the fluorescence signal is measured. This 
measurement generates a value known as cycle threshold (CT), which represents the 
amplification cycle at which the fluorescent signal exceeds a threshold above the 
background fluorescence (baseline). Consequently, the higher the CT value, the lower 
the gene expression. Absolute quantification (calculating the number of copies of a 
specific RNA) or relative quantification (comparing the gene expression in two or 
more samples) are two main methods that q-PCR data can be presented by. 
2.6.6 qPCR primer validation 
Prior to performing qPCR on the biological samples of interest, it is important to 
assess the efficiency of the primers. For each primer set, qPCR was performed on a 
cDNA dilution series (0.1 ng – 100ng diluted to 1000x dilution). Quantitative real-
time PCR was carried out in a MicroAmp® optical 96 well reaction plates (Applied 
Biosystems). Twelve point five µl Fast SYBR ®Green Master Mix (Applied 
Biosystems, Nieuwekerk a/d Ijssel, NL), 5 µl cDNA, 5.5 µl nuclease-free water, 1 µl 
forward primer (1000 µmolar) and 1µl reverse primer (1000 µmolar) were added to 
each well. A negative control containing no cDNA was run for each primer pair that 
was used. MicroAmp® optical adhesive film (Applied Biosystems) was placed on the 
top of the 96 well reaction plate to reduce contamination and evaporation. The plate 
was centrifuged briefly to remove bubbles. Reactions were run in a 7500 Fast Real-
Time PCR System (Applied Biosciences). The qPCR profile was as follows: 95°C for 
20 seconds, 40 cycles of 95°C for 3 seconds followed by 60°C for 30 seconds. 
Following this, a melt curve stage was performed in which the samples were heated to 
95°C for 15 seconds, cooled to 60°C for 1 minute, slowly heated up to 95°C, and 
cooled to 65°C for 15 seconds. The baseline and threshold values were checked to 
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confirm the validity of the automatically generated parameters. In a qPCR reaction, 
the fluorescence signal is measured during the exponential amplification phase 
because it provides the most accurate data for quantification. Cycle threshold (CT) 
values indicate the amplification cycle at which the fluorescent signal exceeds a 
threshold above the background signal (baseline). Thus, the lower the CT value, the 
higher the gene expression. A standard curve was plotted where X-axis = log10 
[cDNA] and Y axis = CT values. Primers passed quality control testing if the gradient 
of the graph was between -3.3 +/- 0.3 as this indicates that the efficiency of the PCR 
reaction is 100% +/- 10% and hence allows for meaningful gene comparison. All 
primers used within this thesis were deemed suitable for qPCR analysis. 
 
2.6.7 Quantitative polymerase chain reaction (QPCR) 
 
QPCR to quantify Notch1, Notch2, Jagged1, TGFβ, TNFα, IL-22, IL-23α (p19), 
MIP1-α and SM22 was performed using a Rotor-Gene Q instrument (Qiagen), with a 
two-step rapid-cycling procedure as described by the manufacturer (Roter-Gene Probe 
Handbook, Qiagen). 
 Triplicate reactions (20ul) of each experimental sample were analysed using FAM 
probes for the gene of interest (TNFα, Mm00443258.m1;Notch1, Mm00435248_m1; 
TGFβ1, Mm01178819_m1; SM22α, Mm00441660_m1and IL23α (P19), 
Mm01160011.g1, Life Technologies) at a final concentration of 900 nM for each 
primer and 250nM for the probe and TaqMan Fast Universal PR master mix (ABI) at 
1x. Reactions were subjected to an initial 3-minute denaturation step at 95oC, 
followed by 45 cycles of 95oC for 3 seconds and 60oC for 10 seconds. Data were 
analysed using the Comparative Quantitation algorithm in the Rotor-Gene software, 
with calibrator samples for each run being compared in a common experiment. 
MIP1α and IL-22 were amplified using unlabeled primers (MIP1α: Forward 5’-
GTTCTTCTCTGTACCATGAC-3’; Reverse 5’- CTCTTAGTCAGGAAAATGAC-
3’, final concentration 400 nM; IL-22: PPM05481A-200, Qiagen; Notch2: 
PPM051378_200,Qiagen, Jagged1: PPM26291A_200,Qiagen) in a reaction using 
SYBR-green master mix (Sigma). Reactions were subjected to an initial 3-minute 
denaturation step at 95oC, followed by 45 cycles of 95oC for 10 seconds, 60oC for 10 
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seconds and 72oC for 10 seconds. Reference genes (GAPDH and β-2 microglobulin 
primers) were used to quantify genes of interest. 
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3  Notch signaling activation during normal 
skin wound healing 
3.1 Introduction  
The mammalian epidermis serves as a barrier to protect the body against entry of 
toxins, chemical compounds and pathogen invasion, as well as providing mechanical 
resistance. The epidermis is essential for maintaining the self-renewing ability of the 
skin. Mitotically active cells located in the basal layer of epidermis constantly 
regenerate the epidermis. Following an injury, the remaining epithelial cells undergo a 
programmed repair mechanism to immediately close the defect (Hunt et al., 2000). 
This highly coordinated process involves a number of cellular functions including 
migration, proliferation and differentiation. Following injury, in the early 
inflammation phase neutrophils and macrophages infiltrate the wound site and clean 
the site of microbial contaminates. Epidermal proliferation, extracellular matrix 
deposition, granulation, vascularisation and wound contraction are described as signs 
of the proliferative phase. Following wound closure, excess cells are removed and the 
remodeling phase of the extracellular matrix begins. While many of the regulatory 
mechanisms governing skin wound healing have been studied before, the role of 
Notch signalling, a critical pathway during development, has not been entirely 
determined (Fuchs and Horsley, 2008, Hunt et al., 2000).  
The Notch signaling pathway is a highly conserved and cell-autonomous network that 
regulates cell fate decisions during development and has critical functions in the skin 
(Artavanis-Tsakonas et al., 1999, Greenwald, 1998, Ambler and Watt, 2010, Demehri 
et al., 2009a). Notch proteins are membrane bound receptors with corresponding 
membrane bound ligands, Delta and Jagged. Binding of ligands results in proteolytic 
cleavages of Notch receptor; first in an extracellular domain and subsequently in the 
transmembrane domain. This releases the Notch intracellular domain (NICD), which 
translocates to the nucleus where it regulates transcription of target genes, such as 
Hairy/Enhancer of Split (Hes) (Bray, 2006, Schroeter et al., 1998). 
Involvement of Notch signalling in the regulation of tissue homeostasis in adults 
recently has been implicated by numerous of studies. Although the importance of 
Notch signalling in several tissues wound healing has been highlighted by numerous 
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studies the involvement of Notch signalling and skin wound healing is still not clearly 
explained.  
Wound healing involves an initial inflammatory response and subsequent changes in 
keratinocytes, fibroblasts and vascular endothelial cells that close the wound and 
regenerate the skin tissue (Hunt et al., 1999, Hunt et al., 2000). Previous studies have 
demonstrated that Notch is involved in lymphocyte expansion regulation and immune 
function (Kared et al., 2006). Another study indicates the involvement of Notch 
signaling in brain injury, showing that Notch is involved in the regulation of neural 
cell responses to injury (Arumugam et al., 2006).  
The essential role of endothelial Notch1 during the formation of new blood vessels, 
angiogenesis, proliferation and migration of epithelial cells during angiogenesis, in 
normal tissues and wounds, has also been highlighted in previous studies (Limbourg 
et al., 2005, Paris et al., 2005, Sainson et al., 2005). Notch has also been shown to 
affect the behavior of keratinocytes, fibroblasts and platelets, additional cell types that 
play important roles in wound healing (Cereseto and Tsai, 2000, Rangarajan et al., 
2001).  
There are four mammalian Notch receptors (Notch1 - Notch4); all of which have 
previously been shown to be expressed in the human epidermis (Nickoloff et al., 
2002). Despite the presence of all four Notch receptors, Notch1 and Notch2 have been 
shown to be the principal receptors involved in maintaining hair and skin epithelia by 
regulating cell differentiation (Pan et al., 2004). However, some studies suggest 
Notch2 also plays a non-redundant role in embryonic development and tissue 
maintenance (Pan et al., 2004).  
In normal human skin, the Notch receptors and ligands are abundantly expressed in 
keratinocytes within the epidermis. Notch1 is primarily confined to keratinocytes in 
the lower and mid level epidermal layers. Notch2 distribution is limited to 
keratinocytes in the basal layer (Blanpain et al., 2006).  
In previous studies, deletion of Notch receptors and ligands and the effects on 
epidermal homeostasis and differentiation were examined.   These reported data that 
presented an epidermal hyperproliferation in mice with postnatal ablation of the 
Notch1 gene, suggesting that Notch1 signaling is required for basal keratinocytes to 
withdraw cell cycling and to promote terminal differentiation into postnatal epidermis 
(Moriyama et al., 2008). Thus, ablation of Notch1 gene caused significant alternation 
in epidermis normal growth as well as a disruption of the well-defined border between 
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basal and upper differentiating layers. While deletion of Notch2 alone does not have 
any reported effects on the epidermis (Krebs et al., 2000, Pan et al., 2004).  
Interestingly, combined loss of Notch1 and Notch2 was demonstrated by another 
study, which results in more severe epidermal phenotypes than loss of Notch1 alone 
(Krebs et al., 2000). This reported evidence suggests a significant role for both 
Notch1 and Notch2 in contribuing to the control of proliferation and differentiation in 
IFE in mice. 
A previous study using topically-applied pan-Notch activators and inhibitors 
suggested that Notch might be involved in wound healing, however, the mechanistic 
details and site of action of Notch activation in skin injury have not been covered in 
previous studies (Chigurupati et al., 2007).  
 
Previous studies have employed 4-hydroxy-tamoxifen-inducible transgene mice 
(K14NICDER), and showed that forced ectopic epidermal Notch1 activity resulted in 
extensive, epidermal proliferation (Figure 3.1 a) and severe inflammation (Figure 3.1 
b) (Ambler and Watt, 2007, Ambler and Watt, 2010, Estrach et al., 2006).  
This evidence of increasing the main phenotypic hallmarks of skin wound healing 
following forced ectopic epidermal Notch1 activity, led attention to investigate the 
role of Notch1 and Notch2 in wound healing. Mechanistic details and/or the site of 
action of Notch activation in skin injury have not been previously studied. In addition, 
controllable Notch1 activation, by using the 4-hydroxy-tamoxifen-inducible transgene 
mice (K14NICDER) model, allowed this study to determine the essential role of 
epidermal Notch1 and Notch2 in the wound healing process.  
To begin exploring the level of Notch activation in response to physical injury during 
wound healing in normal and wounded skin from C57BL/6 mice, Notch1 and Notch2 
activity was analysed at 1, 4 and 7 days post wounding. It has been previously 
presented that in 4OHT-treated K14NICDER back skin, there was a massive infiltrate 
of CD3- and CD4-positive cells, with few CD8-positive T cells  (Figure 3.1b) 
(Ambler and Watt, 2007, Ambler and Watt, 2010, Estrach et al., 2006).  
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Figure 3.1. Characterisation of K14NICDER transgenic mice.  
(A)Haematoxylin and Eosin-stained back skin sections of 4OHT-treated wild-type 
(WT) and K14NICDER littermates. Inset shows a higher magnification view of 
epidermis and underlying dermis. Epidermal layers are indicated. B, basal; S, spinous; 
G, granular; C, cornified. (B).Notch-induced skin inflammations.  Back skin 
sections of 4OHT-treated or Acetone-treated K14NICDER stained with antibodies to 
CD4 and CD8 (brown). Arrows indicate T cells in epidermis and dermis (Ambler and 
Watt, 2010). 
 
 
 
A) 
 
 
 
B) 
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Evidence of the involvement of Notch signalling in wound healing and also 
increasing the main phenotypic hallmarks of skin wound healing by forced ectopic 
epidermal Notch1 activity drew attention to the need to determine how Notch activity 
in epithelium interacts with the wound healing process. 
Therefore it was hypothesised that epidermal Notch signalling may be active in skin 
as a response to wound healing. In this chapter, Notch activation during wound 
healing was examined. Notch1 and Notch2 were both rapidly activated in skin, 
predominantly within epidermal keratinocytes after injury with different timings, 
suggesting epidermal Notch1 and Notch2 might play different roles in skin wound 
healing.  
It has also been reported that Jagged 1 acts as a ligand for all Notch receptors. In 
developing skin, Jagged 1 is detected both in the epidermis and dermis (Powell et al., 
1998) whereas in adult skin, Jagged 1 is primarily expressed in the bulb of anagen 
follicles (Estrach et al., 2006). Research has previously reported the Notch activity via 
Jagged1in mice. Ambler et al., 2010, demonstrated that in 4OHT-treated 
K14NICDER skin Jagged 1 was upregulated in the interfollicular epidermis. The 
increase in Jagged 1 protein was also confirmed by western blotting of total skin 
lysates (Ambler and Watt, 2010). In addition, a previous report also showed that Jag1 
is positively regulated by Notch signalling (Ross and Kadesch, 2004).  
Thus there is clear evidence of an obligate relationship between Jagged1 and Notch 
activity in maintaining the skin epithelium. There is a feedback loop between Notch 
activity and Jagged1; Notch activity induces Jagged1 gene expression in epidermal 
keratinocytes and it has been demonstrated previously that Jagged1 expression in the 
epidermis is required for Notch1 function (Ambler, 2010). This chapter aims to 
consider how the Notch signal is transmitted through specific receptors, Notch1 and 
Notch2 in wound healing. 
Previous research, examined the role of jagged 1 in the Notch-induced skin 
phenotype, by using crossed K14NICDER, K14CreER and Jag1flox/flox strains of 
mice (Ambler, 2010). This work demonstrated that in these mice, 4OHT treatment 
results in deletion of Jag1 in the same cells in which Notch is activated. 
K14NICDER/K14CreER/Jag1flox/flox (triple) transgenic mice were compared with 
untreated K14NICDER/K14CreER/Jag1flox/flox mice and littermates that were wild 
type for Notch. Therefore this work confirmed that epidermal jagged 1 is required for 
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epidermal Notch- induced dermal jagged 1 expression and the accumulation of dermal 
cells (Ambler, 2010). Thus to test if jagged-1 expression is dependent on Notch1 and 
Notch2 activity, K14NICDER/K14CreER/jag1flox/flox triple mice lacking functional 
jagged1 were employed. 
 
 
3.2 Experimental plan  
To begin exploring the level of Notch activation in response to physical injury during 
wound healing in normal and wounded skin from C57 BL/6 mice, I analyzed Notch1 
and Notch2 activity at 1,4 and 7 days post wounding.  
Experimental procedures were performed under a UK government Home Office 
licence (Licence number: 60/3941), in accordance with the UK Animal (Scientific 
Procedures) Act, 1986. For the wounding experiment seven-week-old male, C57BL/6 
mice were used. The generation and characterisation of transgenic mice 
(K14NICDER (also known as K14NICDΔOPER), K14CreER, Jag1flox/flox, in which 
epidermal Notch1  can be induced under the control of 4OHT treatment has been 
described previously, see section2.1). To activate the NICDER and CreER transgenes, 
seven-week-old mice were treated topically with 2 mg 4OHT (Sigma) dissolved in 
acetone (Estrach et al., 2006). Thereafter, 4OHT or acetone was applied topically 
three times per week for 21 days.  
 
3.2.1 Dermal Wounds and Quantification of Healing 
Seven-week-old C57BL/6 were anesthetized using 2 - 2.5% vaporized inhaled 
isoflurane and the dorsal skin cleansed with (iodine povidone solution – 10%), two 
full- thickness dermal wounds were created in the skin on the back of the mouse using 
a 4-mm biopsy punch. A number of mice in each group were euthanized on days 1, 4 
and 7 post wounding and skin tissue samples from the wound site were collected for 
histological and biochemical analyses (Figure 3.2). Animals from each 
genotype/treatment group (n = 3) were evaluated daily for 7 days following 
wounding. Wound size was measured and digital photographs of the injury site were 
taken after injury up to 7 days post wounding. 
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Figure 3.2 Experimental plan1.  
Investigate the level of Notch1 and Notch2 activation during wound healing and 
determine the relation between the activity of Notch1 and Notch2 at different stages 
of normal skin wound healing. 
 
 
 96 
3.2.2 Epidermal Notch activation via a 4OHT-inducible transgene 
K14NICDER, K14CreER, Jag1flox/flox and C57BL/6 mice were treated with vehicle 
(acetone alone) or 2mg of 4OHT (Sigma) dissolved in acetone, applied directly to the 
normal back skin three times per week, for 21 days. A number of animals in each 
group were euthanized between 3 and 14 days post treatment and back skin tissue 
samples were collected from all of the mice for histological and biochemical analyses 
(Figure 3.3). 
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Figure 3.3. Experimental plan 2  
Investigate the level of Notch1 and Notch2 activation in response to forced epidermal 
Notch activity via the K14NICDER transgene, and whether this activation is caused 
by a jagged-1 dependent Notch1 forced activity. 
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3.3 Results 
3.3.1 Histological analyses of normal Skin Wound Healing  
To address whether the Notch signalling pathway is activated during normal wound 
healing, 4 mm cutaneous wounds were performed in male, C57 BL/6 mice and tissue 
collected for molecular analysis. Paraffin embedded sections of wounded and un-
wounded site of skin tissue were prepared as described previously, section 2.3.1, and 
stained with haematoxylin and eosin (H&E) to examine general histological 
characteristics (Figure 3.4). The stratified squamous un-wounded epithelium adjacent 
to the wound site (Figure 3.4, normal skin) showed normal characteristics of un-
wounded epithelium at all time points (A, D, G). The structure of all skin layers 
(epidermis, dermis and hypodermis) is all well organised. By 1-day post wounding, 
the wound area is filled by a blood clot (C). In the transitional site, that is immediately 
next to the migrating epithelial tongue (B), an increase in the thickness of the spinous 
layer has initiated, as a result of the migration of the epithelium behind the leading 
edge.  By day 4 post wounding, an expansion in fibroblast migration and a rapid 
proliferation of epithelial cells to the wound bed are detected, which initiates the 
proliferation and the formation of extracellular matrix. The newly formed 
neoepithelial layer from the marginal edges of the wound, termed granulation tissue 
due to its appearance, is evident and h as thickened (approximately 100 microns) (F). 
A healed wound is demonstrated by a thickened epidermal layer within the newly 
healed lesion and transitional site that is not seen in uninjured skin. By 7 days post 
wounding, although the epidermal thickness (50-60 microns) had not yet been 
restored to the normal level, wound is completely filled with granulation tissue (I). 
The wound is completely covered with a neoepidermis. Increasing the epithelial 
thickness, granulation tissue formation and reduction in the size of the wound are all 
parameters of normal wound healing process and are all observed in this wound 
healing model organism.  Quantification of epithelial thickness, at different stages of 
wound healing in H&E staining sections is shown in Figure 3.5. This quantification 
shows a statistically significant increase in thickness of the wounded epithelia, 4 days 
post wounding when compared to the normal skin adjacent (P value is < 0.0001). 
Comparing the wounded epithelial thickness 1 days post wounding to the normal skin 
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adjacent showed nearly 50% less than it was on 4 dpw, however thickness at 1dpw is 
still significant (P value=0.003). 
 
 
 
Figure 3.4. Representative histological features of cutaneous wound healing in mice.   
Full-thickness, 4 mm, wounds were created in seven-week-old C57BL/6 mice. (A-C 
Upper panel, D-F middle panel and G-I lower panel) Hemotoxylin and eosin stained 
back skin section of tissue removed 1, 4 and 7 days post wounding1dpw, respectively 
(panels A, D and G) displaying the histological characteristic of the unwounded 
epithelium, located around 0.88 mm from the wound site (un-wounded adjacent). This 
is followed by growth in the thickness of the spinous layer (adjacent) located 0.44 mm 
from the wound site (panel B, E and H), and existence of migration epithelial cells 
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that form an epithelial tongue at the wound edge (C, F and I). n=3. 2 biopsies from 
each). Red arrow in panel C indicating blood clot. Black arrow in panel F shows the 
epidermal thickness. Black arrows in panel H indicating myofibroblasts. Scale bar, 
200 microns. 
 
 
 
Figure 3.5. Epithelial thickness at wound site.  
The thickness of the epithelium was measured in histological slides at wound site on day 1, 4 and 7 
post-wounding and compared to the normal skin from unwounded animals. Measurements were done 
in triplicates from 3 different time points and two wounds per each mouse (n=3). Data shown as mean 
+ SEM; **P value <0.005, ***P value <0.0005(compared to normal skin). Student’s t-test. 
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3.3.2 The Notch signalling pathway is activated in wound healing  
The Notch pathway is a key cell-autonomous signalling pathway that directs cell fate 
choices, yet also controls pleiotropic functions in the skin. A previous study using 
topically-applied Notch pathway activators and inhibitors suggested that Notch might 
be involved in wound healing and previous work showed that forced, ectopic 
epidermal Notch activity resulted in extensive, epidermal proliferation and severe 
inflammation –two phenotypic hallmarks of skin wound healing (Ambler, 2010). 
Thus, I analysed Notch1 and Notch2 activity at 1,4 and 7 days post wounding. An 
inactive form of the Notch protein is synthesised in the cytoplasm and translocated 
into the endoplasmic reticulum, before it reaches the plasma membrane due to a 
proteolytic cleavage (S1), it is made into a ligand-accessible form. Cleavage results in 
a C-terminal fragment N (TM) and a N-terminal fragment N (EC). After ligand 
binding the yield of two photolytic cleavages (TACE and NEXT) is the released 
intracellular domain (NICD) from the membrane (Kopan and Ilagan, 2009). 
Immunohistochemical staining of wound samples in this investigation exhibited an 
increase in the levels of activated Notch1 and Notch2 in cells adjacent to the wound 
site at 4 days post wounding. These data demonstrated that at day 4, Notch1 was 
primarily active in basal and suprabasal epidermal keratinocytes and Notch 2 in both 
the epidermal sheet and underlying dermal stroma (Figure 3.6). To validate the data, 
levels of activated Notch1 and Notch2 proteins at 1, 4 and 7 days post wounding were 
quantified by Western Blotting. These data demonstrated that wounding caused in an 
increase in Notch1 and Notch2 activity with peak Notch1 activity detected 4 days post 
wounding (16x)(Figure 3.7) and Notch2 activity 1 day post wounding (2.5x) (Figure 
3.8). Cleaved Notch1 (Val1744) antibody detects endogenous levels of the Notch1 
intracellular domain (NICD) only when released from the membrane by cleavage 
between Gly1753 and Val1754 (equivalent to Gly1743/Val1744 of murine Notch1). 
This antibody does not recognize full-length Notch1, or Notch1 cleaved at other 
positions.  
These results demonstrated that although the Notch pathway is active throughout 
wound healing, maximal activation of Notch1 and Notch2 occurs at different time 
points and in different cells suggesting separate roles during the healing programme.  
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Figure 3.6. Notch1 and Notch2 are activated in response to an injury in skin.  
Representative immunohistochemistry of a cross-section of back skin tissue from 
punch-wounded wild type mice at, 4 days post wounding (4dpw) and normal skin 
(control). Antibodies specific for activated Notch1 and Notch2 reacted with cells 
adjacent to wound 4dpw. Note activated Notch1 is detectable in epidermal cells while 
activated Notch2 is detectable in both epidermal and dermal cells. White stars indicate 
the center of the wound. Scale bar equals 100 microns.   
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Figure 3.7 Quantified levels of activation Notch1 during skin wound healing. 
 (A) Representative immunoblot, showing quantified level of cleaved, activated 
Notch1 (80 KDa) and β-actin (42KDa) in lysates (20 mg/lane) in skin tissue samples 
from three independent punch-wounded (2 wounds on each mouse) wild type mice, 
collected at the indicated post wounding time points. (B) Quantified levels of cleaved, 
A)	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activated Notch1 protein by antibody probes in western immunoblotting assay. As 
loading controls, Notch1 level was standardised to β-actin levels as a loading control 
and normalised to the average back skin protein levels (designated as 1) of Notch1 in 
uninjured littermate mice (n=3). “Un-wounded” back skin is taken from a punch-
wounded mouse at a distal site (minimum 2 cm) from wound site.  Student t-test. 
(Data shown as mean + s.e.m of three individual experiments). **p value 
<0.005;***p value <0.0005.  
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Figure 3.8 Quantified levels of activation Notch2 during skin wound healing.  
(A) Representative immunoblot, showing quantified level of cleaved, activated 
Notch2 (75 KDa) and β-actin (42KDa) in lysates (20 mg/lane) in skin tissue samples 
from three independent punch-wounded (2 wounds on each mouse) wild type mice, 
A) 
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collected at the indicated post wounding time points. (B) Quantified levels of cleaved, 
activated Notch1 protein by antibody probes in western immunoblotting assay. As 
loading controls, Notch1 level was standardised to β-actin levels as a loading control 
and normalised to the average back skin protein levels (designated as 1) of Notch2 in 
uninjured littermate mice (n=3). “Un-wounded” back skin is taken from a punch-
wounded mouse at a distal site (minimum 2 cm) from wound site.  (Data shown as 
mean + s.e.m of three individual experiments). *p value <0.05.  
 
 
 
 
 
 
It has been reported that epidermal Notch1 activation resulted in up regulation of 
jagged1 in both the epidermis and dermis. It also has been demonstrated that jagged1 
has a key function in non-cell autonomous Notch signalling in skin (Ambler, 2010). 
In this project, the level of full-length jagged1 was quantified via Western Blotting. 
Data verified a significant up regulation (5.6x) of full-length jagged1 by day 7 after 
wounding compared to the level of jagged1 in control-uninjured mice. However, the 
level of Jagged1 from day 1 to day 4 was increased (p<0.05) compared to controls, 
(Figure 3.9).  These data also shows a significantly (p<0.0005) higher level of 
jagged1 on day 7 post wounding in compare with day 4 in wounded skin. 
Furthermore, the localisation of this ligand in the wounded area of skin after 1, 4 and 
7 days post injury was confirmed by immunohistochemistry (Figure 3.10).  
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Figure 3.9 Quantified levels of full-length Jagged1 during skin wound healing. 
 (A) Representative immunoblot, showing quantified level of Jagged1 (120 KDa) and 
β-actin (42KDa) in lysates (20 mg/lane) in skin tissue samples from three independent 
punch-wounded (2 wounds on each mouse) wild type mice, collected at the indicated 
post wounding time points. (B) Quantified levels of full-length Jagged1 protein by 
antibody probes in western immunoblotting assay. As loading controls, Jagged1 level 
was standardised to β-actin levels as a loading control and normalised to the average 
back skin protein levels (designated as 1) of Jagged1 in uninjured littermate mice 
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(n=3). “Un-wounded” back skin is taken from a punch-wounded mouse at a distal site 
(minimum 2 cm) from wound site.  (Data shown as mean + s.e.m of three individual 
experiments). *p value <0.05, ***p value <0.0005 (wounded skins are compared to 
the un-wounded at each time point). 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Jagged1 involved in skin wound healing.  
Representative immunohistochemistry of a cross-section of back skin tissue from 
punch-wounded wild type mice at 1,4 and 7 days post wounding. Antibody specific 
for full-length jagged1 (red) reacted with cells in epithelium at 7dpw. Note the full-
length jagged1(before being cleaved) is detected in cells within epidermal layer at 
7dpw, which is delineated from the dermis by a white dotted line. Whereas this full-
length protein is not detectable at 1 and 4dpw. Scale bar equal 100 microns.  
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3.3.3 Transcription of Notch family genes during wound healing  
The results shown in section 3.3.2 suggest that Notch activity is increased during the 
early stages of the wound healing response. To further correlate skin epithelial Notch 
activity initiated by wounding in normal mice with expression and activity of Notch; I  
examined mRNA levels of Notch1, Notch2, and Jagged1 during the process of wound 
healing. To determine how Notch signaling receptors (Notch1 and Notch2) and 
jagged1 ligand gene expression are during the wound healing process, I  analyzed 
gene expression profile of wounded skin from C57BL/6 and littermate controls. 
However, by 1 day after injury, Notch1 and Notch2, mRNAs were increased (1.5x) in 
wounded skin as shown by real time qPCR assays comparing to littermate control 
(skin sample from un-wounded animal). Levels of Notch1 and Notch2 expression 
were higher at the early days (1-2) post wounding. There was no statistical difference 
between the expression level of Notch1 and Notch2 at day 4 and 7 compared to 
littermate controls) (Figure 3.11). Comparing the expression level of Jagged1 at 
applied time points demonstrated a statistically significant difference between day 4 
and 7, compared to the littermate controls. There was no statistical difference 
observed between the level of Jagged1 expression on day 1 post wounding compared 
to control littermates (Figure 3.12).  
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Figure 3.11. Relative Notch1 and Notch2 expression detected by qPCR.  
Quantitative polymerase chain reaction of cDNA from punch-wounded wild type 
mice (n=3), collected at the indicated post wounding time points. Results (mean± 
s.e.m) are expressed relative to Un-wounded mice (=1) (n=3 at day1) for each 
TAQman probe. ***p value <0.0005.  
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Figure 3.12. Relative Jagged1 mRNA levels detected by qPCR.  
 
Quantitative polymerase chain reaction of cDNA from punch-wounded wild type 
mice (n=3), collected at the indicated post wounding time points. Results (mean+ 
s.e.m) are expressed relative to Un-wounded mice (=1) for each TAQman probe. ***p 
value <0.0005.  
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3.3.4 Notch2 activation in response to forced epidermal Notch 
activity via the K14NICDER transgene 
During normal wound healing, activation of Notch1 and Notch2 are detected. It has 
been reported that jagged1 acts as a ligand for all of the family of Notch receptors 
(Blanpain et al., 2006). As Jagged1 acts as a ligand for all Notch receptors and 
Notch2 is activated during normal skin wound healing, this investigation determined 
if Notch2 was activated in a Jagged1-dependent mechanism in 4HOT-treated 
NICDER transgenic skin.  
 
 
 
 
 
Figure 3.13 in absence of physical damage if Notch2 was activated in a jagged1-
dependent mechanism in K14NICDER transgenic mice 
For this reason Notch activation was forced in K14NICDER transgenic mice, where a 
4-hydroxy-amoxifen (4OHT)-inducible, Notch1 intercellular domain (NICD) is 
controlled by the keratin 14 promoter. Back skin of K14NICDER transgenic or 
littermate control mice was treated with 4OHT for 3-14 days before analysis. A 4.9-
fold increase in Notch2 activity was detected in K14NICDER skin 4OHT-treated for 
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3 days compared to control, (Figure 3.14) but epidermal and dermal Notch2 activity 
was undetectable in K14NICDER/K14CreER/ja1flox/flox triple mice lacking functional 
jagged1 (Figure 3.15). Therefore these data presented that the increase of Notch2 
activation in 4OHT-treated k14NICDER transgenic skin after 3 days, strongly 
suggests that Notch2 may have also been activated in a jagged1-depended 
mechanism. 
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Figure 3.14 Forced epidermal Notch1 activity via the K14NICDER transgene, results in 
activation of Notch2.  
(A) Representative immunoblot, showing quantified level of cleaved, activated 
Notch2 (75 KDa) and β-actin (42KDa) in lysates (20 mg/lane) in skin tissue samples 
from K14NICDER and littermate control mice, 4OHT-treated for 3 days (n=3) 
collected at the indicated post wounding time points. (B) Shows the quantitative 
analyses of immunoblot.  The level of activated Notch2 was normalised to β-actin 
level. **p value <0.005 . 
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Figure 3.15. Notch2 activation in K14NICDER is a Jagged-1 dependent mechanism.  
In K14NICDER /Jag1flox/flox/K14NICDER triple transgenic mice lacking functional 
jagged1 cells reactive for activated Notch2 were not detected. Scale bar equals 100 
microns.  
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3.4 Discussion  
The critical involvement of Notch signalling pathway in cell fate determination during 
embryogenesis and also in postnatal life is well established. Data from ongoing 
studies indicate that Notch signaling orchestrates the process of epidermal 
differentiation and proliferation through the sequential activity of different Notch 
ligands, receptors and downstream pathways (Artavanis-Tsakonas et al., 1995, Bray, 
2006, Okuyama et al., 2008). In normal human skin, the Notch receptors and ligands 
are abundantly expressed in keratinocytes within the epidermis (Artavanis-Tsakonas 
et al., 1995, Blanpain et al., 2006). 
It has been suggested that Notch signaling might be involved in wound healing by a 
previous study that had used topically applied pan-Notch activator and inhibitor 
(Chigurupai et al., 2007).   The effect of Notch signalling on skin wound healing, 
demonstrated a significant enhancement in wound healing in mice treated with a 
Notch ligand, Jagged peptide, and a delayed wound repair rate in response to Notch 
inhibitors (Chigurupati et al., 2007). However, the site of action  and mechanism 
remain less clear. Recently it has demonstrated forced activation of epidermal Notch 
signaling promotes dermal accumulation of immune cells via epidermal production of 
TNFα and epidermal proliferation, resembling the remarks of early and middle stages 
of wound healing (Ambler and Watt 2010; Estrach et al., 2006). These results suggest 
a potential link between epidermal Notch signaling and skin wound healing. 
The initial inflammatory response to wounding is typically the release of pro-
inflammatory signals from local damaged tissue, following which the inflammatory 
cells infiltrate to the site of injury. An initial inflammatory response and subsequent 
changes in epithelial and endothelial cells, in order to close the wound, are all 
involved during the healing process to regenerate the skin tissue. A previous study 
demonstrated that forced ectopic epidermal Notch activity caused epidermal 
proliferation and severe inflammation (Ambler and Watt, 2010). The consequence of 
an initial inflammation is able to influence the re-epithelialisation and connective 
tissue contraction that are all hallmarks of skin wound healing. Hence the activation 
of Notch1 and Notch2 at day 1, day 4 & day 7-post wounding were analysed. These 
findings suggest that activated Notch1 and Notch2 levels were highest in the 
inflammatory and proliferative phases of the wound response. This project also 
confirmed that by seven days post wounding, when the wound has closed, both 
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Notch1 (Figure3.7) and Notch2 (Figure 3.8) activity returned to the level of 
unwounded skin. Recent investigations have shown the inhibition of wound closure 
and pro-inflammatory factors in the wound site as consequences of blocking Notch1 
and Notch2 (Ambler et al, unpublished data), thus it can be concluded that Notch1 
and Notch2 play a key role in regulating the wound response.  
 
These findings suggest an increase in Notch1 and Notch2 activity in response to an 
injury at the initial phases of healing process. Maximum Notch1 activation was 
spotted on 4 days post wounding, whereas peak Notch2 activity detected within the 
initial inflammation stage, 1 day post wounding (Figure 3.8). An inflammatory related 
function for Notch2 is proposed by these data, suggesting that Notch2 as a possible 
coordinator element for the early events in the wound-healing cascade. These results 
are confirmed and further extended by ongoing work which has shown Notch activity 
can drive innate lymphoid cells (ILCs) recruitment (unpublished data, Ambler,et al).   
However, all 4 Notch receptors are expressed in skin epithelia and considerable 
evidence in support of a well-maintained role for Notch receptors in interfollicular 
cell fate determination has developed, therefore it would be interesting to determine if 
other Notch receptors have a contributing role in wound healing (Okuyama et al., 
2008, Watt et al., 2008). In this study the activation of Notch1 and Notch2 was 
considered.  Notch1 and Notch2 receptors are abundantly expressed in keratinocytes 
within the epidermis in normal human skin. It has been reported that Notch1 and 
Notch2 are both required for embryo viability, are widely expressed in mammals, and 
are structurally conserved (Kraman and McCright, 2005).  
There is not much evidence to confirm if these two receptors are functionally 
redundant or if they have unique capabilities related to differences in their structure. It 
has been reported that, the amino acid sequences of a large region of the Notch 
intracellular domain are not highly conserved and thus may be able to interact with 
distinct transcription factors and mediate the expression of different sets of genes 
(Kraman and McCright, 2005). These authors stated that even though the amino acid 
sequences of NICD region are only 37% identical, the C-terminal region of the 
Notch1 intracellular domain could functionally replace that of Notch2 in vivo. 
Therefore, they concluded that, NICD, or the activation domain, is functionally 
conserved between Notch1 and Notch2. More evidence for non-redundant receptor 
function can be derived from tissues where both Notch1 and Notch2 are coexpressed, 
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but where deletion of one or the other results in a phenotype. In epidermal cells for 
instance, combined loss of Notch1 and Notch2 results in more severe epidermal 
phenotypes than loss of Notch1 alone (Krebs et al., 2000). 
Previous studies demonstrated that, Notch1 and Notch2 ICDs are functionally 
redundant, although their activation is dependent on differential interaction with 
ligands or the effect of extracellular domain modifiers (Hicks et al., 2000) 
Data presented demonstrate altered rate of Notch1 and Notch2 activity during the 
normal skin wound healing cascade. Strong nuclear expression of both active Notch1 
and Notch2 throughout the epidermis in the inflammatory phase was apparent. 
However, active Notch2 was detected both in the epidermal sheet and underlying 
dermal stroma, with. Notch1 only located in basal and suprabasal epidermal 
keratinocytes. Thus, localisation specificity of cleaved Notch1 and Notch2 can be 
concluded and this provides striking evidence that the maximal activation of Notch1 
and Notch2 occurs at different time points during wound healing, which can be 
correlated with functional specificity and contribute to skin wound healing of these 
receptors.   
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Figure 3.16: Notch signalling activation in the skin during the wound healing.  
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It has been reported that the consequence of epidermal Notch1 activation is an 
increase in expression of Jagged1 in the epidermis and dermis of K14NICDER mice 
(Ambler and Watt, 2010). While previous studies indicated a jagged1-dependent 
mechanism of Notch1 activation, these data also suggest that both Notch2 and Notch1 
are activated during normal wound healing, it was also determined if Notch2 was 
activated shadowing the same mechanism in K14NICDER mice. These findings were 
also confirmed when Notch 2 activity was shown to be undetectable in 
K14NICDER/K14CreER/jag1 flox flox triple mice lacking functional Jagged1.  
 
Both the Notch receptors and their ligands are transmembrane proteins, thus 
signalling is restricted to adjacent cells. Two proteolytic events in the Notch receptor 
are the result of ligand binding which terminates with the translocation of Notch 
intercellular domain (NICD) to the nucleus. It has been confirmed that the activation 
of Notch signalling pathway is affected by post-translational and post-transcriptional 
modification, as well as trafficking of Notch ligands and receptors (Bray, 2006). To 
explain the structural modifications that the ligands and receptors in Notch pathway 
are prone to, different models have been proposed, summarised by Bray, 2006.Similar 
to other membrane-bound proteins, the surface level of Notch receptors and ligands 
are maintained appropriately through ubiquitylation-dependent endocytotic 
degradation in order to prevent over-activation of Notch signalling (Weinmaster and 
Fischer, 2011). The underlying mechanism is not completely understood, however, 
two models involving ligand recycling and pulling force have been proposed in order 
to explain how ligand endocytosis in signal sending cells promotes Notch activation. 
Thus, the surface level of Notch receptor and ligand and subsequent Notch activity 
are regulated by ubiquitylation-dependent constitutive endocytosis that induces 
protein degradation (Weinmaster and Fischer, 2011).  
 
However, the determination of ligand cleavage and the functional consequences of 
ligand proteolysis on Notch signalling in vivo remain unclear. In this study a 
reduction in the level of Jagged1 was detected during the early stages of the wound 
healing. Structurally, the ligands share many characteristics with Notch itself and are 
prone to similar modifications including proteolytic processing (Klueg et al., 1998, Qi 
et al., 1999). However, the purpose of ligand cleavage remains unclear. One 
suggestion is that proteolytic processing of the ligand contributes to ligand 
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downregulation (Qi et al., 1999). Another suggestion is that cleaved or secreted 
ligands antagonize Notch signalling, because, under most circumstances, soluble 
ligand fragments inhibit receptor signaling. These reported works that indicated the 
ligand cleavage after binding of the ligands to the receptor in vivo, may describe the 
observed downregulation of full-length Jagged1 in our data.  
 
In conclusion, these data indicate that skin injury rapidly activated Notch signalling in 
the epidermis. Notch1 and Notch2 activation in the early stages of healing process 
suggests that Notch is a key player in orchestrating the immunological and epidermal 
cell responses during the wound-healing cascade. A beneficial role for Notch 
signalling during inflammation and proliferation stages of wound healing has been 
also supported by previous research conducted in our laboratory (unpublished data). It 
has been demonstrated that differential Notch activation is a key stress/injury signal in 
skin epithelium driving induction of pro-inflammatory production that drive normal 
skin tissue repair. It will be of considerable interest to identify the consequences of 
forced epidermal activation of Notch during the healing cascade and also the role of 
Notch activity in cytokines and chemokines production during skin wound healing.  
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4 The timing and duration of Notch activity 
impacts wound closure and inflammatory cell 
recruitment.  
4.1 Introduction  
Wound healing is a dynamic process which comprises of four distinct, but 
overlapping phases: homeostasis, inflammation, proliferation and remodelling (Geer 
et al., 2004). In acute wounds, blood vessel injury releases platelets, which aggregate 
to form a fibrin-rich clot. Secreted adhesive proteins, growth factors, and cytokines at 
the injured site activate and recruit neutrophils, macrophages, and fibroblasts (Eming 
et al., 2007, Geer et al., 2004). 
 Numerous clinical and experimental studies confirm the essential role of 
inflammation during repair. The inflammation phase can be subdivided into two 
distinct components: early and late inflammation. The sequential entry and exit of 
inflammatory immune cells at appropriate timings are equally important in wound 
closure (Eming et al., 2007, Geer et al., 2004). 
For instance, the transition from early to late inflammation depends on the 
replacement of neutrophils by lymphocytes and monocytes that have become 
activated (Eming et al., 2007). The macrophage has long been considered the key 
regulator for wound healing, they not only act as a predominant type of inflammatory 
cells (M1 macrophage) in the inflammation phase, but also are involved in the 
proliferation phase (M2 macrophage), as well as the remodelling phase, following 
activation by different pathways (Rodero and Khosrotehrani, 2010). 
 Infiltration of neutrophils in the inflammatory phase clears the wound of debris and 
contaminants, while secreting chemoattractants that stimulate monocytes movement 
into the wound (Eming et al., 2007, Geer et al., 2004). Once present, they bind to 
ECM receptors prompting their differentiation into macrophages which secrete a 
barrage of cytokines, including platelet- derived growth factor (PDGF), interleukins 
(ILs), tumour necrosis factor-alpha (TNF-α), and transforming growth factor-alpha 
and beta (TGF-α and -β) (Eming et al., 2007, Greaves et al., 2013). 
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4.2 Chronic wounds  
 
Although numerous stimulating and inhibitory mediators engaged during diverse 
stages of wound healing have been identified, it is the balance between these 
mediators, which is crucial to achieve perfect tissue homeostasis and repair following 
injury (Fonder et al., 2008). Furthermore, a sufficiently regulated balance between a 
complex network of various leukocyte cell subsets and numerous pro- and anti- 
inflammatory mediators is essential to achieve proper tissue homeostasis during 
healing (Eming et al., 2007). Dysregulation of critical parameters in inflammatory 
response interactions results in pathological and chronic inflammatory disease states 
that impair the quality of healing. 
 
A variety of causes have been identified that can delay wound healing including: 
chronic disease, diabetes, neurological defects, vascular insufficiency, nutritional 
deficiencies, age, and local wound-specific contributors; including bacterial biofilms 
and alterations in levels of various proteins (Fonder et al., 2008, Greaves et al., 2013). 
Chronic wounds occur at a high incidence in the general population. Annually in the 
United States, 2–3 million patients are at risk of developing diabetic ulcers, 600,000 
patients develop chronic leg ulcers secondary to venous insufficiency, and 1–3 
million patients suffer pressure ulcers secondary to immobility (Kuehn, 2007). In the 
United Kingdom alone, there are 24,000 hospital admissions per year with diabetic 
foot ulceration (Currie et al., 1998). The prevalence of chronic wounds varies in 
different age groups, being about 1% in the adult population but increasing to 3–5% 
in those over 65 years (Greaves et al., 2013) . 
 
4.3 Mechanisms involved in chronic wound formation 
 
It is a combination of systemic and localised stimuli that collectively overwhelm 
normal healing processes, which result in a hostile wound environment. The 
prolonged inflammation, which is associated with the proliferation and activation of 
macrophages and lymphocytes, and the production of an excess of inflammatory 
growth factors and cytokines, is one of the critical factors that promote hostile 
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conditions for wound healing (Mori et al., 2008). There are a number of common 
factors that promote adverse conditions for wound healing, these are summarised in 
figure 4.1.  
Chronic wounds do not adequately complete the “normal” phases of wound healing 
(Greaves et al., 2013). However, in contrast to the short-lived stimulus that triggers 
the orderly steps of wound healing in the skin, the injurious stimulus caused by 
infections, autoimmune reactions, trauma, and other types of tissue injury, persist in 
chronic diseases, causing organ dysfunction and often organ failure (Mori et al., 
2008). A state of chronic inflammation develops as many of the cells recruited to the 
wound in the proliferative phase of healing, adopt a pro-inflammatory secretory 
profile. Furthermore, inflammatory cells, particularly neutrophils and macrophages 
persist in the wound, creating a highly pro-oxidant, protease- rich environment with 
an abundance of pro-inflammatory cytokines such as interleukin-1 (IL- 1), 
interleukin-6 (IL-6), and TNF-α. The result is a hostile environment with down-
regulation of protease inhibitors and direct damage to extracellular matrix (ECM), 
cellular components, and protective growth factors such as platelet-derived growth 
factor (PDGF) and vascular endothelial growth factor (VEGF). Reactive oxygen 
species and proteases, such as matrix metalloproteinase (MMP) 1, 2, 3, 9, and 13, 
have also been described as deleterious influences  (Figure 4.1.) (Greaves et al., 
2013). 
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Figure 4.1 Mechanisms involved in the development and persistence of chronic wounds 
 (Greaves et al., 2013). Red lines indicate up-regulation and blue lines indicate down- 
regulation.  
 
4.4 Notch signalling and it’s interactions with inflammation  
Beyond being a target of inflammation, recent studies demonstrated that Notch plays 
an active role in the development of inflammatory processes (Fung et al., 2007, Zhou 
et al., 2003). Notch is an important regulator of immune cell differentiation and 
activation. Inflammatory response related to Notch activation in different tissue types 
have also been reported. Numerous studies reported its role in T CD4
+
, CD8
+ 
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lymphocyte, regulatory T-cell, B-cell, natural killer (NK) and dendritic cell 
homeostasis (Kassner et al., 2010, Woollard and Geissmann, 2010). 
In a recent study, Outtz et al., 2010, demonstrated that Notch1 partial deletion 
(Notch1
+/− 
hemizygous mice) induced a decrease in macrophage recruitment to the 
site of vascular injury, associated with an impaired production of TNFα in the wound, 
compared to wild-type controls. Macrophages isolated from Notch1
+/− 
subjects 
secreted less pro-inflammatory cytokines (TNF, IL6, IL12) and chemokines 
(CXCL10, CCL2) in response to (interferon gamma) IFNγ than Notch1
+/+ 
derived 
cells (Outtz et al., 2010).  
Consistenty, constitutive activation of Notch1 in macrophages potentiates the 
induction of IRF-1 (interferon regulatory factor 1), SOCS1 (suppressor of cytokine 
signaling-1), ICAM1 (intercellular adhesion molecule-1) and MHC-II (major 
histocompatibility complex, class II) by IFNγ, while reducing NO (nitric oxide) 
production (Monsalve et al., 2006). 
As an example, immunosuppressive effects by markedly reducing T-cell infiltration 
and proliferation were reported as a consequence of Notch blockade through Jag1-Fc 
or γ-secretase inhibitor treatment in large-vessel vasculitis (Piggott et al., 2011). It has 
also been reported that Notch signalling mediates IL10 production by T-cells via Dll4 
presentation on plasmacytoid dendritic cells (pDCs) (Kassner et al., 2010). 
Interestingly, Dll4 has been shown to reduce the production of the IL8 chemokine in 
response to ischemia or TNF, while selectively inducing the expression of 
inflammatory genes, such as iNOS (inducible nitric oxide synthase), pentraxin 3 and 
Id1 (Al Haj Zen et al., 2010, Fung et al., 2007). In support for a functional role of 
Notch pathway during the response to vascular injury, intimal hyperplasia after 
vascular injury is significantly decreased in hey2
−/− 
mice. This effect correlates with 
reduced cellular proliferation and decreased chemotaxis and migration in response to 
platelet-derived growth factor (PDGF) (Sakata et al., 2004). Overall, Notch signalling 
in macrophages seems to favour pro-inflammatory responses by releasing more 
cytokines and chemokines, supposedly through Notch1 and Notch3 activation. 
Furthermore, Notch activity in the epidermis has wide-ranging effects on both 
epidermal and dermal compartments (Estrach et al., 2006; Blanpain et al., 2006). 
There is increasing evidence to suggest that aberrant Notch signalling may contribute 
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directly to skin pathogenesis and altered expression of Notch receptors identified in 
Keloid disease (KD) (a fibroproliferative disorder). Syed and Bayat, 2012), showed 
the presence of a significant up-regulation of Notch receptors and ligand Jagged-1 
(JAG-1) in KD compared to normal skin tissue samples (Syed and Bayat, 2012). 
Their study also demonstrated that activation/inhibition of JAG-1 and Notch 
signalling significantly altered the behaviour of primary keloid fibroblasts in invasion 
and angiogenesis. Their work demonstrated a potential role for the Notch signalling 
pathway in KD progression and targeting this pathway may provide a novel strategy 
for treatment of KD (Syed and Bayat, 2012). 
Dermal changes including infiltration of the CD4- positive T cells, barrier 
dysfunction, epidermis thickening and epidermal hyperproliferation have been 
introduced as direct effects of forced epidermal Notch activity in un-injured skin 
(Ambler and Watt, 2010).  
A number of growth factors produced in Notch-active keratinocytes were identified 
by microarray analysis as likely candidates for Notch-induced dermal inflammation. 
The gene expression profiling of the epidermis, dermis and whole skin from 
transgenic (K14NICDER) and wild type mice treated with 4OHT for 14 days was 
performed previously (Ambler and Watt, 2010). Examination of the microarray data 
for epidermal growth factors and cytokines demonstrated a more than ten-fold up-
regulation in epidermal TNF α and a three-fold increase in TGFβ as a consequence of 
epidermal Notch activation in 4OHT-treated K14NICDER skin (Ambler and Watt, 
2010). The link between the up-regulation of TNFα following Notch activation, and 
the inflammation has also been reported by another study (Incorvaia et al., 2008). 
In chapter three the level of Notch1 and Notch2 activity in epithelial tissue as a 
response to injury was investigated. Data presented in chapter three demonstrated that 
wounding caused in an increase in Notch1 and Notch2 activity; with peak Notch1 
activity detected 4 dpw (days post wounding) and Notch2 activity observed at 1 dpw. 
The detection of maximal levels of Notch activity in the early inflammation stages 
indicates a functional role for Notch in inflammatory events in the wound-healing 
cascade. Furthermore, a recent study investigating the role of Notch signalling in 
epithelial tissue repair has demonstrated that Notch1 signalling activation in 
epidermal keratinocytes following skin injury, recruits innate lymphoid cells (i.e. 
ILC3s) to the site of injury in a TNFα/ CCL20 -dependent mechanism which controls 
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macrophage/ monocyte recruitment via ILC3-dependent CCL3 (Ambler et al., 
unpublished). Also it found that Notch1 induces epidermal production of IL23, which 
facilitates ILC3s to produce IL22 for epithelial proliferation and skin repair (Ambler 
et al., unpublished).  Using a 4OHT-treated K14NICDER mouse model, where 
Notch1 signalling can be controllably and specifically activated in epidermis, some 
key cytokine or chemokine candidates, including TNFα, and IL23, have been 
identified (Watt et al., 2008). 
In summary, there is significant evidence to indicate the involvement of the Notch 
pathway in production of a number of chemokine and growth factors, via a pleiotropic 
function of Notch pathway in skin wound healing previously (Ambler and Watt, 
2010, Demehri et al., 2009a, Lee et al., 2007). Prior research established Notch 
activation, via a 4-hydroxy-tamoxifen-inducible transgene, resulted in changes in skin 
architecture, induction of dermal inflammatory infiltration up-regulation of several 
growth factors and cytokines, including TNFα .  
The basic mechanisms that occur in the poor healing associated with chronic 
inflammatory diseases are generally similar to the mechanisms of epidermal forced 
Notch activity that have been discussed earlier in chapter three of this thesis. 
Assuming the validity of these pathological effects of Notch activity, the question 
arises whether prolonged activation causes poor healing. Thus it can be hypothesised 
that persistent Notch activity may lead to chronic inflammation and poor wound 
healing. 
It can also be suggested that prolonged epidermal Notch signalling might be involved 
in hindered skin wound healing by promoting a prompt inflammation reaction and 
mediating the interaction between keratinotyes and immune cells. Previous studies 
suggests a role of Notch signalling in promoting skin wound healing through use of a 
pan-Notch inhibitor (Chigurupati et al., 2007). However, the underlying mechanism is 
less clear, and the individual roles of Notch1 and Notch2 are unknown due to lack of 
appropriate inhibitory/stimulatory agents. Recent studies showed forced activation of 
epidermal Notch signalling promotes dermal accumulation of immune cells via 
epidermal production of TNF-α, TGF-β, and SM22α and stimulates epidermal 
proliferation via a mechanism that is less clear (Ambler and Watt, 2010, Estrach et al., 
2006).  
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It is possible that prolonged Notch signalling may also be a consequence of the over-
expression of IL-22 and IL23, which may result in a chronic inflammatory 
environment in wounds. Therefore, the correlation between prolonged Notch activity 
and inflammation using K14NICER models will be examined to investigate the 
expression level of IL-22 and IL-23 genes. The mechanism of how over-Notch 
activity, via TNF-α, regulates wound contraction, the ECM deposition and the 
accumulation of metalloproteinases in dermis will be determined during the healing 
process. 
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4.5 Experimental plan  
 
To examine the influence of Notch activation, on the rate of wound closure, the 
K14NICDER mouse model was used. To active NICDER transgenes, seven-week-old 
K14NICDER and wild type mice were treated topically with 2 mg 4-hydroxy 
tamoxifen (4OHT, Sigma-Aldrich, USA) dissolved in acetone (Estrach et al., 2006). 
Mice were treated in one of the following treatment groups (Figure 4.2):  
(1) 2 mg of 4OHT, three times a week for one week before wounding, followed with 
continuous treatment with 2 mg 4OHT three times a week, until 8 days post wounding  
(2) 2 mg 4OHT, three times per week, before wounding for one week, followed with 
continuous treatment with acetone alone, until 8 days post wounding 
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Figure 4.2. Experimental plan.  
K14NICDER and wild type mice, 7-weeks old, were randomly assigned into two 
groups (n=18 mice per group). Each group of mice received 4OHT three times for one 
week. Wounding procedure was subjected to the mice back skin after a week of 
treatment. One group (Group1) received one more week of 4OHT injections after 
wounding and the other group of mice was exposed to acetone alone treatment after 
wounding (Group2). Back skin samples were collected on 2, 5 and 8 days after 
wounding from both groups for histological and molecular analysis. 
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4.6 Results 
4.6.1 Persistent Notch signalling results in delayed cutaneous wound 
healing  
 
To examine the effect of chronic Notch signalling on wound closure, punch-wounded 
mice were photographed and the wound diameter was measured daily. At five days 
post wounding, the wound size was larger in K14NICDER mice treated with 4OHT 
prior to punch wounding and during wound healing (Group 1) compared to non-
transgenic wild type littermate controls, receiving the same treatment regime and 
K14NICDER that were not treated after wounding (Group 2) (Figure 4.3). Statistical 
analysis demonstrated that there was a significant difference in wound size (p value 
<0.0005) between the two experimental groups from day 4 to 7 post wounding 
(Figure 4.4). By 8 days post wounding, wound size was small in group 2 wild type 
and K14NICDER mice while in K14NICDER mice from group 1,wounds looked 
irritated and were larger compared to the wounds on K14NICDER and wild type mice 
in group 2 (Figure 4.4).  
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Figure 4.3. Full-thickness dermal wounds were created on back skin of K14NICDER 
mice and wild type mice  
(n=3), Images of a representative mouse from each group taken on post-injury days 0, 
2, 5, 8 and are shown.  
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Figure 4.4. Wound sizes percentage at the indicated time points in K14NICDER and 
wild type mice. Values are the mean ± SEM, (n=3 mice) per condition. All comparisons calculated 
against wild type (4OHT-WOUND-NO), *p value<0.05, **p value <0.005; ***p value <0.0005.  
Abbreviations: WT, Wild type; TG, transgenic, 4OHT: 4hydroxy tamoxifen. 
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Detailed histological analysis of Haematoxylin & Eosin (H & E) sections showed 
delayed wound healing in K14NICDER animals treated with 4OHT, before and after 
wounding, at days 5 and 8 post-injury compared to non-transgenic control mice 
(Figure 4.5). On day 5, non-transgenic control mice presented a superficial layer in 
the wound, which was lined by a thin layer of  damaged keratinocytes (Figure 4.5, top 
left panel). Within the damaged tissue of K14NICDER animals from group 1, a larger 
number of mononuclear cells were observed compared to the transitional site and 
normal skin. K14NICDER mice from both treatment groups on day 5 also exhibited 
large numbers of cellular infiltrates (cell density shown with white arrows in Figure 
4.5, top right panel). On day 5, K14NICDER mice had fewer migrating fibroblasts in 
the superficial dermis of the wound site. Quantification of epithelial thickness at the 
wounded site (indicated by yellow arrows in Figure 4.5) of H & E stained sections 
from all experimental mice at day 5 post wounding, is shown in figure 4.6. A 
statistically significant increase in thickness of the wounded epithelia in wild type 
skin from both treatment groups at 5 days post wounding was apparent when 
compared to adjacent normal skin (p<0.0005). Comparing the thickness of epithelia 
from K14NICDER mice treated before and after wounding with normal adjacent skin 
did not show a statistically significant difference.  The thickness of epithelia from 
K14NICDER treated mice, before and after wounding, was lower than that of 
K14NICDER mice treated immediately prior to wounding, but this comparison was 
found to be non-statistically significant (p>0.05, Figure 4.6).  
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Figure 4.5. Histological features of wound healing in mice with increased Notch 
activity and wild type.  
Images of skin tissue sections stained with H & E showing histological changes during the wound 
healing process in non-transgenic control mice and K14NICDER transgenic mice treated with 4OHT at 
post-injury days 5 and 8. K14NICDER transgenic treated with 4OHT mice exhibited delayed wound 
healing, compared to wild type acetone-treated mice. Scale bar = 200 microns. 
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Figure 4.6 Epidermal thicknesses in control and 4OHT-treated wild-type and 
K14NICDER mice,  
  Measurements are on 5 days post wounding (5dpw), from 2 biopsies of each animal , (n=3 mice) per 
group. Mean ± SEM ,  ***p<0.0005. Abbreviations: 4OHT: 4hydroxy tamaxifen; W:wound; AC: 
acetone.  
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4.6.2 The proliferation of basal cells decreased with respect to over-
activation of Notch signalling  
As reported previously, phenotypic characteristics including: thickened, hyper 
proliferative epidermis, blistering and accumulation of dermal cells at the 
epidermal/dermal junction have been observed on the back skin of 4OHT treated 
K14NICDER mice (Ambler and Watt, 2010). To determine the effect of prolonged 
Notch activity in K14NICDER on the proliferation index, the number of Ki67-
positive basal cells and the total number of nuclei were counted per 500 µm length 
from wound edge of the interfollicular epidermis. Ki67 is a nuclear protein, which is 
expressed in proliferating cells (Scholzen and Gerdes, 2000). 
Immunolocalization of Ki67 in skin wound appeared to be localised to the basal layer 
of epidermis, with the level of cell proliferation altering following continuous 
activation of K14NICDER mouse back skin. The percentage Ki67 basal cell 
expression in wild type mice in both groups was 40 ±5 % of the total number of the 
cells within 200 µm length from the wound edge of the interfollicular epidermis at 5 
days post wounding (Figue 4.7). In K14NICDER mice from group 1, the number of 
Ki67 positive cells near the wound site decreased (p<0.01) compared to the wild type. 
Cellular expression of Ki67 was not significantly decreased in transgene mice from 
group 2, however it was lower in these mice compared to the wild type animals within 
the same group (Figure 4.8).   
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Figure 4.7 Activation of Notch signalling before wounding caused delayed wound 
healing coincident with a delay in epidermal proliferation.  
4 mm full-thickness wounds were created in 6-week-old K14NICDER and wild type mice. Sections of 
wounded K14NICDER and wild type skin, treated with 4OHT before and after wounding, and non-
treated after wounding, collected 5 days post wounding were stained with antibodies to Ki67 (White). 
Red, dashed line marks epidermal-dermal boundary; red asterisk marks wound site. Scale bar equal 200 
microns. 
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                                                    Treatment groups   
 
Figure 4.8. A graph to show percentage of total dermal and epidermal cells, which were 
Ki67 positive  within 500 µm of wound site. 
Comparing wild type animals to K14NICDER animals at five days post wounding Mean ± SEM, one 
section per mouse (n=3 mice), **p< 0.01 Student t-test. Abbreviations: 4OHT: 4hydroxy tamoxifen; 
W: wound; AC: acetone.  
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4.6.3 Additional macrophage infiltration as an effect of over-
inflammation 
Previous research has confirmed a role for Notch signalling in recruitment and 
function of macrophages at the site of inflammation via regulation of inflammatory 
cytokines (Outtz et al., 2010). A previous study has shown that forced, ectopic 
epidermal Notch activity resulted in phenotypic hallmarks of skin wound healing 
(Ambler and Watt, 2010).  Data has shown that innate lymphoid cells (ILC) are 
recruited to skin wounds by a Notch/jagged1 dependent mechanism and these 
immune cells are involved in orchestrating immunological and epidermal cell 
responses during the wound healing program (Ambler et al. Unpublished data)  . As 
macrophages play an important role in many pathological processes, understanding 
the link between Notch and macrophages during wound healing may lead to provide 
insights for novel wound therapeutic strategies. The role of Notch signalling in 
regulation of macrophage function during inflammation has been reported previously 
(Outtz et al., 2010). Both pharmacological inhibition of Notch and genetic analysis 
demonstrate that Notch1 regulates cytokine expression in macrophages . It has also 
been reported that Notch1 is important for the inflammatory response during wound 
healing in mice (Outtz et al., 2010).  
This study hypothesised that additional macrophage infiltration as a consequence of 
prolonged Notch activity, may be the purpose of delayed wound closure in 
K14NICDER mice. To test this, dorsal wounds were created in K14NICDER and 
wild type mice from both groups, and wound tissue was harvested to assess 
macrophage infiltrate. Macrophages can be identified by specific expression of a 
number of proteins; the F4/80 antigen is expressed by a majority of mature 
macrophages and is the best marker for this population of cells. Immunolocalization 
of F4/80 in skin wound appeared to be localized to the basal layer of the epidermis 
and dermis, but the level F4/80 positive cells altered following prolonged Notch 
activity in K14NICDER mice (Figure 4.9). This investigation demonstrated that 
F4/80+ cells were plentiful (20-25%) within the K14NICDER dermis in both 
experimental groups, with a highly statistically significant (p<0.005) infiltration of 
macrophages in K14NICDER mice compared to their wild type littermates, within 
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both treatment groups (Figure 4.10). Hence, similar to the chronic wound conditions, 
infiltration of more macrophages that persist in the wound, were observed as a result 
of continued Notch activity prior and after wounding. This condition may create a 
highly pro-oxidant, protease- rich environment for the delayed healing of 
K14NICDER wounded skin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. 5dpw back skin tissues were sectioned and stained with an antibody to F4/80 antigen 
(green) and (Blue) DAPI counterstained 
Abbreviations: 4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone. Scale bar, 50 
microns. 
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Figure 4.10. F4/80 positive dermal cells, as a percentage of total cells counted, in wild 
type animals compared to K14NICDER mice from both treatment groups 5 days post 
wounding  
(4OHT before wounding only and 4OHT before and after wounding). Mean ± SEM, 
n= 3, **p<0.005. Student’s t-test, comparing K14NICDER with Wild type in each 
treatment group. 
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4.6.4 Q-PCR analysis 
q-PCR was completed to determine the differences in Notch-dependent, inflammatory 
and wound healing related gene expression, as well as to try to establish evidence of 
differentiation. Therefore, samples from both treatment groups were prepared for q-
PCR and probed for a number of genes associated with the wound healing and Notch 
activity. Wounded skin tissue samples from all treatment groups at day 5 and 8 post 
wounding were collected. Quantitative RT-PCR of wounded skin samples of all 
experimental groups was applied and data analysed and compared with the littermate 
not wounded, un-treated control mice. In these experiments, the mRNA of each gene 
was normalised to GAPDH or β-2M mRNA. 
 
4.6.4.1 Prolonged Notch activity induced Notch2, Notch1 and 
Jagged1, expression 
Changes were observed in macrophage recruitment and function in K14NICDER 
mice, in response to epidermal Notch activity (Ambler and Watt, 2010), 
characterisation of Notch expression and signalling in K14NICDER wounds, in the 
context of prolonged epidermal Notch activity was required. Previously published 
studies used topically applied Notch pathway activators and inhibitors and showed 
that Notch activity increased expression of Notch1 and Jagged1 (Chigurupati et al., 
2007). Wounded skin tissue samples from all treatment groups at day 5 and 8 post 
wounding were collected in this study. Messenger-RNA (m-RNA) was isolated from 
unwounded controls, wounded wild type or K14NICDER skin collected 5 and 8 dpw. 
Relative mRNA levels of Notch1, Notch2 and Jagged1 were quantified by q-RT-PCR. 
mRNA levels were normalised to unwounded control wild type mice. Notch1 
transcripts were significantly higher in tissue extracts from K14NICDER mice from 
both treatment groups than in normal skin at day 5 post wounding (Figure 4.11). 
Transcribed levels of Notch1 in K14NICDER wounds with prolonged Notch activity 
showed a statistically increased (p=0.0001) comparing to the controls in this group. 
Similar to Notch1, Notch 2 transcripts were increased (p<0.05) in K14NICDER mice 
from group 1 (Figure 4.12). Increased expression of Jagged1 was also detected in 
 145 
response to prolonged Notch activity in K14NICDER mice group1 (p<0.05) and also 
group 2 (p<0.05) than in normal skin at day 5 post wounding, shown in Figure 4.13. 
Transcript levels of Notch1, Notch2 and Jagged1 were induced in response to Notch 
activity over the healing process.  
 
 
 
 
 
Figure 4.11. Relative Notch1 mRNA level 
Messenger RNA isolated from unwounded controls or wounded wild type or K14NICDER skin was 
collected 5 and 8 days post wounding. Relative mRNA levels of Notch1 were quantified by q-RT-PCR. 
mRNA levels were normalised to unwounded control wild type or transgenic mice. Mean ± SEM, n=3 
mice per treatment groups from each genotype at each time point, 2 wounds per animal. Data shown 
are the average of three technical repeats for each animal. Student’s t-test. *p<0.05, ***p<0.0005. 
Comparison indicated the differences between each group to the corresponding control group. 
Abbreviation: dpw; days post wounding; 4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone.  
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Figure 4.12. Relative Notch2 mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of Notch2 were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats. Student’s t-test. *p<0.05. Comparison indicated the differences 
between each group to the corresponding control group Abbreviation: dpw; days post wounding; 
4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone.  
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Figure 4.13. Relative Jagged1 mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of Jagged1 were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats. Student t-test .*p<0.05. Comparison indicated the differences 
between each group to the corresponding control group. Abbreviation: dpw; days post wounding; 
4OHT: 4hydroxy tamoxifen; W:wound; AC: acetone.  
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4.6.4.2 Prolonged epidermal Notch1 activation induces TGF-β1 and 
TNF-α  expression in K14NICDER mice  
Tumor necrosis factor-α (TNF-α) is an effective inflammatory cytokine expressed 
during the inflammatory phase of wound healing (Goldberg et al., 2007, Singer and 
Clark, 1999). Previous studies have confirmed the association of Notch pathway and 
TNFα up-regulation with epidermal barrier disruption and skin inflammation 
(Incorvaia et al., 2008). As reported previously, the up-regulation of TNFα and TGFβ 
are related to epidermal Jagged1-dependent Notch activation (Ambler and Watt, 
2010). To gain insight into potential mechanisms by which persistent epidermal 
Notch activation during the healing cascade could induce the expression of factors 
such as TNFα and TGFβ, quantitative RT-PCR of wounded skin samples of all 
experimental groups was applied. These data demonstrated an extremely statistically 
significant (p= 0.0002) difference in the level of TGFβ expression at 5 days post 
wounding in K14NICDER mice with prolonged activated Notch, compared to the 
littermate controls (Figure 4.14). The level of TGFβ expression at 5 days post 
wounding in K14NICDER mice with activated Notch just before wounding, also 
demonstrated statistically significant (p= 0.0022) difference compared to the 
littermate controls. TNFα expression levels were also upregulated at 5 days post 
wounding in both groups of K14NICDER mice, compared to their corresponding 
controls (p<0.0005). Although the detected expression level of TNFα in wounded 
wild type skin tissue was statistically significant (p<0.05), comparing the 
K14NICDER with wild type mice from both groups on day 5 after wounding, 
K14NICDER mice still showed a higher level of TNFα transcribed level (p<0.05)  
(Figure 4.15).  Presented data here not only confirmed the association of Notch 
pathway, inflammatory response with TNFα upregulation during the healing process, 
but also promoted increased transcript levels of TNFα and TGFβ in response to 
prolonged Notch activity over the healing process.  
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Figure 4.14. Relative TGFβ mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of TGFβ were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats. **p<0.005, ***p<0.0005. Student’s t-test. Comparison indicates the 
difference between each group of mice at different treatment groups and their corresponding controls. 
Abbreviation: dpw; days post wounding; 4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone.  
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Figure 4.15. Relative TNF-α mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of TNF-α were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats. *p<0.05, ***p<0.0005. #p<0.05. Student’s t-test. Comparison 
indicates the difference between each group of mice at different treatment groups and their 
corresponding controls. Abbreviation: dpw; days post wounding; 4OHT: 4hydroxy tamoxifen; W: 
wound; AC: acetone.  
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4.6.4.3  Transcript levels of major cytokines implicated in wounding 
(IL22 and IL23) were induced in response to prolonged Notch 
activity over the healing process 
Identification of crucial cytokines for wound healing regulation, such as TNF-α has 
been well established. Other cytokines including IL22 and IL23 were also found to 
contribute to this regulation and immune responses (Robinson and O'Garra, 2002). 
Previous research suggested that IL-22-deficient mice displayed major defects in the 
skin's dermal compartment after full-thickness wounding (McGee et al., 2013). The 
involvement of IL-22 signalling in wound healing has been further confirmed by 
demonstrating the activation of IL22 signalling in fibroblasts, using in vitro assays 
with primary fibroblasts, and that IL-22 directs extracellular matrix (ECM) gene 
expression and myofibroblast differentiation both in vitro and in vivo. These data 
defined that the IL22 receptor signalling pathway has a key role in skin wound 
healing by mediating interactions between immune cells and fibroblasts (McGee et 
al., 2013). Ambler et al., unpublished data, has recently provided evidence, which 
confirms that the control of wound closure occurs in part through activating the 
immune response, through a TNFα-dependent recruitment of IL22 producing ILCs 
(ILC22). This work has identified that Notch-regulated secreted factors including 
TNF-α and IL23, are up regulated in 4OHT-treated K14NICDER skin, which could 
facilitate immune cell infiltration into the dermis. These findings demonstrated that 
epidermal Notch activation induces TNF-α, which leads to IL22 production that 
drives normal skin tissue repair (Ambler et al, unpublished). As previously described, 
the link between IL23 and the stimulation of ILCs, leading to IL22 secretion 
(Sonnenberg et al., 2011) was reported. It can be hypothesised that a high transcript 
level of these cytokines via prolonged Notch activation, may explain the delay of 
wound closure by stimulation of more ILCs and over immune cell infiltration into the 
dermis. To test whether elongated epidermal Notch activation would affect the 
expression pattern of the major cytokines implicated in wound healing, the relative 
mRNA levels of IL22 and IL23 were quantified by q-RT-PCR. mRNA was isolated 
from unwounded controls or wounded wild type or K14NICDER skin collected 5 and 
8 dpw. Relative mRNA levels of IL22 and IL23 were quantified by q-RT-PCR. 
mRNA levels were normalised to unwounded control wild type or control transgenic 
animals. These data demonstrated that the samples from K14NICDER mice that had 
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an epidermally stimulated Notch activity during the healing process and K14NICDER 
mice that had Notch activity only prior to wounding, express high levels of IL22 and 
IL23 sequences comparing to controls. Increased transcribed levels of IL22 were 
induced as a response to prolonged Notch activation in K14NICDER mice 
(p=0.0013), likewise, in K14NICDER mice from group 2, where Notch was only 
activated before wounding, IL22 expression level increased (0.0012) at 5dpw 
compared to littermate control mice  (Figure 4.16). IL23 relative mRNA levels in 
K14NICDER mice from group1 and group2 at 5dpw, showed a statistically 
significant increase (p=0.0001, p=0042; respectively) compared to littermate control 
mice (Figure 4.17).  
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Figure 4.16. Relative IL22 mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of IL22 were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats.  **p<0.005. Student’s t-test. Comparison indicates the difference 
between each group of mice at different treatment groups and their corresponding controls. 
Abbreviation: dpw; days post wounding; 4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone.  
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Figure 4.17. Relative IL23 mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of  IL23 were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats. **p<0.005, ***p<0.0005. Student’s t-test. Comparison indicates the 
difference between each group of mice at different treatment groups and their corresponding controls. 
Abbreviation: dpw; days post wounding; 4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone.  
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4.6.4.4 Negative effect of an excessive inflammatory response on 
Sm22-α  expression 
 
An efficient contraction of the granulation tissue that brings the wound margins 
together will be achieved when the mesenchymal cells of the granulation tissue 
differentiate into myofibroblasts. SM22 is a 22KDa protein expressed abundantly in 
the smooth muscle cells of vertebrates. Hence, induction of SM22 expression in 
fibroblasts is a critical step in wound healing. However, the link between 
inflammation and SM22 expression is still unclear; a recent study investigated 
whether SM22 disruption independently promoted arterial inflammation and 
characterised the underlying mechanisms of SM22 expression and inflammation. The 
authors concluded that disruption of SM22 expression promotes inflammation after 
artery injury via nuclear factor kappaB activation (Shen et al., 2010). The next 
question is to determine whether over-activation of Notch pathway during the 
inflammatory phase of healing suppresses the levels of SM22, at the mRNA level 
(Figure 4.18). In these experiments, quantitative real-time reverse transcriptase-PCR 
was used to determine the levels of expression of SM22. mRNA was isolated from 
unwounded controls, wounded wild type or K14NICDER mouse skin collected 5 and 
8 dpw. Relative mRNA levels of Notch1, Notch2 and Jagged1 were quantified by q-
RT-PCR. mRNA levels were normalized unwounded control wild type. These data 
showed that the relative SM22 mRNA level at 8dpw in wild type mice in both groups, 
was higher (p<0.005) compared to their corresponding controls (Figure 4.18). 
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Figure 4.18. Relative SM22- α mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of SM22-α were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats.  **p<0.005. Abbreviation: dpw; days post wounding; 4OHT: 
4hydroxy tamoxifen; W: wound; AC: acetone.  
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It was important to determine whether over-activation of epidermal Notch1 could 
induce SM22 expression that characterises myofibroblasts. Skin tissue samples from 
4OHT-treated K14NICDER animals prior and post wounding, were collected at day 8 
post wounding. The immunofluorescence, using monoclonal antibody–recognising 
mouse SM22, showed that Notch over activity decreased in dermal cells containing 
SM22 compared with the control group. Although previous studies reported a positive 
effect of TGFβ on SM22 expression in fibroblasts (Desmouliere et al., 1993), the 
incompatible activities of TNF-α against TGF-β-induced myofibroblast 
(fibroproliferative) phenotypic genes, for example, SM22, collagen type 1A, and 
fibronectin at the mRNA level, have been reported previously (Abraham et al., 2000, 
Goldberg et al., 2007, Verrecchia et al., 2002). The data in this investigation detected 
a diminution in the number of Sm22 positive cells after continued induction of Notch 
activity in K14NICDER wounded skin before and after wounding (Figure 4.18).  
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Figure. 4.19 back skin tissues were sectioned and stained with an antibody to SM22 
8dpw back skin tissues were sectioned and stained with an antibody to SM22 antigen (Red) and DAPI 
(Blue) counterstained. Abbreviations; dpw, days post wounding; WT, wild type; 4OHT: 4hydroxy 
tamoxifen; W: wound; AC: acetone. Scale bar 100 microns. 
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4.6.4.5 Increasing  chemokines expression initiated by over-activation 
of Notch signalling 
Although the functional capacity of the macrophage within the healing wound is well 
documented, little is known about the mechanisms of the monocyte recruitment into 
the wound bed. Among chemoattractants for monocytes that have been identified by 
previous studies, macrophage inflammatory protein1-α (Mip1-α) has been introduced 
as one of the most critical chemokines in mediating leukocyte infiltration into the site 
of injury. During the inflammatory phase of the normal healing process Mip1-α levels 
increase and as inflammation resolves and repair progresses, it decreases.  
Data demonstrated in chapter 3, showed the activation of Notch1 and Notch2 in the 
wound site, with maximal Notch2 activity occurring 24 hours after wounding, during 
the acute inflammatory phase. To verify a conclusive function for chemokines, such 
Mip-1, throughout wound healing, and the relationship between this chemokine and 
prolonged inflammation, via over-activity of epidermal Notch, the expression pattern 
of Mip1-α in wounded K14NICDER and their corresponding wild-types and controls 
from both treatment groups were assessed. These data display statistically significant 
upregulation of Mip-1 at 5 and 8 days post wounding in K14NICDER mice with 
prolonged Notch activation (at 5dpw, p<0.0005), as well as in K14NICDER treated 
animals only prior to wounding (at 5dpw, p=0.004) (Figure 4.20). 
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Figure 4.20. Relative  Mip1 mRNA level 
mRNA was isolated from unwounded controls or wounded wild type or K14NICDER skin collected 5 
and 8 days post wounding. Relative mRNA levels of  Mip-1 were quantified by q-RT-PCR. mRNA 
levels were normalised unwounded control wild type or transgenic mice. Mean ± SEM, n=3 mice per 
treatment groups from each genotype at each time point, 2 wounds per animal. Data shown are the 
average of three technical repeats. **p<0.005, ***p<0.0005. Student’s t-test. Comparison indicates the 
difference between each group of mice at different treatment groups and their corresponding controls. 
Abbreviation: dpw; days post wounding; 4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone.  
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4.6.5 Accumulation of dermal MMP1 as a result of over-activation 
of Notch signalling 
Chemokine and cytokine production during the inflammatory phase of the healing 
process is influenced by effector proteins, which include metalloproteinases (MMPs). 
Previous research demonstrated the inflammation regulatory functions of epithelial- 
derived MMPs, such as induction of leukocyte migration and chemokines activation 
during wound healing (Yong, 2005). Another study showed that up-regulation of 
MMPs, which are influenced by the inflammatory response, can alter many aspects of 
the wound healing process (Nguyen et al., 2006, Zhou et al., 2003). As delayed 
wound closure in K14NICDER mice treated before and after wounding was observed, 
metalloproteinase, such as MMP-1, within the wound may be responsible for this 
delay and overall impaired healing. The level of MMP1 protein accumulation within 
the wounded area of skin of K14NICDER animals, which were 4OHT, treated before 
and after wounding, at day 8 after wounding was investigated (Figure 4.21).   
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Figure 4.21. Quantification of MMP1 Levels.  
(A) Representative immunoblot, showing MMP1(72 KDa) and β-actin (43KDa) in lysates (20 mg/lane) 
in skin tissue samples from punch-wounded wild type and K14NICDER mice, within indicated 
treatment groups, collected at 8dpw. Un-wounded back skin tissue taken from un-injured mice of each 
genotype as a control. (B) Quantitative analyses of immunoblot from in A). MMP1 levels were 
standardised to β-actin level and statistically compared to the average back skin protein level (defined 
as 1) of MMP1in Un-wounded littermate mice. Mean ± SEM, n=3..* p value <0.05. Abbreviations; 
4OHT: 4hydroxy tamoxifen; W: wound; AC: acetone. 
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4.7 Discussion  
 
This chapter explored the functional consequence of prolonged epidermal Notch 
activation in the context of inflammation during wound healing, using 4-mm punch 
biopsies on the dorsal skin of 7-week-old transgenic (K14NICDER) mice and non-
transgenic litter- mates. Evidence demonstrated that persisted epidermal Notch 
activity during wounding in K14NICDER mice, results in postponed wound healing 
in these mice.  
Normal wound healing goes through three overlapping phases: inflammation, 
proliferation, and remodelling (Geer et al., 2004). This project focused on time points 
during the inflammatory and early proliferative phases, where Notch activation is 
most pronounced (data presented in chapter three). Wound healing was delayed at 
post-injury day 4 to 8 within group 1 (Notch activated was prolonged) K14NICDER 
mice, and increased expression of pro-inflammatory cytokines was observed in the 
wounded mouse skin.  
The results of persistent activity of epidermal Notch1 on wound healing are likely to 
be similar to that in chronic wounds as Notch may effect the function of multiple cell 
types that would be expected to play a role in inflammatory phase of wound healing. 
This is validated by a previous investigation that demonstrated that mice with 
myeloid-specific deletion of Notch1, display decreased macrophage recruitment and 
decreased TNF-α expression in wounds (Outtz et al., 2010). It was also reported that 
Notch signalling plays a role in regulating macrophage responses to inflammation. In 
a wound-healing assay, macrophage recruitment was decreased in Notch1+/− mice, 
and the wounds were characterised by decreased TNF-α expression (Outtz et al., 
2010). 
It is likely that the changes in accumulation of macrophages observed in 
K14NICDER wounds are due to Notch activity in epidermal cells, where Notch 
function within the epidermal immune response and in regulation of the macrophage 
response to inflammation has been well documented (Ambler and Watt, 2010, Outtz 
et al., 2010).  
Macrophages have long been considered the key regulator for wound healing, since 
they not only act as a predominant type of inflammatory cells (M1 macrophage) in 
inflammation phase, but also are involved in proliferation phase (M2 macrophage) as 
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well as remodelling phase, following activation by different pathways (Rodero and 
Khosrotehrani, 2010).  The abnormal macrophage activation found in the chronic 
wound may fail to lead to the inflammatory phase and hence transmit the wound 
straight into repair phase. Consequently, constitutive over-activation of Notch may 
result in excessive inflammation, which over-rides other positive effects of Notch in 
wound healing. Taken together, the genetic mouse model (K14NICDER) has 
established a specific role for Notch signalling in control of the inflammatory 
response during wound healing, but further study is needed to elaborate on how 
Notch1 and Notch2 in other cell types may contribute to wound healing and 
inflammation. 
Furthermore, expression levels of cytokines that are under the control of Notch 
activation may also affect wound healing. Pro-inflammatory cytokines such as IL-1α, 
IL-1β, IL6 and TNFα, have been demonstrated to be principal mediators during the 
inflammation phase of skin wound healing and up-regulated at this stage of healing 
cascade (Hubner et al., 1996). Ambler et al., unpublished data, recently presented that 
the blocked Notch1 inhibited the wound closure, TNFα, IL23 and IL22 production. 
Hence the fundamental role of Notch signalling as a wound response regulator can be 
concluded. It has been reported that neutrophils and macrophages are major sources 
of these cytokines (Mori et al., 2004).  TNF- α is a pleiotropic pro-inflammatory 
cytokine that is involved in the pathogenesis of a number of inflammatory diseases 
and has been specifically implicated in the tissue damage associated with chronic 
venous disease (Cowin et al., 2006). Previous studies demonstrated higher levels of 
TNF-α in wound fluid from non-healing ulcers compared with wound fluid from 
healing ulcers (Cowin et al., 2006, Murphy et al., 2002). Data presented in this 
investigation concurs with previous reports,with a higher level of TNFα in delayed 
wound closure skin samples from K14NICDER mice in-group 1 that received a 
prolonged Notch activity. These results can be supported by another study that 
illustrated a delayed in wound closure as a result of TNF-α deficiency that affected 
expansion of neutrophils, macrophage infiltration and reduced the rate of 
angiogenesis and collagen deposition at the wound site (Ishida, 2006). These studies 
provide unique insights into a better understanding of the effects of Notch on skin 
wound healing, which will facilitate the development of new therapies for impaired 
wound healing through modulating Notch signalling.  
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Previous research provided evidence that Notch plays a role in regulating the 
inflammatory response and wound healing. This study hypothesised that the constant 
epidermal Notch activity in K14NICDER mice would provide an over-inflammatory 
level of cytokine expression. Notch1 and Notch2 prolonged activation in the 
epidermis showed that the expression level of TNF-α and TGB-β largely boosted in 
K14NICDER mice. Increasing the level of IL23 and IL22 production as a result of 
prolonged Notch activation in wound healing was also detected. However, an 
enhanced induction of the immune response to the wound site, with the over 
recruitment of ILC and increased cytockines production may inhibit wound closure. 
These results suggest that over-activation of epidermal Notch is able to inhibit a 
normal wound closure by increasing the pro-inflammatory cytokines present in the 
wound tissue. It is possibly promising that a reduced activation level of Notch may be 
able to inhibit the presence of TNF-α in chronic wounds. Detecting the influence of 
constant epidermal Notch activity during skin wound healing on pro-inflammatory 
cytokines expression, may deliver new therapeutic aspects for non-healing chronic 
wounds. For instance, a decrease in TNF-α expression by controlling Notch activity 
could result in a decline in chronic inflammation, and non-healing wounds may then 
be able to enter a healing phase resulting in improved healing. 
In addition, the consequence of continuous epidermal Notch activation leads to 
excessive TGF-β1 expression. A previous study has confirmed an up-regulation of 
TGF-β in the skin as a result of inducible epidermal Notch activation (Ambler and 
Watt, 2010). TGF-β has been introduced as a pivotal mediator in wound healing, 
which contributes to the infiltration and activation of inflammatory cells (Ashcroft 
1999). After injury, TGF-β is rapidly upregulated and secreted by keratinocytes, 
platelets, and macrophages (Singer and Clark, 1999). TGF-β is essential for initiating 
inflammation and granulation tissue formation (McCartney-Francis and Wahl, 1994). 
Additionally, TGFβ may be required for cell migration during wound repair (Gailit et 
al., 1994; Zambruno et al., 1995). Previous wounding experiments have shown an 
impaired wound healing in humans by reducing the TGF-β expression level (Schmid 
et al., 1993; Cowin et al., 2001; Jude et al., 2002). Furthermore, the application of 
exogenous TGF-β, in animal models of impaired wound healing in which TGF-β 
expression was reduced, improved the rate of healing (Pierce et al., 1989; Salomon et 
al., 1990; Beck et al., 1991, 1993). Correspondingly TGFβ has also been 
 166 
demonstrated that directly induces the α-smooth muscle actin expression in 
fibroblasts by which controls and encourages wound contraction (Montesano and 
Orci, 1988; Desmouliere et al., 1993). 
Considering that TGF-β is a potent chemotactic cytokine for virtually all leukocytes, 
as well as endothelial cells and fibroblasts (Wahl et al., 1987, 1993; Wahl, 1992, 
1994), all of which are involved in the development of inflammation, the pro- 
inflammatory effect of TGF-β is likely to predominate in the skin. In supporting this 
notion, overexpression of TGF-β in basal keratinocytes and hair follicles initiates 
chronic skin inflammation, marked by epidermal hyperplasia, leukocyte infiltration, 
and angiogenesis (Liu et al., 2001; Li et al., 2004).  
It has been demonstrated that transgenic mice constitutively overexpressing wild-type 
TGFβ in keratinocytes (K5. TGF-β wt) exhibited a significant delay in full-thickness 
wound healing compared to non-transgenic mice. This previous work suggested that 
the reason for the delayed wound healing was linked with profound inflammation 
throughout all stages of wound healing in K5. TGF-β wt mice. The authors suggested 
that excessive and prolonged TGFβ at the wound site does not benefit wound healing, 
which is partially owing to its pro-inflammatory effect. Likewise, presented data in 
this chapter demonstrated that the level of TGF-β reached a peak level in mice with 
the prolonged Notch activity, which coincide with the peak of the inflammation. 
Therefore, the reason of the delayed wound healing in K14NICDER mice can be 
linked with profound inflammation and rising the TGF-β expression level in response 
to over-activation of Notch.  
Beside the fundamental roles of growth factors and pro-inflammatory cytokines 
during inflammation, the significance of other mediators that are involved in healing 
process know as chemokines are also highlighted (Lusier, 1998).  
 
To verify a conclusive function for chemokines, such as Mip-1(macrophage 
inflammatory protein 1), throughout wound healing and particularly during the 
inflammatory phase, genetically modified mouse models with altered expression of 
these exclusive chemokines have been evaluated. A transgenic mouse model, which 
lacks the critical macrophage chemoattractant did not show an alternation with the 
total number of macrophages at wound site whereas the angiogenesis, collagen 
synthesis and re-epithelialisation in this model was significantly reduced and delayed 
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wound closure was reported (Low, 2001). This study described an unaffected healing 
process in animals lacking Mip1-α (Low2001). A previous study isolated bone 
marrow-derived macrophages (BMM) from mice and characterized Notch signalling 
in the context of stimulation. Outtz and colleagues stimulated BMM with LPS/IFN-γ, 
then collected culture supernatants and assessed cytokine levels. They demonstrated a 
Notch related increased levels of MIP-1α, IL-6, IL-12, MCP-1 and TNF-α in the 
supernatant of stimulated BMM. They also proved that the induction of these 
cytokines upon stimulation was diminished when Notch signalling was inhibited with 
(Outtz et al., 2010). The data presented here exhibited no changes at the level of Mip-
1α expression during day 5 and 8 post wounding in wild-type littermates from both 
treatment groups. Surprisingly, the level of Mip-1shows a significant increase at 5 and 
8 days after wounding in K14NICDER with prolonged Notch activation, as well as in 
K14NICDER mice treated just before wounding. This magnification of Mip-1α 
expression might be related with the activation and recruitment of macrophages 
caused by over-activation of Notch in these mice.  
This investigation provides data that suggest that the delayed cutaneous wound 
healing in K14NICDER mice with an over activation of Notch, can be partially 
attributed to excessive inflammation throughout all stages of wound healing. 
Involvement of some proteases, such as matrix metalloproteinase (MMP 1, MMP2, 
MMP3, and MMP9) in cell migration during wound healing has been reported 
previously (Eming et al., 2007).  
The expression and activity of all these MMP classes have also been shown to be up-
regulated in chronic venous ulcers (Eming et al., 2007). It has been reported that pro-
inflammatory cytokines are potent inducers of MMP expression in chronic wounds, 
and have been shown to down-regulate tissue inhibitors of metalloproteinase 
expression, thereby creating an environment with a relative excess of MMP activity. 
This investigation presented the accumulative level of MMP1 in K14NICDER in a 
response to prolonged Notch activity. Therefore, prolonged inflammation in 
K14NICDER wounds creates an environment with a relative excess of MMP1 
activity. Indeed, components of the ECM (fibronectin and vibronectin) are 
downgraded or inactivated within chronic wounds (Grinnell et al., 1992, Grinnell and 
Zhu, 1996). This matrix degradation may explain the delay in wound closure seen in 
K14NICDER mice when Notch was over-activated. Previous research has shown that 
 168 
in chronic wounds, protective growth factors such as PDGF and vascular endothelial 
growth factor are also targeted when there is excess protease activity (Mendez et al., 
1998, Roth et al., 2006). 
Normally, TNF-αis not present during the re-epithelialisation and ECM reorganisation 
phases of wound healing (Singer and Clark, 1999). Healing proceeds only after the 
inflammation has subsided. Under pathological conditions, such as in chronic 
wounds, the cascade of wound healing is disrupted and the wounds are locked into a 
state of inflammation characterised by abundant neutrophil infiltration with associated 
reactive inflammatory cytokines (TNF-α). Previous research has reported a very high 
level of TNF-α in chronic wounds fluid compared to healing wounds (Trengove et al., 
2000). 
The results from this study showed high levels of TNF-α in prolonged Notch 
activated mice and suppression of SM22. It has been reported that in the chronic 
wound healing process TNF-α- suppressed myofibroblast differentiation and 
cytoskeletal changes are required for normal matrix contraction (Goldberg et al., 
2007). TNF-α mediates its antagonistic effects on TGF-β1 through the JNK pathway. 
Inhibition of Smad3 phosphorylation leads to a decrease in transcription of TGF-β1 
response genes, that is, collagen 1A, fibronectin, and α-SMA (Goldberg et al., 2007).  
Therefore, chronic wounds with a high level of TNF-α would fail to contract in a 
normal fashion. Consequently, continued inflammation, mediated by TNF- α, as a 
result of prolonged Notch activation, might prevent normal matrix deposition and 
myofibroblast- dependent wound contraction in normal wound healing. 
 
Conclusion: Although several studies have documented that a prolonged 
inflammatory phase in wounds impairs tissue repair (Fonder et al., 2008, Greaves et 
al., 2013), other reports have raised questions as to whether prolonged Notch 
activation at the wound site is necessary or conducive for wound healing. Due to the 
extra release of inflammatory cytokines and accumulation of further macrophages, 
elongated epidermal Notch activation at the wound site may be associated with tissue 
destruction that prevents the proliferation and remodelling that is necessary for wound 
resolution. Accordingly, the activation of Notch signalling plays an important role in 
whether they promote or prevent wound healing, and inflammation, the over-
activation of Notch may do more harm than good in terms of over inflammatory 
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response at the wound site. Using K14NICDER mice, this study has shown that 
Notch1 and Notch2 are important for TNF-α expression and infiltration of 
inflammatory macrophages to wounds. These data suggest that Notch plays an 
important role in early stages of skin healing process, a finding that has implications 
in a variety of settings, including in wound inflammatory response.  
Thus, although a great deal of work remains to be done, the ability of Notch signalling 
to regulate the activity of bioactive molecules, such as growth factors, cytokines and 
chemokines, proposes an fundamental role for Notch family genes in all phases of 
wound healing.  
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5 Different rate of healing on wounds located at 
different anatomic regions of the mouse body 
 
5.1 Introduction  
 
There are numerous factors that effect one or more phases of the wound healing 
process, these are classified into local and systemic factors (Guo and Dipietro, 2010). 
Local factors are those that directly influence the characteristics of the wound itself, 
while systemic factors are the overall health or disease state of the individual that 
affect the ability to heal.  Local factors that influence wound healing include growth 
factors, tissue fluid (oedema), blood supply, oxygen and infection. Many of these 
factors are related, and the systemic factors act through the local factors to effect 
wound healing. Single or multiple factors may play a role in any one or more 
individual phases, contributing to the overall outcome of the healing process (Hess, 
2012). Although different factors have been extensively researched for their roles in 
tissue repair, the role of the anatomical location has not been fully defined. 
 
The anatomical position of wound is a critical factor in entire healing process; the 
quality and the duration of healing. Wounds located on mobile areas, such as around a 
joint, or located on areas that are under pressure, are more difficult to be managed 
during the healing process than other anatomical locations (Blume et al., 2008, Hess, 
2012). Previous research focusing on the diabetic foot has shown that it is a 
particularly difficult location for wound healing, with the site of the foot ulceration 
particularly important in healing (Hess, 2012). Research has demonstrated, that while 
the overall healing rates of foot ulcers were similar at different locations, heel ulcers 
tended to heal more slowly (Falanga, 2005, Harding et al., 2002).  
A number of anecdotal reports suggest that wound location in mice also impacts upon 
closure rates. In most wound healing studies, multiple wounds are created on each 
animal. A few studies emphasised in their experimental design the randomized 
assignment of differently sited skin wounds to each treatment (Falanga, 2005, 
Harding et al., 2002, Mendoza et al., 2012); however, many have not clearly stated 
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the factors which determine the anatomical location. Literature searches have not 
produced any studies, prior to this investigation, which directly compare wound 
healing on different sites on mouse back skin, although previous burn healing studies 
reported rapid healing on the posterior quarter to third of the animal (but without 
providing data) (Davis et al., 1996, Davis et al., 1990). Another study indicated no 
difference between the healing of cranial or caudal burns (Singer and McClain, 2003) 
whereas, Wang, et al.,(2009)  examined healing in different sites on a porcine burn 
model and indicated that caudal burns healed significantly better than cranial burns, 
demonstrated by earlier closure of caudal wounds and less scar formation (Wang et 
al., 2009).  This investigation examined the reason of different rate of healing on 
wounds located at different anatomic regions of the mouse body. Data presented in 
this chapter showed that lower body wounds healed significantly better than those in 
the upper posterior, or middle to posterior of the mouse back skin wounding model. 
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5.2 Experimental plan  
 
Male C57BL/6 mice at 7 weeks of age (the resting stage in hair cycle) were 
employed. The back skin of the mice was shaved and animals anesthetised using 2 to 
2.5% vaporised inhaled isoflurane. A line was drawn to indicate the distance between 
the tip of the nose and the caudal edge of the hair region of the body. This distance 
was measured and taken to be 100%. Lines of 75%, 50% and 10% from the caudal 
border of the hair region were drawn (Figure 5.1).  
Dorsal skin was cleaned with Iodine/Povidone 10% solution and wiped with distilled 
water. Full-thickness dermal wounds were created in the skin of the back of the mice 
(Figure 5.1) using a 4-mm biopsy punch (Stiefel, USA) pressed into skin with 
twisting motion until both layers of skin were punched through. Wounds were made 
at different anatomic regions; upper posterior (A=75%), middle to posterior (B=50%) 
and posterior-most (caudal) (C=10%) (Figure 5.1). At the desired time points (1, 4 
and 7 days after wounding) three mice wounded at  each wound location were 
sacrificed. Skin tissue samples were excised at the wounds, including a few 
millimeters of the surrounding skin from all of animals for histological and 
biochemical analyses. For RNA extraction and protein lysates, the same amount of 
intact tissue was collected from each mouse. Digital photographs of the injury site 
were taken; wound size was measured and quantified. 
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Figure 5.1 Diagram showing the relative position of injured sites.  
Several percentage lines were drawn between the tip of the nose (100%) and the 
caudal edge of the hair region of the body (0%). 4 mm wounds were made at the mid 
line of the body (A, B, C). 
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5.3  Results  
5.3.1 Anterior and mid-region wound healing was delayed compared 
with posterior wounds in mice back skin 
As skin wound healing is a complex and dynamic process, consisting of various 
sequential phases, the wound repair was carefully analysed over different stages of 
healing. 4 mm wounds were created in the back skin of wild-type mice at different 
regions and the healing process was analysed at days 1, 4 and 7 post-injury (n=3 for 
each time point and each wound location). As wound healing of the middle and upper 
posterior region wounds were visibly delayed, to assess the role of anatomical region 
in wound healing in vivo, wound sizes were measured daily until complete 
epithelialisation. Macroscopically, wound sizes were larger in upper and middle sites 
(Figure 5.2 a). Daily measurements revealed a statistically significant difference in 
wound sizes between the three locations from day 2 (p<0.0005) to day 5 (p<0.005) 
post wounding (Figure 5.2 b).  
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Figure 5.2. Daily measurements of wound size at different locations 
Lower wounds heal faster than the middle and upper sites A) Representative appearance of wounds at 
day 1 to 7 at different regions. B) Maximum length  of the wound in posterior, middle-posterior and 
upper-posterior regions post wounding (n=3, for each time point and location). Data are presented as 
mean ± SEM. *P<0.05, **P<0.005, ***P<0.0005. Student’s t-test. 
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Figure 5.3 shows representative micrographs of wounded skin at days 4 and 7 post 
wounding, showing a larger wound gap in the upper and middle locations compared 
with the lower site of mouse back skin (posterior). These findings suggest that 
posterior wounds heal faster than the middle and upper sites of mouse back skin. 
 
Histological analysis demonstrated keratinocyte migration into the wounded area and 
subsequent migration of epithelial leading edges in wounds from all considered 
locations at (Figure 5.3).  
In conclusion, most posterior wounds demonstrated faster re-epithelialisation and 
completion in closure of wounds, compared with anterior and middle wounds by 4 
dpw (Figure 5.3). Arrowheads signify the wound margins at 4 dpw, the distance 
between the migrating epidermal tip and the original wound edge was also measured. 
The length of the migrating epidermis of upper and middle wounds was greater than 
that of wounds located in the caudal region at day 4 post wounding, these 
measurements showed an statistically significant (p<0.05) difference between both 
upper and middle wounds compared with the lower ones (Figure 5.4).  
Seven days after injury, the wounds on all locations exhibited near-complete wound 
closure. However, Van Gieson staining revealed elastic fibres had not yet regenerated 
in the wound bed of upper and middle body injuries, whereas dense elastic fibres were 
observed in lower body dermis adjacent to the wound (Figure 5.5 arrows).  These data 
indicate that the absence of elastic fibres in anterior and middle regions of mouse 
back skin negatively affected wound closure in these anatomical locations. 
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Figure 5.3. Representative micrographs of wounded skin at days 4  post wounding 
Hematoxylin and eosin (H&E) staining of wounded skin at day 4 post wounding. Arrowheads 
demarcate the wound margins and arrows indicate the centre of the wound injury. Scale bar=200 
microns.  
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Figure 5.4 distances between the original wound sites and migrated epidermis 
The distance from the original wound site to the migrating wound tip from different anatomical sites of 
mouse back skin at 4 dpw. (n=3 from each location). * p value<0.05, indicate a significant difference 
between upper and middle wounds, comparing with the lower wounds. 
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Figure 5.5. Verhoeff’s Van Gieson staining for elastic fibres 
Verhoeff’s Van Gieson staining for elastic fibres shows a network of elastic fibres in the dermis 
adjacent to the wound in the lower body wounded skin after 7 days (arrows), which is not seen in the 
upper and middle body wounds.  
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5.3.2 The delayed re-epithelialisation in upper and middle body 
wounds may be a result of decreased keratinocyte proliferation 
Location of the wound may be functional in the proliferation and migration of 
keratinocytes at the early stages of healing. The delayed re-epithelialisation in upper 
and middle wounds may occur as a result of decreased keratinocyte proliferation. The 
number of both epidermal and dermal Ki67-positive cells after wounding were 
compared to assess keratinocyte proliferation in wounds located at different regions 
(Figure 5.6). In lower body wounds, the number of epidermal and dermal Ki67- 
positive cells was increased (p<0.005), with a peak (50% increase) observed 4 days 
after wounding. However, the increase in Ki67-positive cells was delayed in upper 
and middle wounds at day 4 (32-36%). Lower wounds showed more Ki67- positive 
cells at day 4 post wounding, both within dermal and epidermal cells (Figure 5.7). 
These results suggest the existence of a posterior-anterior gradient in dermal and 
epidermal proliferation and wound closure in response to injury.  
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Figure 5.6. The epidermal and dermal Ki67-positive cells 
Location of the wound may be functional in the proliferation 4 mm full-thickness wounds were created 
in 7-week-old wild type mice at different locations (Upper-posterior (A-C) middle posterior (D-E) and 
lower-posterior (G-I)). Sections of wounded skin were collected 1,4 and 7 days post wounding and 
stained with antibodies to Ki67 (White). The red dashed line mark the epidermal-dermal boundary; red 
asterisk marks wound site. Scale bar equal 200 microns. 
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Figure 5.7. Quantification of the total Ki67 positive basal epidermal and dermal cells 
Graph shows the number of Ki67 positive basal epidermal and dermal cells within 500 microns of the 
different regional wounds at 1, 4 and 7 days post wounding. Mean ± SEM ; T-test ,**P value<0.005. 
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5.3.3  No Changes in the Notch1 activity at different regional 
wounds 
Findings in previous chapters suggest that activated Notch1 and Notch2 levels are 
highest in the inflammatory and proliferation phase of the wound response. The link 
between the wound healing and the effects of Notch activity during the healing 
process has been confirmed (Chigurupati et al., 2007). Previously, this study showed 
that throughout the skin wounding, Notch1 and Notch2 activity increased steadily in 
the upper stratum spinosum in wounded skin until day 4 post wounding, at which 
point activation subsided but remained detectable at day 7. To examine the possibility 
of site-dependent Notch1 activity on wounded mouse back skin by 4dpw, western blot 
analysis was employed. These data did not detect greater increase in Notch1 activity 
in wounded skin at different regions during wound healing (4dpw) (Figure5.8). 
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Figure 5.8. Relative levels of activated Notch1 at different locations 
A) Representative immunoblot, showing relative levels of activated Notch1 (75 kDa) and B-actin (42 
kDa) in lysate (20 mg/lane) in wounded skin samples from different locations of mouse back skin. B) 
show the quantitative analyses of immunoblot data. mean values ± SEM, n=3. 
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5.3.4 No detectable change in production of inflammatory cytokines 
in wounds at different regions 
Immediately after injury, during the early inflammation phase, platelets and 
fibronectin accumulate to form a clot at the injured site. This clot acts as a source 
from which several chemotactic substances are released, including vascular 
endothelial growth factor (VEGF), epidermal growth factor (EGF), platelet derived 
growth factor (PDGF), transforming growth factor-β (TGF-β), and immunoregulatory 
cytokines, providing a provisional matrix that allows cell migration (Amadeu et al., 
2003, Gosain and DiPietro, 2004). An exaggerated inflammatory response results in 
increased production of pro-inflammatory cytokines in the initial wounding response. 
Wounds within an environment of sustained inflammation, matrix degradation and 
reduced growth factor activity, present with reduced tissue repair, cellular 
proliferation and angiogenesis (Chen et al., 1997, Harding et al., 2002, Medina et al., 
2005). Levels of inflammatory cytokines, including tumour necrosis factor-α (TNF-α) 
and transforming growth factor- β (TGF-β), were compared between wounds at three 
different locations (Figure 5.9). Tumour necrosis factor-α mRNA at all wound sites 
was significantly upregulated (p=0.0001), compared to that  in un-wounded skin at 
day 4 post wounding, although there was no significant difference between wounding 
locations. TGF-β levels in all wounded areas was significantly (p<0.005) increased 
compared with un-wounded skin; however, the expression level was higher at days 4 
(p<0.005) and 7 (p<0.05) compared control at all locations, with no significant 
difference between the regions (Figure 5.10).  
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Figure 5.9. Relative TNF-α mRNA level 
mRNA was isolated from unwounded controls or wounded skin from different sites of wild type mice 
back skin collected 4 and 7 dpw. Relative mRNA levels of TNF-α were quantified by q-RT-PCR. 
mRNA levels were normalised unwounded control. Mean ± SEM (standard error of the mean). ** p 
value <0.005,*** p value<0.0005, show a significant difference between upper and middle wounds, 
compared with the lower wounds. (Representing the comparisons between each location at 4dpw or 
7dpw with un-wounded control skin). ###p value <0.0005, representing the significant difference 
between wounds at different location on 4dpw with their equals on 7dpw. Student’s t-test, n=3 mice. 
Wounds were collected from 3 mice and 2 wounds per mice at each location at each time point. Data 
presented here is the average of 3 different biological replications in 3 runs of q-PCR with 3 technical 
replication at each run. 
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Figure 5.10. Relative TGFβ mRNA level 
mRNA was isolated from unwounded controls or wounded skin from different sites of  wild type mice 
back skin collected 4 and 7 dpw. Relative mRNA levels of TGFβ were quantified by q-RT-PCR. 
mRNA levels were normalized unwounded control. Mean ± SEM (standard error of the mean). 
*pvalue<0.05,** p value<0.005, indicate a significant difference between upper and middle wounds, 
compared with the lower wounds. (Representing the comparisons between each location at 4dpw or 
7dpw with un-wounded control skin). Sstudent’s t-test, n=3 mice. Wounds were collected from 3 mice 
and 2 wounds per mice at each location at each time point. Data presented here is the average of 3 
different biological replications in 3 runs of Q-pcr with 3 technical replication at each run. 
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Epidermal T cells have been shown to play unique roles in tissue homeostasis and 
repair  in mice through local secretion of distinct growth factors in the skin. Previous 
research showed that epidermal T cells contribute to the effective healing of acute 
wounds and are functionally defective in patients with non-healing wounds (Eming et 
al., 2007, Sonnenberg et al., 2011). Therefore it can be hypothesised that the alteration 
of wound healing at different anatomical locations is related to the number of T cells 
at the wound sites. To visualise of T cells, skin sections were analysed by using CD3, 
to detect all T cell subsets. Dendritic epidermal T cells (DETCs) were detected in the 
interfollicular epidermal basal layer with dendritic morphology, while a few CD3+ T 
cells were also detected in dermis (Figure 5.11), but this was not statistically 
significant compared to different regions (Figure 5.12).  
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Figure 5.11. Immunostaining with CD3 and DAPI  
Representative immunohistochemistry of a cross-section in the different regions of injured back skin 
day 4 post-wounding. Immunostaining with CD3 and DAPI. Scale bar = 100 µm 
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Figure 5.12. Quantification of CD3 positive T cells within 500 microns of the wound site 
Graph to show the percentage of CD3 positive T cells within 500 microns of the wound site from 3 
different locations at 4dpw (n=3 mice for each location). Mean ± SEM (standard error of the mean). 
All comparisons were non-significant. 
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5.3.5  SM22 expression and local MMP-1 differ at different location  
It has been reported that the up-regulation of SM22 expression in the injured tissue 
may be related to a multistep modification process in which fibroblasts are converted 
to myofibroblasts (Faggin et al., 1999). SM22 alpha is a protein that is expressed 
specifically in adult smooth muscle. Approximately one week after wounding, the 
provisional matrix is replaced by neo-formed connective tissue, essentially composed 
of small vessels, extracellular matrix, and fibroblastic cells that become activated and 
differentiate into myofibroblasts. Myofibroblasts are recognised to play a central role 
in closing the wound tissue, through their capacity to produce a strong contractile 
force possibly generated within stress fibers (Faggin et al., 1999). Therefore it was 
hypothesised that the fibroblasts maturation into myofibroblasts in mouse back skin 
wounds, may depend upon the anatomical locations of wounds in mouse back skin. 
Immunohistochemistry showed that SM22α levels were weak and confined to the 
dermis at day 4 post wounding (Figure 5.13), but increased until day 7 in all regional 
wounds (Figure 5.13). At day 7 post-wounding, in lower and middle body wounds, 
SM22α immunoreactivity was detected in the dermal area of the wound edges and 
labelling was diffuse in the areas away from the wound bed. In contrast, in wounds 
located at the upper body, SM22α was not localised on the cell membrane in the 
dermal cells as much as lower and middle wounds (Figure 5.13).  
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Figure 5.13. Immunostaining of mouse back skin with SM22α 
Representative immunohistochemistry of a cross-section in the wound at different regions (upper, 
middle and lower) of mouse back skin at day 4 and 7 post-wounding.  Immunostaining of mouse back 
skin with SM22α (red and DAPI (blue).  Scale bars equal 100 microns. 
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Among the many gene products that are critical for the restoration of normal tissue 
architecture, several members of the matrix metalloproteinase (MMP) family function 
as positive regulators of repair processes. It has been reported that MMP-1 is essential 
in vitro for the migration of corneal epithelial cells over a type I collagen matrix 
(Daniels et al., 2003). The expression level of MMP-1 was examined at different sites 
of mouse injured back skin. The presence of MMP-1 was highly localised behind the 
leading edge of the basal epithelium and dermis at lower body wounds, compared to 
the upper and middle body located wounds where it was not present (Figure 5.14). 
These data may suggest that local MMP-1 expression may influence the regional 
wound healing responses.  
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Figure 5.14 Immunostaining of mouse back skin with MMP1 
Representative immunohistochemistry of a cross-section at the different injured regions of mouse back 
skin at day 7 post-wound. Immunostaining of mouse back skin with MMP1 (green) and DAPI (blue).   
Scale bar = 100 µm. 
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5.4 Discussion  
 
A substantial quantity of work regarding wound healing has been published from 
various points of view (Broughton et al., 2006a). However, it seems that the 
occurrence of regional differences in wound closure has not been reported in mice. 
Clinically, it has been observed that burns heal differently depending on their 
anatomical location (Wang et al., 2009). In addition, previous studies have reported 
that hypertrophic scarring occurs frequently in areas of high tension and movement, 
such as anterior surfaces of the neck, shoulder and chest wall, and flexor surfaces of 
the extremities, but virtually never appears in certain body areas such as the scalp, 
eyelid, palm, and sole (Greenhalgh, 2005, Greenhalgh, 2012, Matsumura et al., 2001). 
In this chapter, it was noted that mouse dorsal lower body wounds healed better. 
These investigations clearly indicate that there is a regional difference in wound 
closure rate of the mouse skin. The rate of the healing and wound closure was higher 
in the lower posterior region than healing rates in the anterior and in the middle-
posterior region. This would suggest the existence of a posterior-anterior gradient in 
epidermal response to injury.  
One might suspect that the differences in healing might be partly due to differences in 
skin proliferation. Keratinocytes in the wounded margins begin to proliferate behind 
the actively migrating region during early days post injury (Singer and Clark, 1999). 
In this project, keratinocyte proliferation was significantly increased in posterior 
region wounds compared with in anterior and in the middle-posterior region wounds 
at the relatively early stages of wound healing (1–4 days post wounding), suggesting 
an involvement of regional proliferation in skin wound healing.  
 
Interestingly, in middle-posterior and anterior region wounds, the level of 
keratinocyte proliferation and migration appear to approach that of posterior wounds 
after day 4 post-wounding. The reduction in wound size appeared to also follow this 
trend; wounds in middle-posterior and anterior region were larger in the early days 
after wounding, but their size approached that of posterior region after day 5. These 
observations suggest that the differences in keratinocyte migration and proliferation in 
the early stages of wound healing in this study may be influenced by wound location. 
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Re-epithelialisation and wound contraction are two essential factors during the 
healing process. Myofibroblasts that express SM22, are believed to be one the main 
factors affecting contraction formation (Desmouliere et al., 2005, Greenhalgh, 2012). 
It is unknown whether or not more expression of SM22 directly results in faster 
contraction in posterior wounds compared with anterior and middle wounds. What is 
clear is that these wounds close earlier by re-epithelialisation and cell migration 
compared with anterior and middle wounds. In contrast to the data described in this 
investigation, an earlier study using a full-thickness excision porcine model, still 
reported wound contraction to be dependent on wound location, however less 
contraction in lateral-caudal was observed in comparison to lateral-cranial locations 
(Hinrichsen et al., 1998). Hinrichsen et al., (1998) demonstrated that healing time was 
longer in lateral-caudal than lateral-cranial wounds, but no histological or other 
clinical wound healing assessments were provided. 
 
It is well recognised that extended inflammatory responses delay wound healing. In 
this study, no wounds showed a typical over-inflammatory response in all considered 
locations of the skin. The level of CD3 positive T cells and the amount of the relative 
mRNA expression of TNF α in wounds from all locations did not show any 
significant difference. Therefore, it is unlikely that the differences in healing between 
the cranial and caudal wounds are attributable to impaired inflammatory factors. 
 
The matrix metalloproteinases (MMPs) are proteins from metalloproteinase enzyme 
family that facilitate biological reactions. MMPs play a critical role in wound healing 
(Baker and Leaper, 2003). During the normal process of the wound healing MMPs are 
produced from activated inflammatory cells at the wound site, as well as epithelial 
cells, fibroblasts and vascular endothelial cells. At each stage of the normal wound-
healing cascade, MMPs play essential and beneficial roles. During the inflammation 
phase MMPs are involved in removal of the damaged extracellular matrix (ECM) and 
bacteria, in the proliferation phase MMPs are responsible for degradation of the 
capillary basement membrane for angiogenesis and the migration of epidermal cells. 
During the remodelling of the wound healing process, MMPs contribute to 
contraction of scar ECM and remodelling of scar ECM (Baker and Leaper, 2003). 
Involvement of MMPs in angiogenesis and contraction has been considered as the key 
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factors that MMPs control during the wound healing process. MMPs degrade the 
basement membrane that surrounds capillaries, which allows vascular endothelial 
cells to migrate from capillaries near the wound and to establish new blood vessels in 
the wound bed (Muller et al., 2008). MMPs secreted by myofibroblasts are necessary 
for contraction of newly synthesised scar ECM. MMP-1 has been previously been 
introduced as a key member of MMPs family in the wound healing process. MMP-1 
is essential for the migration of epithelial cells over a type I collagen matrix (Daniels 
et al., 2003). In this project, a close relationship between MMP-1 and the rate of the 
wound closure was established, as the MMP-1 expression after wounding was 
significantly marked in posterior wounds compared to other locations. These data is 
suggest that MMP-1 effects the wound closure rate, however whether this is directly 
or indirectly remains to be determined. 
In conclusion, these data showed that wound location is involved in wound healing 
associated with keratinocyte proliferation and differentiation in response to skin 
injury. Further understanding of the anatomical location’s role in wound healing may 
reveal new therapeutic strategies in this area. It is conceivable that alterations in 
proliferation and keratinocyte migration at different sites of the body represent true 
regional differences in epidermal wound closure in response to injury. Assuming the 
validity of this suggestion, the question arises why such a regional difference in 
proliferation and migration accrues after injury. One possible explanation is the 
existence of an anterior-posterior gradient of MMP inhibitors, wound contraction 
disruption, collagen deposition and proliferation inhibitors. The faster healing in 
posterior compared with anterior locations observed in this study is significant. 
However, there remains cause to examine the regional disruption of wound healing 
factors in the mouse skin, this problem remains the subject of future investigation. 
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6 General discussion  
Previous studies have established that in adult skin Notch signalling sustains the 
epidermal barrier by promoting cell-autonomous keratinocyte terminal differentiation 
(Blanpain and Fuchs, 2006). Notch1 and Notch2 receptors are described as the main 
Notch signalling mediators in postnatal skin (Rangarajan et al., 2001). 
Recent studies of Notch in adult tissue homeostasis have also shown that Notch 
orchestrates communication between the epithelial and immune compartments of the 
skin to prevent chronic inflammation and inflammatory skin disease (Dumortier et al., 
2010, Goud and Deshpande, 2011). Although it seems that the role of Notch is well 
established in immune and inflammatory diseases, little is known about the role of 
this signalling pathway in normal physiological processes, such as cutaneous wound 
healing.  
Firstly, work performed previously provides strong evidence that Notch is involved in 
wound healing, however the specific feature or the site of action was unspecified 
(Ambler and Watt, 2010, Chigurupati et al., 2007). The results presented in this study 
demonstrate distinct, temporal activation of Notch1 and Notch2 in the wound site 
with maximal Notch2 activity occurring at 24 hours after injury during the acute 
inflammatory phase of normal healing. This work showed that wounding caused in an 
increase in Notch1 activity with peak activity detected 4 days post wounding. By 
seven days post wounding, when the epithelium has closed, the remodelling phase has 
initiated and the risk of microbial contamination has reduced, the activity of both 
Notch1 and Notch2 return to unwounded skin levels.  
 
It has been reported that epidermal Notch activity affects multiple processes that are 
related to wound healing (Nicolas et al., 2003). For example, epidermal Notch activity 
increases the production of TNFα, CCL20, IL22 and IL23 during the inflammatory 
and proliferation phase of the healing process. Maintenance of the epidermal stress 
response is now accepted as an established role for Notch activation in adult skin 
(Nicolas et al., 2003).  
 
Contribution of Notch signalling in inflammatory processes, including the activation 
of macrophages (Monsalve et al., 2006) and dermal T cells infiltration (Ambler and 
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Watt, 2010) drew attention to determine the consequence of continued epidermal 
Notch activation during the healing process on  wound closure. By using a transgenic 
mouse (K14NICDER) where Notch can be controllably activated in the epidermis, 
this work demonstrated a mechanism by which epidermal Notch activity was induced 
before wounding and during the healing process to determine the effects of over-
activation of Notch on wound closure. Skin wounding activates the Notch pathway in 
the basal and suprabasal epidermis. Injury induced Notch1 and Notch2 activity, as 
well as upregulation of TNF-α and TGF-β. Forced epidermal over-activation of 
Notch, stimulated the production of IL22 and IL23 and Mip1, which subsequently 
influences epidermal proliferation and macrophage recruitment. Stimulation of SM22, 
and MMP1 are also the major consequence of over-activation of epidermal Notch 
signalling (Figure 6.1). Hence, although previous research showed that the epidermal 
Notch activation via a 4-hydroxy-tamoxifen-inducible transgene caused epidermal 
thickening and inflammation, via dermal accumulation of T lymphocytes (Ambler and 
Watt, 2010), continuous Notch activity before and after wounding was not helpful to 
wound closure rate. 
Non-healing chronic wounds (Ulcers) or hyperthropic scars are the most established 
wound-healing disorders in the clinic. The most common clinical entities in 
association with chronic wounds are diabetes mellitus, venous insufficiency, pressure 
necrosis and vacuities (Eming et al., 2007). The prolongation of the inflammatory 
phase throughout the healing process has been described as one of the most 
significant causes of the non-healing wounds (Agren et al., 2000, Eming et al., 2007). 
Remaining in a chronic inflammatory state generates a cascade of tissue responses 
that amplify the hostile microenvironment within the wound. Immune suppression is 
the only reported effective treatment for most systemic and metabolic defects 
affecting the individual’s inflammatory reaction and wound healing (Eming et al., 
2007). 
Presented data in this thesis showed that inflammatory phase elongation caused by the 
over-activation of Notch signalling, may contribute to impaired repair mechanisms of 
the K14NICDER mouse model. This result may have been accomplished by 
interference with the repair mechanisms increasing the inflammatory response (Figure 
6.1).  
 
 200 
 
 
 
 
Figure 6.1. Model of molecular and cellular mechanisms in response to prolonged epidermal 
Notch activity.  
Modified from (Eming et al., 2007).Wounds with epidermal over-activated Notch fail 
to progress through the normal pattern of wound repair, but instead remain in a state 
of chronic inflammation predominantly characterised by abundant inflammatory cells 
infiltration. Persistant Notch activation and inflammatory cells play a major role in the 
generation of proinflammatory cytokines (TNF-α, IL- 22 and IL23) and increased 
expression of MMPs (MMP- 1) that leads to degradation of structural proteins of the 
extracellular matrix crucial for repair (Eming et al., 2007) .  
 
 
Indeed, there is convincing evidence that unbalanced protease activity is one of the 
major underlying mechanisms of non-healing wounds (Pa- lolathi et al., 1993; Harris 
et al., 1995; Saarialho-Kere, 1998; Barrick et al., 1999). The expression and the 
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activity of various MMP classes, including collagenases (MMP-1, MMP-8), have 
been shown to be highly upregulated in chronic venous stasis ulcers (Saarialho-Kere, 
1998; Norgauer et al., 2002). The data presented in this thesis demonstrated the 
expression and the activity of collagenase (MMP-1) to be highly upregulated in 
response to over-activity of Notch signalling in K14NICDER wounded skin. 
 
In a normal wound healing process, activated keratinocytes at the wound edge, 
fibroblasts, endothelial cells, as well as invading neutrophils and macrophages are 
considered as potent inducers of MMP expression. In chronic wounds 
proinflammatory cytokines have been shown to down regulate the expression of tissue 
inhibitor of metalloproteinases, thus creating an environment with a relative excess of 
MMP activity. The release of pro-inflammatory signals from the blood clot and the 
local damaged tissue results in the infiltration of inflammatory cells to the wound site 
in normal healing. Pro-inflammatory signals together with signals from invading 
inflammatory cells, control the vital re-epithelialisation and connective tissue 
contraction of the wound (Desmouliere et al., 2005, Hunt et al., 2000). Indeed it was 
recently reported that Notch signalling is involved in infiltration of inflammatory cells 
into the damaged tissue and plays a key role in the inflammatory cell responses during 
the wound healing (Arumugam et al., 2006, Chigurupati et al., 2007). The 
significance of Notch signalling in the recruitment and activation of leukocytes to the 
site of injury in mice was reported previously (Arumugam et al., 2006).This 
investigation has demonstrated that over-activation of Notch signalling resulted in 
activation of transcription factors that control the expression of proinflammatory 
cytokines (IL-22, -23, and TNF-α), chemokines and proteolytic enzymes, including 
MMP-1. Elevated levels of various serine proteinases, the expression and the activity 
of various MMP classes, including collagenases (MMP-1, MMP-8) and the activation 
of transcription factors that control the expression of proinflammatory cytokines (IL-
1, -6, and TNF-α) and chemokines (Wenk et al., 2001) are all defined within the 
chronic wound microenvironment, and act to amplify the persistent inflammatory 
state of non-healing wounds (Grinnell et al., 1992; Grinnell and Zhu, 1996; Barrick et 
al., 1999). 
Based on these observations, the similarity between the consequences of over-
activation of Notch and exacerbation of chronic wound conditions has been indicated. 
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In addition, it is a well-accepted concept that successful therapy toward healing of the 
chronic wound must disturb the proinflammatory cycle. Blocking Notch pathway in 
tissue repair might be an important avenue to develop protective strategies, which 
shield the regenerative tissue from damage caused by the chronically inflamed 
microenvironment of the non-healing wound. The excessive and unbalanced 
inflammation characterising the chronic wounds and wounds with over-activated 
Notch suggests a promising target for future therapeutic interventions. 
 
In summary, various clinical and experimental studies confirm the critical role of 
inflammation during repair. The balance between a complex network of several 
leukocyte cell subsets and numerous pro- and anti- inflammatory mediators is an 
essential factor to accomplish appropriate tissue homeostasis during healing.  
Over-activation of Notch results in deregulation of critical parameter inflammatory 
mediators that impair the quality of healing in mouse skin wounding. The potential 
implications of Notch activity in skin wound healing inflammatory response are wide, 
from macrophage activation and recruitment, pro-inflammatory cytokine expression, 
epidermal proliferation and migration and ECM deposition. Nevertheless, precise 
understanding of Notch’s contribution in inflammation is still poorly characterised. 
Moreover, before the findings outlined in this study can be applied to development of 
possible therapies, further elucidation of the players, the functions and the regulatory 
events involved in the specificity and control of the Notch pathway in skin wound 
healing and inflammatory response. 
 
 
6.1 Further Research 
In order to continue this investigation, there are two key points that require further 
key focus. Firstly, investigation into the effects of over activation of Notch signaling 
on further time points during healing process of K14NICDER wounded skin.  
Following the observation that the effects of prolonged Notch activity differ between 
K14NICDER mice before wounding as well as during the healing process to those 
treated only before wounding, similar investigations with K14NICDER mice, Notch 
activity from early inflammatory stage up to day seven post wounding would be of 
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significant interest.it would also be of interest to investigate the rate of the wound 
closure in mice treated with 4OHT for three weeks after wounding. 
 
Secondly it is key to investigate the consequences of blocking of Notch signalling by 
using experimental mouse models. This would be particularly useful to answer the 
regulation of wound closure and Notch activity and inhibition. Diabetic foot ulcers 
represent one of the most feared and invalidating complications of diabetes with high 
financial pressure for the healthcare system.  For the moment there is no specific 
therapy available and it has become a priority to develop novel rational therapeutic 
strategies based on new pathophysiological mechanisms. Further work would be 
interesting to test the hypothesis that Notch signalling plays a role in the pathogenesis 
of diabetic foot ulcer and to determine whether pharmacological inhibition of Notch 
signalling with γ-secretase inhibitors can ameliorate the wound healing process in a 
diabetic animal model. 
In addition, data presented in chapter 5 of this thesis, has demonstrated that wound 
healing in mouse back skin is highly dependent on the anatomical site of the lesion. 
This investigation examined the reason of different rate of healing on wounds located 
at different anatomical regions of the mouse body. Data presented in this chapter 
showed that lower body wounds healed significantly better than those in the upper 
posterior, or middle to posterior of the mouse back skin wounding model. These 
presented data; might be explained by the existence of an anterior-posterior gradient 
of protease inhibitors, or a faster wound contraction, and collagen deposition in the 
wounds located in the lower body regions. However, the regional disruption of wound 
healing factors in the mouse skin remains the subject of future investigation. Previous 
studies presented that exercise activity has been shown to have a positive effect on 
wound healing. It has been reported that a relatively short-term exercise intervention 
is associated with enhanced rates of wound healing among healthy older adults. Thus, 
more activity and movement of the lower body region in mice may be an important 
component to promote wound healing (Keylock et al., 2008). Previous research 
confirmed that health factors appear to have an effect on both immune function and 
wound healing. Among the most commonly studied health criteria (e.g., smoking, 
diet, exercise), physical exercise is especially relevant because of its influence on 
multiple components of the wound-healing system, including associations with 
immune and endocrine function (Keylock et al., 2008). Thus, it would be interesting 
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to evaluate the influence of lower body activity, tail stretch and movement, and 
whether they influence wound closure in mice. 
 
Hair follicles undergo continuous cycles of growth and regression throughout life, and 
thus contain huge regenerative potential. Over recent years it has become evident that 
hair follicles play a major role in skin wound healing. For example, it has been shown 
that hair follicle growth stage has a profound effect on healing. Recent studies have 
shown that progenitor cells residing in hair follicles (HFs) are able to contribute to 
this re-epithelialization of wounds in vivo (Ansell et al., 2011). A significant 
acceleration of healing during the anagen phase of HF cycling in vivo, associated with 
alterations in epithelial, endothelial, and inflammatory cell types has been reported 
(Ansell et al., 2011).  
 
Hair follicles during most of anagen appear grey or black, while hair follicles in 
telogen have no pigment and the skin becomes pink. Patchy regions (domains) of 
black and pink are revealed, corresponding to areas of hair growth and quiescence. 
These domains are seen on both the dorsal and ventral sides of the body. They appear 
because pelage hair follicle populations in the mouse do not cycle independently, but 
rather show coordinated hair cycle stages within the same domain and discordant 
stages among adjacent domains. Interestingly, these domains develop into complex 
patterns from cycle to cycle as age progresses (Plikus and Chuong, 2008). Although, 
the hair growth cycle was considered during this project and mice that were chosen 
for wounding experiments were all in their telegen phase, many questions remain 
unanswered: What are the signals that allow hair follicle cells to contribute to 
healing? Is it possible to control the contribution of hair follicles to healing?   Does 
differed anatomical location has different hair growth stages? Do the different hair 
growth stages affect the rate of the healing at different anatomical locations?  As 
previously stated, to aid in understanding of differed anatomical wound closure and 
the distribution of hair follicles at different location, it would be advantageous to 
investigate longitudinal sections of a single skin strip to facilitate more precise 
molecular profiling of hair cycle stages at different locations. Finally, it will also help 
the development of new models to fully determine the relationship between the hair 
pattern formation in living mammals and regional wound closure. A comprehensive 
analysis using varied techniques including molecular and cellular analysis, surgery 
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and histological phenotyping of wounds, could be combined with the gene expression 
profiling of hair cycle and wound healing at different anatomical locations. The aim 
would be the identification and manipulation of signals involved in the hair cycle 
contribution to wound repair and location, lineage tracing of hair follicle cells during 
healing, and understanding of the hair follicle contribution to pathological wound 
repair at different anatomical locations. 
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